<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2020v4.2">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2022-02-09T08:58:44-06:00</ReturnTs>
    <TaxPeriodEndDt>2021-03-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>271728945</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PKF O'CONNOR DAVIES LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>500 MAMARONECK AVENUE</AddressLine1Txt>
        <CityNm>HARRISON</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>105281633</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2020-04-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>137184401</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE LEONA M AND HARRY B HELMSLEY</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>CHARITABLE TRUST</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>LEON</BusinessNameControlTxt>
      <PhoneNum>2126793600</PhoneNum>
      <USAddress>
        <AddressLine1Txt>230 PARK AVENUE NO 659</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10169</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>NICHOLAS J SCHIAVO</PersonNm>
      <PersonTitleTxt>CFO</PersonTitleTxt>
      <PhoneNum>2126793600</PhoneNum>
      <SignatureDt>2022-02-09</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>NICHOLAS</PersonFirstNm>
        <PersonLastNm>SCHIAVO</PersonLastNm>
      </PersonFullName>
      <SSN>XXX-XX-XXXX</SSN>
    </SigningOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>THOMAS BLANEY</PreparerPersonNm>
      <PTIN>P00234022</PTIN>
      <PhoneNum>9143818900</PhoneNum>
      <PreparationDt>2022-02-09</PreparationDt>
    </PreparerPersonGrp>
    <AdditionalFilerInformation>
      <TrustedCustomerGrp>
        <TrustedCustomerCd>3</TrustedCustomerCd>
        <AuthenticationAssuranceLevelCd>AAL1</AuthenticationAssuranceLevelCd>
        <IdentityAssuranceLevelCd>IAL1</IdentityAssuranceLevelCd>
      </TrustedCustomerGrp>
    </AdditionalFilerInformation>
    <TaxYr>2020</TaxYr>
    <BuildTS>2022-09-23 18:48:47Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="19">
    <IRS990PF documentId="RetDoc1235000001" referenceDocumentId="RetDoc2258700001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>8313587896</FMVAssetsEOYAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AnalysisOfRevenueAndExpenses>
        <ScheduleBNotRequiredInd>X</ScheduleBNotRequiredInd>
        <InterestOnSavRevAndExpnssAmt>28719</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>28719</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>37385955</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>97017480</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>659637776</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>2071987213</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>601574917</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="RetDoc2001500001">26128856</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>49566269</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>723181306</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>748187385</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>3613914</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>1567151</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>2023684</CompOfcrDirTrstDsbrsChrtblAmt>
        <OthEmplSlrsWgsRevAndExpnssAmt>14383810</OthEmplSlrsWgsRevAndExpnssAmt>
        <OthEmplSlrsWgsNetInvstIncmAmt>4775290</OthEmplSlrsWgsNetInvstIncmAmt>
        <OthEmplSlrsWgsDsbrsChrtblAmt>9641533</OthEmplSlrsWgsDsbrsChrtblAmt>
        <PensionEmplBnftRevAndExpnssAmt>6895039</PensionEmplBnftRevAndExpnssAmt>
        <PensionEmplBnftNetInvstIncmAmt>1685774</PensionEmplBnftNetInvstIncmAmt>
        <PensionEmplBnftDsbrsChrtblAmt>5153874</PensionEmplBnftDsbrsChrtblAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002100001">262850</LegalFeesRevAndExpnssAmt>
        <LegalFeesNetInvstIncmAmt>133581</LegalFeesNetInvstIncmAmt>
        <LegalFeesDsbrsChrtblAmt>161894</LegalFeesDsbrsChrtblAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002200001">619577</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesNetInvstIncmAmt>266068</AccountingFeesNetInvstIncmAmt>
        <AccountingFeesChrtblPrpsAmt>266276</AccountingFeesChrtblPrpsAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002300001">10909386</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>8522418</OtherProfFeesNetInvstIncmAmt>
        <OtherProfFeesDsbrsChrtblAmt>2241433</OtherProfFeesDsbrsChrtblAmt>
        <InterestRevAndExpnssAmt>212495</InterestRevAndExpnssAmt>
        <InterestNetInvstIncmAmt>1803848</InterestNetInvstIncmAmt>
        <InterestDsbrsChrtblAmt>0</InterestDsbrsChrtblAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc2002500001">754916</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>1892038</TaxesNetInvstIncmAmt>
        <TaxesDsbrsChrtblAmt>0</TaxesDsbrsChrtblAmt>
        <DeprecAndDpltnRevAndExpnssAmt>164637</DeprecAndDpltnRevAndExpnssAmt>
        <DeprecAndDpltnNetInvstIncmAmt>30238</DeprecAndDpltnNetInvstIncmAmt>
        <OccupancyRevAndExpnssAmt>1201887</OccupancyRevAndExpnssAmt>
        <OccupancyNetInvstIncmAmt>102934</OccupancyNetInvstIncmAmt>
        <OccupancyDsbrsChrtblAmt>1138697</OccupancyDsbrsChrtblAmt>
        <TravConfMeetingRevAndExpnssAmt>138760</TravConfMeetingRevAndExpnssAmt>
        <TravConfMeetingNetInvstIncmAmt>0</TravConfMeetingNetInvstIncmAmt>
        <TravConfMeetingDsbrsChrtblAmt>125928</TravConfMeetingDsbrsChrtblAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc2003200001">16774852</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>45572654</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>1654174</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>55932123</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>66351994</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>22407493</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>312349253</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>262300602</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>368281376</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>66351994</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>284708095</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>354899930</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>681835391</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>10602008</CashBOYAmt>
        <CashEOYAmt>32275203</CashEOYAmt>
        <CashEOYFMVAmt>32275203</CashEOYFMVAmt>
        <SavAndTempCashInvstBOYAmt>77680854</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>62457618</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>62457618</SavAndTempCashInvstEOYFMVAmt>
        <PrepaidExpensesBOYAmt>979159</PrepaidExpensesBOYAmt>
        <PrepaidExpensesEOYAmt>1132903</PrepaidExpensesEOYAmt>
        <PrepaidExpensesEOYFMVAmt>1132903</PrepaidExpensesEOYFMVAmt>
        <CorporateStockBOYAmt>524476973</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="RetDoc2018900001">736377294</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>736377294</CorporateStockEOYFMVAmt>
        <OtherInvestmentsBOYAmt>5217346465</OtherInvestmentsBOYAmt>
        <OtherInvestmentsEOYAmt referenceDocumentId="RetDoc2018100001">7438326657</OtherInvestmentsEOYAmt>
        <OtherInvestmentsEOYFMVAmt>7438326657</OtherInvestmentsEOYFMVAmt>
        <LandBldgEquipCostOrOtherBssAmt>4682311</LandBldgEquipCostOrOtherBssAmt>
        <LandBldgEquipAccumDeprecAmt>1925369</LandBldgEquipAccumDeprecAmt>
        <LandBOYAmt>1025578</LandBOYAmt>
        <LandEOYAmt referenceDocumentId="RetDoc2059000001">2756942</LandEOYAmt>
        <LandEOYFMVAmt>2756942</LandEOYFMVAmt>
        <OtherAssetsBOYAmt referenceDocumentId="RetDoc2046600001">79660360</OtherAssetsBOYAmt>
        <OtherAssetsEOYAmt referenceDocumentId="RetDoc2046600001">40261279</OtherAssetsEOYAmt>
        <OtherAssetsEOYFMVAmt referenceDocumentId="RetDoc2046600001">40261279</OtherAssetsEOYFMVAmt>
        <TotalAssetsBOYAmt>5911771397</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>8313587896</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>8313587896</TotalAssetsEOYFMVAmt>
        <AccountsPayableBOYAmt>5889356</AccountsPayableBOYAmt>
        <AccountsPayableEOYAmt>11454781</AccountsPayableEOYAmt>
        <GrantsPayableBOYAmt>335690225</GrantsPayableBOYAmt>
        <GrantsPayableEOYAmt>385738876</GrantsPayableEOYAmt>
        <OtherLiabilitiesBOYAmt referenceDocumentId="RetDoc2065700001">26766352</OtherLiabilitiesBOYAmt>
        <OtherLiabilitiesEOYAmt referenceDocumentId="RetDoc2065700001">48968356</OtherLiabilitiesEOYAmt>
        <TotalLiabilitiesBOYAmt>368345933</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>446162013</TotalLiabilitiesEOYAmt>
        <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
        <NoDonorRstrNetAssestsBOYAmt>5543425464</NoDonorRstrNetAssestsBOYAmt>
        <NoDonorRstrNetAssestsEOYAmt>7867425883</NoDonorRstrNetAssestsEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>5543425464</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>7867425883</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>5911771397</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>8313587896</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>5543425464</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>354899930</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt referenceDocumentId="RetDoc2049700001">1989603066</OtherIncreasesAmt>
        <SubtotalAmt>7887928460</SubtotalAmt>
        <OtherDecreasesAmt referenceDocumentId="RetDoc2049800001">20502577</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>7867425883</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SALE OF PUBLICLY TRADED SECURITIES</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GrossSalesPriceAmt>1235142034</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>832013562</CostOrOtherBasisAmt>
          <GainOrLossAmt>403128472</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>403128472</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EPIRIS II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-23</SoldDt>
          <GrossSalesPriceAmt>255481</GrossSalesPriceAmt>
          <GainOrLossAmt>255481</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>255481</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>YORK EUROPEAN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-07</SoldDt>
          <GrossSalesPriceAmt>1339367</GrossSalesPriceAmt>
          <GainOrLossAmt>1339367</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1339367</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>YORK EUROPEAN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-26</SoldDt>
          <GrossSalesPriceAmt>142596</GrossSalesPriceAmt>
          <GainOrLossAmt>142596</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>142596</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JERICHO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>10000000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4717074</CostOrOtherBasisAmt>
          <GainOrLossAmt>5282926</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>5282926</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JERICHO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>20000000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>9642075</CostOrOtherBasisAmt>
          <GainOrLossAmt>10357925</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>10357925</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CAP GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-16</SoldDt>
          <GrossSalesPriceAmt>5195105</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1576049</CostOrOtherBasisAmt>
          <GainOrLossAmt>3619056</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3619056</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CAP GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-16</SoldDt>
          <GrossSalesPriceAmt>19804895</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6008248</CostOrOtherBasisAmt>
          <GainOrLossAmt>13796647</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>13796647</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CAP GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-21</SoldDt>
          <GrossSalesPriceAmt>15000000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3581091</CostOrOtherBasisAmt>
          <GainOrLossAmt>11418909</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>11418909</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-28</SoldDt>
          <GrossSalesPriceAmt>104106</GrossSalesPriceAmt>
          <GainOrLossAmt>104106</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>104106</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>106901</GrossSalesPriceAmt>
          <GainOrLossAmt>106901</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>106901</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-31</SoldDt>
          <GrossSalesPriceAmt>101939</GrossSalesPriceAmt>
          <GainOrLossAmt>101939</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>101939</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>103950</GrossSalesPriceAmt>
          <GainOrLossAmt>103950</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>103950</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-30</SoldDt>
          <GrossSalesPriceAmt>98381</GrossSalesPriceAmt>
          <GainOrLossAmt>98381</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>98381</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-31</SoldDt>
          <GrossSalesPriceAmt>85123</GrossSalesPriceAmt>
          <GainOrLossAmt>85123</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>85123</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-30</SoldDt>
          <GrossSalesPriceAmt>88054</GrossSalesPriceAmt>
          <GainOrLossAmt>88054</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>88054</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-31</SoldDt>
          <GrossSalesPriceAmt>89739</GrossSalesPriceAmt>
          <GainOrLossAmt>89739</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>89739</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-31</SoldDt>
          <GrossSalesPriceAmt>83612</GrossSalesPriceAmt>
          <GainOrLossAmt>83612</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>83612</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-30</SoldDt>
          <GrossSalesPriceAmt>83364</GrossSalesPriceAmt>
          <GainOrLossAmt>83364</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>83364</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-31</SoldDt>
          <GrossSalesPriceAmt>82479</GrossSalesPriceAmt>
          <GainOrLossAmt>82479</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>82479</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SMID</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <GrossSalesPriceAmt>78549</GrossSalesPriceAmt>
          <GainOrLossAmt>78549</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>78549</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-31</SoldDt>
          <GrossSalesPriceAmt>152717</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>152724</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>197655</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>694241</CostOrOtherBasisAmt>
          <GainOrLossAmt>-496586</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-496586</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-30</SoldDt>
          <GrossSalesPriceAmt>117231</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>117236</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-31</SoldDt>
          <GrossSalesPriceAmt>107681</GrossSalesPriceAmt>
          <GainOrLossAmt>107681</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>107681</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <GrossSalesPriceAmt>102950</GrossSalesPriceAmt>
          <GainOrLossAmt>102950</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>102950</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-30</SoldDt>
          <GrossSalesPriceAmt>163093</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>163100</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-31</SoldDt>
          <GrossSalesPriceAmt>159431</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>159438</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-30</SoldDt>
          <GrossSalesPriceAmt>178493</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>587027</CostOrOtherBasisAmt>
          <GainOrLossAmt>-408534</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-408534</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>190510</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>626548</CostOrOtherBasisAmt>
          <GainOrLossAmt>-436038</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-436038</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-31</SoldDt>
          <GrossSalesPriceAmt>189954</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>624720</CostOrOtherBasisAmt>
          <GainOrLossAmt>-434766</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-434766</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-28</SoldDt>
          <GrossSalesPriceAmt>192461</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1838618</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1646157</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1646157</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIGHCLERE INTL SC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-31</SoldDt>
          <GrossSalesPriceAmt>143290</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>143296</CostOrOtherBasisAmt>
          <GainOrLossAmt>-6</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-6</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACADIAN FRONTIER</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2019-07-01</SoldDt>
          <GrossSalesPriceAmt>66630</GrossSalesPriceAmt>
          <GainOrLossAmt>66630</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>66630</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACADIAN FRONTIER</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2019-07-01</SoldDt>
          <GrossSalesPriceAmt>443545</GrossSalesPriceAmt>
          <GainOrLossAmt>443545</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>443545</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACADIAN FRONTIER</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2019-07-01</SoldDt>
          <GrossSalesPriceAmt>63875</GrossSalesPriceAmt>
          <GainOrLossAmt>63875</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>63875</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACADIAN FRONTIER</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2019-07-01</SoldDt>
          <CostOrOtherBasisAmt>574050</CostOrOtherBasisAmt>
          <GainOrLossAmt>-574050</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-574050</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BLACKROCK US DEBT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-28</SoldDt>
          <GrossSalesPriceAmt>20506</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>19516</CostOrOtherBasisAmt>
          <GainOrLossAmt>990</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>990</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BLACKROCK US DEBT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-02</SoldDt>
          <GrossSalesPriceAmt>20000000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>18986274</CostOrOtherBasisAmt>
          <GainOrLossAmt>1013726</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1013726</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BLACKROCK US DEBT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-11</SoldDt>
          <GrossSalesPriceAmt>19627</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>19130</CostOrOtherBasisAmt>
          <GainOrLossAmt>497</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>497</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BLACKROCK US DEBT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-28</SoldDt>
          <GrossSalesPriceAmt>20034</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>18926</CostOrOtherBasisAmt>
          <GainOrLossAmt>1108</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1108</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BLACKROCK US DEBT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-26</SoldDt>
          <GrossSalesPriceAmt>19994</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>18978</CostOrOtherBasisAmt>
          <GainOrLossAmt>1016</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1016</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CHATHAM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>5000000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3476537</CostOrOtherBasisAmt>
          <GainOrLossAmt>1523463</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1523463</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CHATHAM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-30</SoldDt>
          <GrossSalesPriceAmt>7500000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5600990</CostOrOtherBasisAmt>
          <GainOrLossAmt>1899010</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1899010</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CHATHAM OFFSHORE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-30</SoldDt>
          <GrossSalesPriceAmt>7500000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5633927</CostOrOtherBasisAmt>
          <GainOrLossAmt>1866073</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1866073</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CHATHAM OFFSHORE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>5000000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3497839</CostOrOtherBasisAmt>
          <GainOrLossAmt>1502161</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1502161</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDENTREE OFFSHORE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>483659</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>966450</CostOrOtherBasisAmt>
          <GainOrLossAmt>-482791</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-482791</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-31</SoldDt>
          <GrossSalesPriceAmt>21576</GrossSalesPriceAmt>
          <GainOrLossAmt>21576</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>21576</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-30</SoldDt>
          <GrossSalesPriceAmt>21139</GrossSalesPriceAmt>
          <GainOrLossAmt>21139</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>21139</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-31</SoldDt>
          <GrossSalesPriceAmt>20761</GrossSalesPriceAmt>
          <GainOrLossAmt>20761</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>20761</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-30</SoldDt>
          <GrossSalesPriceAmt>22730</GrossSalesPriceAmt>
          <GainOrLossAmt>22730</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>22730</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>23672</GrossSalesPriceAmt>
          <GainOrLossAmt>23672</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>23672</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-31</SoldDt>
          <GrossSalesPriceAmt>23403</GrossSalesPriceAmt>
          <GainOrLossAmt>23403</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>23403</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-28</SoldDt>
          <GrossSalesPriceAmt>23764</GrossSalesPriceAmt>
          <GainOrLossAmt>23764</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>23764</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-01</SoldDt>
          <GrossSalesPriceAmt>25000000</GrossSalesPriceAmt>
          <GainOrLossAmt>25000000</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>25000000</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-31</SoldDt>
          <GrossSalesPriceAmt>20654</GrossSalesPriceAmt>
          <GainOrLossAmt>20654</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>20654</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-01</SoldDt>
          <GrossSalesPriceAmt>30000000</GrossSalesPriceAmt>
          <GainOrLossAmt>30000000</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>30000000</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-30</SoldDt>
          <GrossSalesPriceAmt>24459</GrossSalesPriceAmt>
          <GainOrLossAmt>24459</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>24459</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <GrossSalesPriceAmt>22941</GrossSalesPriceAmt>
          <GainOrLossAmt>22941</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>22941</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>24466</GrossSalesPriceAmt>
          <GainOrLossAmt>24466</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>24466</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LA CAPITAL GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-31</SoldDt>
          <GrossSalesPriceAmt>24039</GrossSalesPriceAmt>
          <GainOrLossAmt>24039</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>24039</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <GrossSalesPriceAmt>86529</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>94744</CostOrOtherBasisAmt>
          <GainOrLossAmt>-8215</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-8215</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-30</SoldDt>
          <GrossSalesPriceAmt>89236</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>93481</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4245</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4245</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-31</SoldDt>
          <GrossSalesPriceAmt>93680</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>91681</CostOrOtherBasisAmt>
          <GainOrLossAmt>1999</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1999</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-30</SoldDt>
          <GrossSalesPriceAmt>92349</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>92112</CostOrOtherBasisAmt>
          <GainOrLossAmt>237</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>237</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-30</SoldDt>
          <GrossSalesPriceAmt>90659</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>92701</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2042</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2042</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-30</SoldDt>
          <GrossSalesPriceAmt>97839</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>90129</CostOrOtherBasisAmt>
          <GainOrLossAmt>7710</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>7710</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>101424</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>88999</CostOrOtherBasisAmt>
          <GainOrLossAmt>12425</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>12425</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-29</SoldDt>
          <GrossSalesPriceAmt>99373</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>89554</CostOrOtherBasisAmt>
          <GainOrLossAmt>9819</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>9819</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-26</SoldDt>
          <GrossSalesPriceAmt>101226</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>88957</CostOrOtherBasisAmt>
          <GainOrLossAmt>12269</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>12269</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>105470</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>87750</CostOrOtherBasisAmt>
          <GainOrLossAmt>17720</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>17720</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-29</SoldDt>
          <GrossSalesPriceAmt>88467</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>93853</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5386</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5386</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MARATHON GLOBAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-31</SoldDt>
          <GrossSalesPriceAmt>90995</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>92729</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1734</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1734</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LACM WORLD SMALL CAP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-29</SoldDt>
          <GrossSalesPriceAmt>23754</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>613806</CostOrOtherBasisAmt>
          <GainOrLossAmt>-590052</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-590052</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LACM WORLD SMALL CAP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-26</SoldDt>
          <GrossSalesPriceAmt>25083</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>648137</CostOrOtherBasisAmt>
          <GainOrLossAmt>-623054</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-623054</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LACM WORLD SMALL CAP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>25789</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>666390</CostOrOtherBasisAmt>
          <GainOrLossAmt>-640601</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-640601</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDARY</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-04</SoldDt>
          <GrossSalesPriceAmt>96904</GrossSalesPriceAmt>
          <GainOrLossAmt>96904</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>96904</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDARY</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-22</SoldDt>
          <GrossSalesPriceAmt>217804</GrossSalesPriceAmt>
          <GainOrLossAmt>217804</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>217804</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ORBIMED ROYALTY II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-24</SoldDt>
          <GrossSalesPriceAmt>72525</GrossSalesPriceAmt>
          <GainOrLossAmt>72525</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>72525</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ORBIMED ROYALTY II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-21</SoldDt>
          <GrossSalesPriceAmt>394109</GrossSalesPriceAmt>
          <GainOrLossAmt>394109</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>394109</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ORBIMED ROYALTY II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-07</SoldDt>
          <GrossSalesPriceAmt>93020</GrossSalesPriceAmt>
          <GainOrLossAmt>93020</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>93020</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARBORETUM IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-18</SoldDt>
          <GrossSalesPriceAmt>1712268</GrossSalesPriceAmt>
          <GainOrLossAmt>1712268</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1712268</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ORBIMED PI VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-17</SoldDt>
          <GrossSalesPriceAmt>2110493</GrossSalesPriceAmt>
          <GainOrLossAmt>2110493</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2110493</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ORBIMED PI VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-12</SoldDt>
          <GrossSalesPriceAmt>3610463</GrossSalesPriceAmt>
          <GainOrLossAmt>3610463</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3610463</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ORBIMED PI VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-15</SoldDt>
          <GrossSalesPriceAmt>1311700</GrossSalesPriceAmt>
          <GainOrLossAmt>1311700</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1311700</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ORBIMED ISRAEL II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>2376283</GrossSalesPriceAmt>
          <GainOrLossAmt>2376283</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2376283</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA INDIA V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-10</SoldDt>
          <GrossSalesPriceAmt>128000</GrossSalesPriceAmt>
          <GainOrLossAmt>128000</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>128000</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA INDIA V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>56938</GrossSalesPriceAmt>
          <GainOrLossAmt>56938</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>56938</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GRWTH VII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-23</SoldDt>
          <GrossSalesPriceAmt>76370</GrossSalesPriceAmt>
          <GainOrLossAmt>76370</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>76370</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ANGELENO INV III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-14</SoldDt>
          <GrossSalesPriceAmt>285753</GrossSalesPriceAmt>
          <GainOrLossAmt>285753</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>285753</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EIG ENERGY XV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-20</SoldDt>
          <GrossSalesPriceAmt>189380</GrossSalesPriceAmt>
          <GainOrLossAmt>189380</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>189380</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARBORETUM III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-29</SoldDt>
          <GrossSalesPriceAmt>5816252</GrossSalesPriceAmt>
          <GainOrLossAmt>5816252</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>5816252</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG BIOVENTURE II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-28</SoldDt>
          <GrossSalesPriceAmt>2994995</GrossSalesPriceAmt>
          <GainOrLossAmt>2994995</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2994995</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IDG-ACCEL CHINA GWTH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-11</SoldDt>
          <GrossSalesPriceAmt>1520903</GrossSalesPriceAmt>
          <GainOrLossAmt>1520903</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1520903</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IDG-ACCEL CHINA GWTH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-31</SoldDt>
          <GrossSalesPriceAmt>1189120</GrossSalesPriceAmt>
          <GainOrLossAmt>1189120</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1189120</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IDG-ACCEL CHINA GWTH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-29</SoldDt>
          <GrossSalesPriceAmt>1293192</GrossSalesPriceAmt>
          <GainOrLossAmt>1293192</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1293192</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IDG-ACCEL CHINA GWTH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-30</SoldDt>
          <GrossSalesPriceAmt>187857</GrossSalesPriceAmt>
          <GainOrLossAmt>187857</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>187857</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IDG-ACCEL CHINA CAP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-27</SoldDt>
          <GrossSalesPriceAmt>576183</GrossSalesPriceAmt>
          <GainOrLossAmt>576183</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>576183</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IDG-ACCEL CHINA CAP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-30</SoldDt>
          <GrossSalesPriceAmt>1149011</GrossSalesPriceAmt>
          <GainOrLossAmt>1149011</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1149011</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG GROWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-22</SoldDt>
          <GrossSalesPriceAmt>1729166</GrossSalesPriceAmt>
          <GainOrLossAmt>1729166</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1729166</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>COLLER VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-08</SoldDt>
          <GrossSalesPriceAmt>382965</GrossSalesPriceAmt>
          <GainOrLossAmt>382965</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>382965</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>COLLER VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-26</SoldDt>
          <GrossSalesPriceAmt>720466</GrossSalesPriceAmt>
          <GainOrLossAmt>720466</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>720466</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>COLLER VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-02</SoldDt>
          <GrossSalesPriceAmt>282252</GrossSalesPriceAmt>
          <GainOrLossAmt>282252</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>282252</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>COLLER VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-10</SoldDt>
          <GrossSalesPriceAmt>559234</GrossSalesPriceAmt>
          <GainOrLossAmt>559234</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>559234</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>COLLER VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-02</SoldDt>
          <GrossSalesPriceAmt>450320</GrossSalesPriceAmt>
          <GainOrLossAmt>450320</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>450320</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-23</SoldDt>
          <GrossSalesPriceAmt>4133731</GrossSalesPriceAmt>
          <GainOrLossAmt>4133731</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4133731</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-15</SoldDt>
          <GrossSalesPriceAmt>2467744</GrossSalesPriceAmt>
          <GainOrLossAmt>2467744</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2467744</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-15</SoldDt>
          <GrossSalesPriceAmt>2287411</GrossSalesPriceAmt>
          <GainOrLossAmt>2287411</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2287411</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-16</SoldDt>
          <GrossSalesPriceAmt>5751</GrossSalesPriceAmt>
          <GainOrLossAmt>5751</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>5751</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-16</SoldDt>
          <GrossSalesPriceAmt>301</GrossSalesPriceAmt>
          <GainOrLossAmt>301</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>301</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-16</SoldDt>
          <GrossSalesPriceAmt>56602</GrossSalesPriceAmt>
          <GainOrLossAmt>56602</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>56602</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-16</SoldDt>
          <GrossSalesPriceAmt>103714</GrossSalesPriceAmt>
          <GainOrLossAmt>103714</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>103714</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <GrossSalesPriceAmt>36832</GrossSalesPriceAmt>
          <GainOrLossAmt>36832</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>36832</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDEN GATE OPPS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-23</SoldDt>
          <GrossSalesPriceAmt>4354352</GrossSalesPriceAmt>
          <GainOrLossAmt>4354352</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4354352</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GLB GROWTH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-24</SoldDt>
          <GrossSalesPriceAmt>244075</GrossSalesPriceAmt>
          <GainOrLossAmt>244075</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>244075</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US VTR XIV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-26</SoldDt>
          <GrossSalesPriceAmt>214907</GrossSalesPriceAmt>
          <GainOrLossAmt>214907</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>214907</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US VTR XIV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-25</SoldDt>
          <GrossSalesPriceAmt>80282</GrossSalesPriceAmt>
          <GainOrLossAmt>80282</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>80282</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA ISRAEL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-20</SoldDt>
          <GrossSalesPriceAmt>808232</GrossSalesPriceAmt>
          <GainOrLossAmt>808232</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>808232</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GSO CAPITAL SOLS II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-22</SoldDt>
          <GrossSalesPriceAmt>115188</GrossSalesPriceAmt>
          <GainOrLossAmt>115188</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>115188</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GSO CAPITAL SOLS II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-24</SoldDt>
          <GrossSalesPriceAmt>75848</GrossSalesPriceAmt>
          <GainOrLossAmt>75848</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>75848</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG BAYSIDE III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-30</SoldDt>
          <GrossSalesPriceAmt>108176</GrossSalesPriceAmt>
          <GainOrLossAmt>108176</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>108176</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG BAYSIDE III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <CostOrOtherBasisAmt>1205</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1205</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1205</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-25</SoldDt>
          <GrossSalesPriceAmt>1874746</GrossSalesPriceAmt>
          <GainOrLossAmt>1874746</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1874746</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-29</SoldDt>
          <GrossSalesPriceAmt>936165</GrossSalesPriceAmt>
          <GainOrLossAmt>936165</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>936165</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-30</SoldDt>
          <GrossSalesPriceAmt>590244</GrossSalesPriceAmt>
          <GainOrLossAmt>590244</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>590244</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-07</SoldDt>
          <GrossSalesPriceAmt>216951</GrossSalesPriceAmt>
          <GainOrLossAmt>216951</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>216951</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-15</SoldDt>
          <GrossSalesPriceAmt>208215</GrossSalesPriceAmt>
          <GainOrLossAmt>208215</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>208215</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-27</SoldDt>
          <GrossSalesPriceAmt>2475390</GrossSalesPriceAmt>
          <GainOrLossAmt>2475390</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2475390</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-01</SoldDt>
          <GrossSalesPriceAmt>126143</GrossSalesPriceAmt>
          <GainOrLossAmt>126143</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>126143</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-12</SoldDt>
          <GrossSalesPriceAmt>660415</GrossSalesPriceAmt>
          <GainOrLossAmt>660415</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>660415</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-18</SoldDt>
          <GrossSalesPriceAmt>3580790</GrossSalesPriceAmt>
          <GainOrLossAmt>3580790</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3580790</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-08</SoldDt>
          <CostOrOtherBasisAmt>3586</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3586</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3586</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-15</SoldDt>
          <GrossSalesPriceAmt>1240506</GrossSalesPriceAmt>
          <GainOrLossAmt>1240506</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1240506</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-18</SoldDt>
          <GrossSalesPriceAmt>6016</GrossSalesPriceAmt>
          <GainOrLossAmt>6016</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>6016</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-22</SoldDt>
          <GrossSalesPriceAmt>4932</GrossSalesPriceAmt>
          <GainOrLossAmt>4932</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4932</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-03</SoldDt>
          <GrossSalesPriceAmt>4996</GrossSalesPriceAmt>
          <GainOrLossAmt>4996</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4996</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-10</SoldDt>
          <GrossSalesPriceAmt>1084124</GrossSalesPriceAmt>
          <GainOrLossAmt>1084124</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1084124</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-12</SoldDt>
          <GrossSalesPriceAmt>349110</GrossSalesPriceAmt>
          <GainOrLossAmt>349110</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>349110</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-15</SoldDt>
          <GrossSalesPriceAmt>4541716</GrossSalesPriceAmt>
          <GainOrLossAmt>4541716</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4541716</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-23</SoldDt>
          <CostOrOtherBasisAmt>281891</CostOrOtherBasisAmt>
          <GainOrLossAmt>-281891</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-281891</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG CAPITAL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-05</SoldDt>
          <GrossSalesPriceAmt>2816095</GrossSalesPriceAmt>
          <GainOrLossAmt>2816095</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2816095</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG CAPITAL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-22</SoldDt>
          <GrossSalesPriceAmt>898833</GrossSalesPriceAmt>
          <GainOrLossAmt>898833</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>898833</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDARY II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-15</SoldDt>
          <GrossSalesPriceAmt>1222497</GrossSalesPriceAmt>
          <GainOrLossAmt>1222497</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1222497</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDARY II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-23</SoldDt>
          <CostOrOtherBasisAmt>417684</CostOrOtherBasisAmt>
          <GainOrLossAmt>-417684</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-417684</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDARY II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-04</SoldDt>
          <GrossSalesPriceAmt>277951</GrossSalesPriceAmt>
          <GainOrLossAmt>277951</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>277951</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EIG ENERGY FUND XVI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-20</SoldDt>
          <GrossSalesPriceAmt>261467</GrossSalesPriceAmt>
          <GainOrLossAmt>261467</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>261467</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CRESTVIEW III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-22</SoldDt>
          <GrossSalesPriceAmt>87138</GrossSalesPriceAmt>
          <GainOrLossAmt>87138</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>87138</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG MID MARKET II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-11</SoldDt>
          <GrossSalesPriceAmt>6919420</GrossSalesPriceAmt>
          <GainOrLossAmt>6919420</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>6919420</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HIG MID MARKET II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-29</SoldDt>
          <GrossSalesPriceAmt>166071</GrossSalesPriceAmt>
          <GainOrLossAmt>166071</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>166071</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-28</SoldDt>
          <GrossSalesPriceAmt>209577</GrossSalesPriceAmt>
          <GainOrLossAmt>209577</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>209577</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GWTH VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-29</SoldDt>
          <GrossSalesPriceAmt>496690</GrossSalesPriceAmt>
          <GainOrLossAmt>496690</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>496690</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GWTH VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-26</SoldDt>
          <GrossSalesPriceAmt>53819</GrossSalesPriceAmt>
          <GainOrLossAmt>53819</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>53819</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GR III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-07</SoldDt>
          <GrossSalesPriceAmt>132402</GrossSalesPriceAmt>
          <GainOrLossAmt>132402</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>132402</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GR III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-05</SoldDt>
          <GrossSalesPriceAmt>263898</GrossSalesPriceAmt>
          <GainOrLossAmt>263898</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>263898</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GAVEA V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-11</SoldDt>
          <GrossSalesPriceAmt>379015</GrossSalesPriceAmt>
          <GainOrLossAmt>379015</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>379015</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GAVEA V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-25</SoldDt>
          <GrossSalesPriceAmt>447866</GrossSalesPriceAmt>
          <GainOrLossAmt>447866</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>447866</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FRAZIER X</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-22</SoldDt>
          <GrossSalesPriceAmt>301495</GrossSalesPriceAmt>
          <GainOrLossAmt>301495</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>301495</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FRAZIER X</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-01</SoldDt>
          <GrossSalesPriceAmt>144758</GrossSalesPriceAmt>
          <GainOrLossAmt>144758</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>144758</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDRY III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-13</SoldDt>
          <CostOrOtherBasisAmt>726566</CostOrOtherBasisAmt>
          <GainOrLossAmt>-726566</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-726566</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDRY III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-10</SoldDt>
          <GrossSalesPriceAmt>178204</GrossSalesPriceAmt>
          <GainOrLossAmt>178204</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>178204</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JPM PEG SECONDRY III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-12</SoldDt>
          <GrossSalesPriceAmt>655861</GrossSalesPriceAmt>
          <GainOrLossAmt>655861</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>655861</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>YORK DISTRESSED III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-18</SoldDt>
          <GrossSalesPriceAmt>1344381</GrossSalesPriceAmt>
          <GainOrLossAmt>1344381</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1344381</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GSO CAP SOLUTION III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-24</SoldDt>
          <GrossSalesPriceAmt>51938</GrossSalesPriceAmt>
          <GainOrLossAmt>51938</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>51938</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GSO CAP SOLUTION III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-25</SoldDt>
          <GrossSalesPriceAmt>49902</GrossSalesPriceAmt>
          <GainOrLossAmt>49902</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>49902</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GSO CAP SOLUTION III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-12</SoldDt>
          <GrossSalesPriceAmt>85685</GrossSalesPriceAmt>
          <GainOrLossAmt>85685</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>85685</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GSO CAP SOLUTION III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>50530</GrossSalesPriceAmt>
          <GainOrLossAmt>50530</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>50530</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EIG ENERGY XVII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-19</SoldDt>
          <GrossSalesPriceAmt>16607</GrossSalesPriceAmt>
          <GainOrLossAmt>16607</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>16607</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GAVEA V PLUS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-03</SoldDt>
          <GrossSalesPriceAmt>1119858</GrossSalesPriceAmt>
          <GainOrLossAmt>1119858</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1119858</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GAVEA V PLUS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-14</SoldDt>
          <GrossSalesPriceAmt>2737532</GrossSalesPriceAmt>
          <GainOrLossAmt>2737532</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2737532</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-08</SoldDt>
          <CostOrOtherBasisAmt>23186</CostOrOtherBasisAmt>
          <GainOrLossAmt>-23186</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-23186</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-25</SoldDt>
          <GrossSalesPriceAmt>218167</GrossSalesPriceAmt>
          <GainOrLossAmt>218167</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>218167</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-16</SoldDt>
          <GrossSalesPriceAmt>50515</GrossSalesPriceAmt>
          <GainOrLossAmt>50515</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>50515</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-19</SoldDt>
          <GrossSalesPriceAmt>138602</GrossSalesPriceAmt>
          <GainOrLossAmt>138602</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>138602</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IDG CHINA VTR IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-29</SoldDt>
          <GrossSalesPriceAmt>1572191</GrossSalesPriceAmt>
          <GainOrLossAmt>1572191</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1572191</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HARBOUR ENERGY</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>17409877</GrossSalesPriceAmt>
          <GainOrLossAmt>17409877</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>17409877</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GR IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-30</SoldDt>
          <GrossSalesPriceAmt>1743112</GrossSalesPriceAmt>
          <GainOrLossAmt>1743112</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1743112</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GR IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-17</SoldDt>
          <GrossSalesPriceAmt>146281</GrossSalesPriceAmt>
          <GainOrLossAmt>146281</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>146281</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GR IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-20</SoldDt>
          <GrossSalesPriceAmt>71903</GrossSalesPriceAmt>
          <GainOrLossAmt>71903</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>71903</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GRWTH VII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-08</SoldDt>
          <GrossSalesPriceAmt>1645204</GrossSalesPriceAmt>
          <GainOrLossAmt>1645204</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1645204</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GRWTH VII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-15</SoldDt>
          <GrossSalesPriceAmt>13261</GrossSalesPriceAmt>
          <GainOrLossAmt>13261</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>13261</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GRWTH VII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-23</SoldDt>
          <GrossSalesPriceAmt>3027098</GrossSalesPriceAmt>
          <GainOrLossAmt>3027098</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3027098</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GLB GRWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-08</SoldDt>
          <GrossSalesPriceAmt>866190</GrossSalesPriceAmt>
          <GainOrLossAmt>866190</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>866190</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GLB GRWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-20</SoldDt>
          <GrossSalesPriceAmt>279997</GrossSalesPriceAmt>
          <GainOrLossAmt>279997</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>279997</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GLB GRWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-23</SoldDt>
          <GrossSalesPriceAmt>1596721</GrossSalesPriceAmt>
          <GainOrLossAmt>1596721</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1596721</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GLB GRWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-17</SoldDt>
          <GrossSalesPriceAmt>162032</GrossSalesPriceAmt>
          <GainOrLossAmt>162032</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>162032</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GLB GRWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-30</SoldDt>
          <GrossSalesPriceAmt>1215663</GrossSalesPriceAmt>
          <GainOrLossAmt>1215663</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1215663</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL LEADERS FUND</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-13</SoldDt>
          <GrossSalesPriceAmt>1094590</GrossSalesPriceAmt>
          <GainOrLossAmt>1094590</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1094590</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL LEADERS FUND</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-10</SoldDt>
          <GrossSalesPriceAmt>972934</GrossSalesPriceAmt>
          <GainOrLossAmt>972934</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>972934</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL LEADERS FUND</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-06</SoldDt>
          <GrossSalesPriceAmt>1301379</GrossSalesPriceAmt>
          <GainOrLossAmt>1301379</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1301379</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH FUND IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-04</SoldDt>
          <GrossSalesPriceAmt>737511</GrossSalesPriceAmt>
          <GainOrLossAmt>737511</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>737511</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH FUND IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-01</SoldDt>
          <GrossSalesPriceAmt>647340</GrossSalesPriceAmt>
          <GainOrLossAmt>647340</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>647340</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ENERVEST ENGY XII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-03-31</SoldDt>
          <CostOrOtherBasisAmt>18484315</CostOrOtherBasisAmt>
          <GainOrLossAmt>-18484315</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-18484315</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-15</SoldDt>
          <GrossSalesPriceAmt>2074326</GrossSalesPriceAmt>
          <GainOrLossAmt>2074326</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2074326</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-03</SoldDt>
          <GrossSalesPriceAmt>2741901</GrossSalesPriceAmt>
          <GainOrLossAmt>2741901</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2741901</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-09</SoldDt>
          <GrossSalesPriceAmt>757395</GrossSalesPriceAmt>
          <GainOrLossAmt>757395</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>757395</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-03</SoldDt>
          <GrossSalesPriceAmt>1117144</GrossSalesPriceAmt>
          <GainOrLossAmt>1117144</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1117144</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-17</SoldDt>
          <GrossSalesPriceAmt>1447294</GrossSalesPriceAmt>
          <GainOrLossAmt>1447294</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1447294</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-02</SoldDt>
          <GrossSalesPriceAmt>2482617</GrossSalesPriceAmt>
          <GainOrLossAmt>2482617</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2482617</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-05</SoldDt>
          <GrossSalesPriceAmt>2414151</GrossSalesPriceAmt>
          <GainOrLossAmt>2414151</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2414151</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-02</SoldDt>
          <CostOrOtherBasisAmt>635533</CostOrOtherBasisAmt>
          <GainOrLossAmt>-635533</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-635533</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-02</SoldDt>
          <GrossSalesPriceAmt>635533</GrossSalesPriceAmt>
          <GainOrLossAmt>635533</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>635533</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-01</SoldDt>
          <GrossSalesPriceAmt>635533</GrossSalesPriceAmt>
          <GainOrLossAmt>635533</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>635533</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-12</SoldDt>
          <GrossSalesPriceAmt>2093245</GrossSalesPriceAmt>
          <GainOrLossAmt>2093245</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2093245</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-14</SoldDt>
          <GrossSalesPriceAmt>8214</GrossSalesPriceAmt>
          <GainOrLossAmt>8214</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>8214</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-17</SoldDt>
          <GrossSalesPriceAmt>7586</GrossSalesPriceAmt>
          <GainOrLossAmt>7586</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>7586</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-21</SoldDt>
          <GrossSalesPriceAmt>7922</GrossSalesPriceAmt>
          <GainOrLossAmt>7922</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>7922</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-23</SoldDt>
          <GrossSalesPriceAmt>4634</GrossSalesPriceAmt>
          <GainOrLossAmt>4634</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4634</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-08</SoldDt>
          <GrossSalesPriceAmt>13822</GrossSalesPriceAmt>
          <GainOrLossAmt>13822</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>13822</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-23</SoldDt>
          <GrossSalesPriceAmt>26353</GrossSalesPriceAmt>
          <GainOrLossAmt>26353</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>26353</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-13</SoldDt>
          <GrossSalesPriceAmt>8192</GrossSalesPriceAmt>
          <GainOrLossAmt>8192</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>8192</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EMERGENCE III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-16</SoldDt>
          <GrossSalesPriceAmt>101647268</GrossSalesPriceAmt>
          <GainOrLossAmt>101647268</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>101647268</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EMERGENCE III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-20</SoldDt>
          <GrossSalesPriceAmt>157004416</GrossSalesPriceAmt>
          <GainOrLossAmt>157004416</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>157004416</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EMERGENCE III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-20</SoldDt>
          <CostOrOtherBasisAmt>157004416</CostOrOtherBasisAmt>
          <GainOrLossAmt>-157004416</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-157004416</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EMERGENCE III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-22</SoldDt>
          <GrossSalesPriceAmt>157004416</GrossSalesPriceAmt>
          <GainOrLossAmt>157004416</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>157004416</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-10</SoldDt>
          <GrossSalesPriceAmt>1514148</GrossSalesPriceAmt>
          <GainOrLossAmt>1514148</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1514148</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-11</SoldDt>
          <GrossSalesPriceAmt>597404</GrossSalesPriceAmt>
          <GainOrLossAmt>597404</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>597404</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-29</SoldDt>
          <GrossSalesPriceAmt>346809</GrossSalesPriceAmt>
          <GainOrLossAmt>346809</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>346809</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-14</SoldDt>
          <GrossSalesPriceAmt>461935</GrossSalesPriceAmt>
          <GainOrLossAmt>461935</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>461935</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-03</SoldDt>
          <GrossSalesPriceAmt>313358</GrossSalesPriceAmt>
          <GainOrLossAmt>313358</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>313358</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-09</SoldDt>
          <GrossSalesPriceAmt>65870</GrossSalesPriceAmt>
          <GainOrLossAmt>65870</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>65870</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-08</SoldDt>
          <GrossSalesPriceAmt>84508</GrossSalesPriceAmt>
          <GainOrLossAmt>84508</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>84508</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-08</SoldDt>
          <GrossSalesPriceAmt>94111</GrossSalesPriceAmt>
          <GainOrLossAmt>94111</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>94111</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-09</SoldDt>
          <GrossSalesPriceAmt>73349</GrossSalesPriceAmt>
          <GainOrLossAmt>73349</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>73349</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-10</SoldDt>
          <GrossSalesPriceAmt>73349</GrossSalesPriceAmt>
          <GainOrLossAmt>73349</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>73349</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-10</SoldDt>
          <CostOrOtherBasisAmt>73349</CostOrOtherBasisAmt>
          <GainOrLossAmt>-73349</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-73349</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-03</SoldDt>
          <GrossSalesPriceAmt>348955</GrossSalesPriceAmt>
          <GainOrLossAmt>348955</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>348955</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-14</SoldDt>
          <GrossSalesPriceAmt>260771</GrossSalesPriceAmt>
          <GainOrLossAmt>260771</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>260771</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-29</SoldDt>
          <GrossSalesPriceAmt>304311</GrossSalesPriceAmt>
          <GainOrLossAmt>304311</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>304311</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-29</SoldDt>
          <CostOrOtherBasisAmt>304311</CostOrOtherBasisAmt>
          <GainOrLossAmt>-304311</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-304311</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-29</SoldDt>
          <GrossSalesPriceAmt>304311</GrossSalesPriceAmt>
          <GainOrLossAmt>304311</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>304311</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-30</SoldDt>
          <GrossSalesPriceAmt>304311</GrossSalesPriceAmt>
          <GainOrLossAmt>304311</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>304311</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-30</SoldDt>
          <CostOrOtherBasisAmt>304311</CostOrOtherBasisAmt>
          <GainOrLossAmt>-304311</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-304311</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-11</SoldDt>
          <GrossSalesPriceAmt>344048</GrossSalesPriceAmt>
          <GainOrLossAmt>344048</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>344048</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-10</SoldDt>
          <GrossSalesPriceAmt>726935</GrossSalesPriceAmt>
          <GainOrLossAmt>726935</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>726935</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GLB GROWTH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-20</SoldDt>
          <GrossSalesPriceAmt>481681</GrossSalesPriceAmt>
          <GainOrLossAmt>481681</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>481681</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-22</SoldDt>
          <GrossSalesPriceAmt>442522</GrossSalesPriceAmt>
          <GainOrLossAmt>442522</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>442522</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-22</SoldDt>
          <GrossSalesPriceAmt>741161</GrossSalesPriceAmt>
          <GainOrLossAmt>741161</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>741161</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-10</SoldDt>
          <GrossSalesPriceAmt>737158</GrossSalesPriceAmt>
          <GainOrLossAmt>737158</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>737158</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA ISRAEL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-09</SoldDt>
          <GrossSalesPriceAmt>1127129</GrossSalesPriceAmt>
          <GainOrLossAmt>1127129</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1127129</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA ISRAEL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-10</SoldDt>
          <GrossSalesPriceAmt>1112745</GrossSalesPriceAmt>
          <GainOrLossAmt>1112745</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1112745</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA ISRAEL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-05</SoldDt>
          <GrossSalesPriceAmt>1119522</GrossSalesPriceAmt>
          <GainOrLossAmt>1119522</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1119522</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA ISRAEL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-16</SoldDt>
          <GrossSalesPriceAmt>233024</GrossSalesPriceAmt>
          <GainOrLossAmt>233024</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>233024</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA ISRAEL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-24</SoldDt>
          <GrossSalesPriceAmt>487177</GrossSalesPriceAmt>
          <GainOrLossAmt>487177</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>487177</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA ISRAEL V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-30</SoldDt>
          <GrossSalesPriceAmt>489203</GrossSalesPriceAmt>
          <GainOrLossAmt>489203</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>489203</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>WTI VLL VII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-17</SoldDt>
          <GrossSalesPriceAmt>575726</GrossSalesPriceAmt>
          <GainOrLossAmt>575726</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>575726</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-29</SoldDt>
          <GrossSalesPriceAmt>56865</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>69567</CostOrOtherBasisAmt>
          <GainOrLossAmt>-12702</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-12702</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <GrossSalesPriceAmt>41256</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>51231</CostOrOtherBasisAmt>
          <GainOrLossAmt>-9975</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-9975</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-30</SoldDt>
          <GrossSalesPriceAmt>57933</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>69088</CostOrOtherBasisAmt>
          <GainOrLossAmt>-11155</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-11155</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-31</SoldDt>
          <GrossSalesPriceAmt>57905</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>69061</CostOrOtherBasisAmt>
          <GainOrLossAmt>-11156</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-11156</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-31</SoldDt>
          <GrossSalesPriceAmt>60561</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>68019</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7458</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7458</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>86280</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>80195</CostOrOtherBasisAmt>
          <GainOrLossAmt>6085</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>6085</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-30</SoldDt>
          <GrossSalesPriceAmt>57528</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>69099</CostOrOtherBasisAmt>
          <GainOrLossAmt>-11571</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-11571</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-30</SoldDt>
          <GrossSalesPriceAmt>63884</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>66804</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2920</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2920</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-31</SoldDt>
          <GrossSalesPriceAmt>66121</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>66106</CostOrOtherBasisAmt>
          <GainOrLossAmt>15</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>15</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-29</SoldDt>
          <GrossSalesPriceAmt>66672</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>65917</CostOrOtherBasisAmt>
          <GainOrLossAmt>755</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>755</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-26</SoldDt>
          <GrossSalesPriceAmt>84024</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>79717</CostOrOtherBasisAmt>
          <GainOrLossAmt>4307</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4307</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SILCHESTER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-30</SoldDt>
          <GrossSalesPriceAmt>59298</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>68444</CostOrOtherBasisAmt>
          <GainOrLossAmt>-9146</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-9146</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-28</SoldDt>
          <GrossSalesPriceAmt>164471</GrossSalesPriceAmt>
          <GainOrLossAmt>164471</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>164471</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-05</SoldDt>
          <GrossSalesPriceAmt>1491087</GrossSalesPriceAmt>
          <GainOrLossAmt>1491087</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1491087</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-12</SoldDt>
          <GrossSalesPriceAmt>922103</GrossSalesPriceAmt>
          <GainOrLossAmt>922103</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>922103</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL XII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-04</SoldDt>
          <GrossSalesPriceAmt>830049</GrossSalesPriceAmt>
          <GainOrLossAmt>830049</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>830049</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-18</SoldDt>
          <GrossSalesPriceAmt>2540662</GrossSalesPriceAmt>
          <GainOrLossAmt>2540662</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2540662</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-15</SoldDt>
          <GrossSalesPriceAmt>730060</GrossSalesPriceAmt>
          <GainOrLossAmt>730060</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>730060</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-22</SoldDt>
          <GrossSalesPriceAmt>2357632</GrossSalesPriceAmt>
          <GainOrLossAmt>2357632</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2357632</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-12</SoldDt>
          <GrossSalesPriceAmt>791542</GrossSalesPriceAmt>
          <GainOrLossAmt>791542</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>791542</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GWTH VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-12</SoldDt>
          <GrossSalesPriceAmt>187327</GrossSalesPriceAmt>
          <GainOrLossAmt>187327</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>187327</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US GWTH VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-09</SoldDt>
          <GrossSalesPriceAmt>183726</GrossSalesPriceAmt>
          <GainOrLossAmt>183726</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>183726</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GR III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-18</SoldDt>
          <GrossSalesPriceAmt>54843</GrossSalesPriceAmt>
          <GainOrLossAmt>54843</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>54843</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GR III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>16536</GrossSalesPriceAmt>
          <GainOrLossAmt>16536</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>16536</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH IV PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-02</SoldDt>
          <GrossSalesPriceAmt>301349</GrossSalesPriceAmt>
          <GainOrLossAmt>301349</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>301349</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH IV PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-03</SoldDt>
          <CostOrOtherBasisAmt>301349</CostOrOtherBasisAmt>
          <GainOrLossAmt>-301349</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-301349</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH IV PARALLEL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-03</SoldDt>
          <GrossSalesPriceAmt>301349</GrossSalesPriceAmt>
          <GainOrLossAmt>301349</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>301349</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-03</SoldDt>
          <CostOrOtherBasisAmt>863383</CostOrOtherBasisAmt>
          <GainOrLossAmt>-863383</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-863383</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-02</SoldDt>
          <GrossSalesPriceAmt>863383</GrossSalesPriceAmt>
          <GainOrLossAmt>863383</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>863383</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AH IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-03</SoldDt>
          <GrossSalesPriceAmt>863383</GrossSalesPriceAmt>
          <GainOrLossAmt>863383</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>863383</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-10</SoldDt>
          <GrossSalesPriceAmt>77552</GrossSalesPriceAmt>
          <GainOrLossAmt>77552</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>77552</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-22</SoldDt>
          <GrossSalesPriceAmt>75419</GrossSalesPriceAmt>
          <GainOrLossAmt>75419</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>75419</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-28</SoldDt>
          <GrossSalesPriceAmt>47556</GrossSalesPriceAmt>
          <GainOrLossAmt>47556</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>47556</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR VI</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-16</SoldDt>
          <GrossSalesPriceAmt>32083</GrossSalesPriceAmt>
          <GainOrLossAmt>32083</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>32083</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FRAZIER IX</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-12</SoldDt>
          <GrossSalesPriceAmt>1653738</GrossSalesPriceAmt>
          <GainOrLossAmt>1653738</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1653738</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA GRTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-30</SoldDt>
          <GrossSalesPriceAmt>86864</GrossSalesPriceAmt>
          <GainOrLossAmt>86864</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>86864</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA GBL GRTH III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-30</SoldDt>
          <GrossSalesPriceAmt>254887</GrossSalesPriceAmt>
          <GainOrLossAmt>254887</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>254887</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR AXIOM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-05</SoldDt>
          <GrossSalesPriceAmt>1799603</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1761406</CostOrOtherBasisAmt>
          <GainOrLossAmt>38197</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>38197</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR AXIOM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-08-27</SoldDt>
          <GrossSalesPriceAmt>2899419</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2369120</CostOrOtherBasisAmt>
          <GainOrLossAmt>530299</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>530299</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR AXIOM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-16</SoldDt>
          <GrossSalesPriceAmt>488727</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>410207</CostOrOtherBasisAmt>
          <GainOrLossAmt>78520</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>78520</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR AXIOM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-13</SoldDt>
          <GrossSalesPriceAmt>6975079</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5699349</CostOrOtherBasisAmt>
          <GainOrLossAmt>1275730</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1275730</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-12</SoldDt>
          <GrossSalesPriceAmt>849513</GrossSalesPriceAmt>
          <GainOrLossAmt>849513</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>849513</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACCEL GROWTH V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-10</SoldDt>
          <GrossSalesPriceAmt>958920</GrossSalesPriceAmt>
          <GainOrLossAmt>958920</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>958920</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-16</SoldDt>
          <GrossSalesPriceAmt>37106</GrossSalesPriceAmt>
          <GainOrLossAmt>37106</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>37106</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-18</SoldDt>
          <GrossSalesPriceAmt>1102343</GrossSalesPriceAmt>
          <GainOrLossAmt>1102343</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1102343</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-12-28</SoldDt>
          <GrossSalesPriceAmt>55522</GrossSalesPriceAmt>
          <GainOrLossAmt>55522</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>55522</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-31</SoldDt>
          <GrossSalesPriceAmt>504467</GrossSalesPriceAmt>
          <GainOrLossAmt>504467</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>504467</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA CHINA VTR V</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-20</SoldDt>
          <GrossSalesPriceAmt>18622</GrossSalesPriceAmt>
          <GainOrLossAmt>18622</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>18622</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US VTR XV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-09</SoldDt>
          <GrossSalesPriceAmt>81994</GrossSalesPriceAmt>
          <GainOrLossAmt>81994</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>81994</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SEQUOIA US VTR XV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-12</SoldDt>
          <GrossSalesPriceAmt>83601</GrossSalesPriceAmt>
          <GainOrLossAmt>83601</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>83601</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARBORETUM III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-29</SoldDt>
          <GrossSalesPriceAmt>1710132</GrossSalesPriceAmt>
          <GainOrLossAmt>1710132</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1710132</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARBORETUM IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-18</SoldDt>
          <GrossSalesPriceAmt>1994717</GrossSalesPriceAmt>
          <GainOrLossAmt>1994717</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1994717</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CRESTVIEW III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-08</SoldDt>
          <GrossSalesPriceAmt>371528</GrossSalesPriceAmt>
          <GainOrLossAmt>371528</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>371528</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EIG ENERGY XVII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-16</SoldDt>
          <GrossSalesPriceAmt>15255</GrossSalesPriceAmt>
          <GainOrLossAmt>15255</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>15255</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EIG ENERGY XVII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-15</SoldDt>
          <GrossSalesPriceAmt>22208</GrossSalesPriceAmt>
          <GainOrLossAmt>22208</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>22208</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EIG ENERGY XVII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-19</SoldDt>
          <GrossSalesPriceAmt>3323</GrossSalesPriceAmt>
          <GainOrLossAmt>3323</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3323</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EPIRIS II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-23</SoldDt>
          <GrossSalesPriceAmt>1186972</GrossSalesPriceAmt>
          <GainOrLossAmt>1186972</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1186972</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FORTISSIMO IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-19</SoldDt>
          <GrossSalesPriceAmt>4447527</GrossSalesPriceAmt>
          <GainOrLossAmt>4447527</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4447527</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-21</SoldDt>
          <CostOrOtherBasisAmt>800727</CostOrOtherBasisAmt>
          <GainOrLossAmt>-800727</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-800727</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-06-10</SoldDt>
          <GrossSalesPriceAmt>22293</GrossSalesPriceAmt>
          <GainOrLossAmt>22293</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>22293</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-12</SoldDt>
          <GrossSalesPriceAmt>22441</GrossSalesPriceAmt>
          <GainOrLossAmt>22441</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>22441</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2013</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-07</SoldDt>
          <GrossSalesPriceAmt>141627</GrossSalesPriceAmt>
          <GainOrLossAmt>141627</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>141627</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-15</SoldDt>
          <GrossSalesPriceAmt>564314</GrossSalesPriceAmt>
          <GainOrLossAmt>564314</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>564314</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-21</SoldDt>
          <CostOrOtherBasisAmt>26737</CostOrOtherBasisAmt>
          <GainOrLossAmt>-26737</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-26737</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-15</SoldDt>
          <GrossSalesPriceAmt>68859</GrossSalesPriceAmt>
          <GainOrLossAmt>68859</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>68859</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-13</SoldDt>
          <GrossSalesPriceAmt>117783</GrossSalesPriceAmt>
          <GainOrLossAmt>117783</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>117783</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-15</SoldDt>
          <GrossSalesPriceAmt>24233</GrossSalesPriceAmt>
          <GainOrLossAmt>24233</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>24233</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERL ATLANTIC 2018</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-01-27</SoldDt>
          <GrossSalesPriceAmt>858</GrossSalesPriceAmt>
          <GainOrLossAmt>858</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>858</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IRON POINT IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-30</SoldDt>
          <GrossSalesPriceAmt>135447</GrossSalesPriceAmt>
          <GainOrLossAmt>135447</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>135447</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IRON POINT IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-09-29</SoldDt>
          <GrossSalesPriceAmt>60254</GrossSalesPriceAmt>
          <GainOrLossAmt>60254</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>60254</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR INST PARTNERS IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-04-16</SoldDt>
          <GrossSalesPriceAmt>247060</GrossSalesPriceAmt>
          <GainOrLossAmt>247060</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>247060</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR INST PARTNERS IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-05-08</SoldDt>
          <GrossSalesPriceAmt>94997</GrossSalesPriceAmt>
          <GainOrLossAmt>94997</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>94997</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR INST PARTNERS IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-07-29</SoldDt>
          <GrossSalesPriceAmt>30322</GrossSalesPriceAmt>
          <GainOrLossAmt>30322</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>30322</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR INST PARTNERS IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-10-16</SoldDt>
          <GrossSalesPriceAmt>68069</GrossSalesPriceAmt>
          <GainOrLossAmt>68069</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>68069</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR INST PARTNERS IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2020-11-23</SoldDt>
          <GrossSalesPriceAmt>207195</GrossSalesPriceAmt>
          <GainOrLossAmt>207195</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>207195</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MHR INST PARTNERS IV</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-02-26</SoldDt>
          <GrossSalesPriceAmt>211306</GrossSalesPriceAmt>
          <GainOrLossAmt>211306</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>211306</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>WTI VLL IX</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-29</SoldDt>
          <GrossSalesPriceAmt>145200</GrossSalesPriceAmt>
          <GainOrLossAmt>145200</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>145200</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>WTI VLL VIII</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2021-03-25</SoldDt>
          <GrossSalesPriceAmt>269500</GrossSalesPriceAmt>
          <GainOrLossAmt>269500</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>269500</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GENERAL ATLANTIC 98H</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <CostOrOtherBasisAmt>4738</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4738</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4738</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>K-1 ADJUSTMENTS, NET OF UBI AND RELATED AMOUNTS ABOVE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GainOrLossAmt>-374608992</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-374608992</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CAPITAL GAINS DIVIDENDS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GrossSalesPriceAmt>49103379</GrossSalesPriceAmt>
          <GainOrLossAmt>49103379</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>49103379</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>601574917</CapitalGainNetIncomeAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>9477512</InvestmentIncomeExciseTaxAmt>
        <TaxUnderSection511Amt>0</TaxUnderSection511Amt>
        <SubtotalAmt>9477512</SubtotalAmt>
        <SubtitleATaxAmt>0</SubtitleATaxAmt>
        <TaxBasedOnInvestmentIncomeAmt>9477512</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>18438500</EstimatedPlusOvpmtIncmTxAmt>
        <ExemptFrgnOrgTaxWthldAtSrceAmt>0</ExemptFrgnOrgTaxWthldAtSrceAmt>
        <ExtsnRequestIncomeTaxPaidAmt>0</ExtsnRequestIncomeTaxPaidAmt>
        <BackupWithholdingWithheldAmt>0</BackupWithholdingWithheldAmt>
        <TotalPaymentsAndCreditsAmt>18438500</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="RetDoc1192000001">X</Form2220AttachedInd>
        <EsPenaltyAmt>0</EsPenaltyAmt>
        <OverpaymentAmt>8960988</OverpaymentAmt>
        <AppliedToESTaxAmt>8960988</AppliedToESTaxAmt>
        <RefundAmt>0</RefundAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>0</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>0</MoreThan100SpentInd>
        <Form1120POLFiledInd>0</Form1120POLFiledInd>
        <Section4955OrganizationTaxAmt>0</Section4955OrganizationTaxAmt>
        <Section4955ManagersTaxAmt>0</Section4955ManagersTaxAmt>
        <TaxReimbursedAmt>0</TaxReimbursedAmt>
        <ActivitiesNotPreviouslyRptInd>0</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>0</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>1</UnrelatedBusIncmOverLimitInd>
        <Form990TFiledInd>1</Form990TFiledInd>
        <OrganizationDissolvedEtcInd>0</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>1</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>1</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>NY</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>1</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>0</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>0</NewSubstantialContributorsInd>
        <OwnControlledEntityInd referenceDocumentId="RetDoc2204900001 RetDoc2205000001">1</OwnControlledEntityInd>
        <DonorAdvisedFundInd>0</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>1</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>HELMSLEYTRUST.ORG</WebsiteAddressTxt>
        <IndividualWithBooksNm>NICHOLAS J SCHIAVO CFO</IndividualWithBooksNm>
        <PhoneNum>2126793600</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>230 PARK AVENUE SUITE 659</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10169</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>1</ForeignAccountsQuestionInd>
        <ForeignCountryCd>AS</ForeignCountryCd>
        <ForeignCountryCd>AU</ForeignCountryCd>
        <ForeignCountryCd>BE</ForeignCountryCd>
        <ForeignCountryCd>BR</ForeignCountryCd>
        <ForeignCountryCd>CA</ForeignCountryCd>
        <ForeignCountryCd>CO</ForeignCountryCd>
        <ForeignCountryCd>EZ</ForeignCountryCd>
        <ForeignCountryCd>DA</ForeignCountryCd>
        <ForeignCountryCd>FI</ForeignCountryCd>
        <ForeignCountryCd>FR</ForeignCountryCd>
        <ForeignCountryCd>GM</ForeignCountryCd>
        <ForeignCountryCd>GR</ForeignCountryCd>
        <ForeignCountryCd>HK</ForeignCountryCd>
        <ForeignCountryCd>IN</ForeignCountryCd>
        <ForeignCountryCd>IS</ForeignCountryCd>
        <ForeignCountryCd>IT</ForeignCountryCd>
        <ForeignCountryCd>JA</ForeignCountryCd>
        <ForeignCountryCd>MY</ForeignCountryCd>
        <ForeignCountryCd>MX</ForeignCountryCd>
        <ForeignCountryCd>NL</ForeignCountryCd>
        <ForeignCountryCd>NZ</ForeignCountryCd>
        <ForeignCountryCd>NO</ForeignCountryCd>
        <ForeignCountryCd>RP</ForeignCountryCd>
        <ForeignCountryCd>PL</ForeignCountryCd>
        <ForeignCountryCd>PO</ForeignCountryCd>
        <ForeignCountryCd>QA</ForeignCountryCd>
        <ForeignCountryCd>RS</ForeignCountryCd>
        <ForeignCountryCd>SN</ForeignCountryCd>
        <ForeignCountryCd>SF</ForeignCountryCd>
        <ForeignCountryCd>KS</ForeignCountryCd>
        <ForeignCountryCd>SP</ForeignCountryCd>
        <ForeignCountryCd>SW</ForeignCountryCd>
        <ForeignCountryCd>SZ</ForeignCountryCd>
        <ForeignCountryCd>TW</ForeignCountryCd>
        <ForeignCountryCd>TH</ForeignCountryCd>
        <ForeignCountryCd>AE</ForeignCountryCd>
        <ForeignCountryCd>UK</ForeignCountryCd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>1</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>1</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>1</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>1</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>0</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>0</PaymentToGovernmentOfficialInd>
        <ActsFailToQlfyAsExceptionsInd>0</ActsFailToQlfyAsExceptionsInd>
        <UncorrectedPriorActsInd>0</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>0</UndistributedIncomePYInd>
        <BusinessHoldingsInd>1</BusinessHoldingsInd>
        <ExcessBusinessHoldingsInd>0</ExcessBusinessHoldingsInd>
        <JeopardyInvestmentsInd>0</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>0</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>0</InfluenceLegislationInd>
        <InfluenceElectionInd>0</InfluenceElectionInd>
        <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>1</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>0</NoncharitablePurposeInd>
        <TransactionsFailToQlfyAsExcInd>0</TransactionsFailToQlfyAsExcInd>
        <MaintainedExpenditureRspnsInd referenceDocumentId="RetDoc2118100001">1</MaintainedExpenditureRspnsInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>1</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>SANDOR FRANKEL</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>25.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>125000</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>DAVID PANZIRER</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>35.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>125000</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>WALTER PANZIRER</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>32.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>125000</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>STEPHANIE A CUSKLEY</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>965057</CompensationAmt>
          <EmployeeBenefitProgramAmt>185162</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>ROSALIND M HEWSENIAN</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>CHIEF INVESTMENT OFFICER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>1588713</CompensationAmt>
          <EmployeeBenefitProgramAmt>263952</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>SARAH E PAUL</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>GENERAL COUNSEL</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>580056</CompensationAmt>
          <EmployeeBenefitProgramAmt>136906</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>NICHOLAS J SCHIAVO</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>CHIEF FINANCIAL OFFICER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>356127</CompensationAmt>
          <EmployeeBenefitProgramAmt>108602</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>MEENAKSHI C LAKSHMAN</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>DIR. OF STRATEGY &amp; R</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>866279</CompensationAmt>
          <EmployeeBenefitsAmt>187827</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>AL Y KIM</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR OF INVESTME</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>861271</CompensationAmt>
          <EmployeeBenefitsAmt>187827</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>JOSHUA W FENTON</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR OF INVESTME</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>849022</CompensationAmt>
          <EmployeeBenefitsAmt>187827</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>CHRISTOPHER J RAPCEWICZ</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>DIR. OF RISK MNGMT.</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>845117</CompensationAmt>
          <EmployeeBenefitsAmt>172794</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <CompensationHighestPaidEmplGrp>
          <PersonNm>BRIAN B CHUN</PersonNm>
          <USAddress>
            <AddressLine1Txt>C/O TRUST 230 PARK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10169</ZIPCd>
          </USAddress>
          <TitleTxt>INVESTMENT OFFICER</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>422200</CompensationAmt>
          <EmployeeBenefitsAmt>84252</EmployeeBenefitsAmt>
          <ExpenseAccountAmt>0</ExpenseAccountAmt>
        </CompensationHighestPaidEmplGrp>
        <OtherEmployeePaidOver50kCnt>82</OtherEmployeePaidOver50kCnt>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>HIGHCLERE INTERNATIONAL INVESTORS</BusinessNameLine1Txt>
          </BusinessName>
          <ForeignAddress>
            <AddressLine1Txt>2 MANCHESTER SQUARE</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </ForeignAddress>
          <ServiceTypeTxt>INVESTMENT MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>3001663</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>T ROWE PRICE ASSOCIATES INC</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>PO BOX 64043</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>212644043</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>INVESTMENT MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>2865935</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>IFP GLOBAL EQUITY LP</BusinessNameLine1Txt>
          </BusinessName>
          <ForeignAddress>
            <AddressLine1Txt>LEVEL 1 10 PORTMAN SQUARE</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
            <ForeignPostalCd>W1H 6AZ</ForeignPostalCd>
          </ForeignAddress>
          <ServiceTypeTxt>INVESTMENT MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>1637020</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>ORBIMED PRIVATE INVESTMENTS VI LP</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>601 LEXINGTON AVE 54TH FL</AddressLine1Txt>
            <CityNm>NY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100224629</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>INVESTMENT MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>1528039</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>HIG MIDDLE MARKET LBO FUND II LP</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>600 5TH AVE 24TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10020</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>INVESTMENT MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>1438870</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <ContractorPaidOver50kCnt>41</ContractorPaidOver50kCnt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SummaryOfDirectChrtblActyGrp>
        <Description1Txt>FOR VIDEO AND DESIGN SUPPORT TO COMMUNICATE IMPACT IN FURTHERANCE OF THE FOUNDATION'S MISSION.</Description1Txt>
        <Expenses1Amt>943510</Expenses1Amt>
        <Description2Txt>FOR TECHNICAL SUPPORT TO GRANTEES TO MEET THEIR STRATEGIC AND COMMUNICATIONS NEEDS TO DRIVE FURTHER IMPACT OF THEIR WORK.</Description2Txt>
        <Expenses2Amt>560008</Expenses2Amt>
        <Description3Txt>FOR CONVENING EXPERTS TO EXPLORE PROGRAM PRIORITIES, SHARE RESEARCH AND IDEAS, AND BRAINSTORM NEW AREAS OF IMPACT IN SUPPORT OF OUR MISSION.</Description3Txt>
        <Expenses3Amt>41878</Expenses3Amt>
      </SummaryOfDirectChrtblActyGrp>
      <SumOfProgramRelatedInvstGrp>
        <Description1Txt>AKSTON BIOSCIENCES CORPORATION - PRECLINICAL TRIAL OF INSULIN-FUSION TO END AUTOIMMUNITY &amp; IMPROVE T1D CARE</Description1Txt>
        <Expenses1Amt>1557500</Expenses1Amt>
        <Description2Txt>CAPILLARY BIOMEDICAL, INC. - ADVANCED EXTENDED INFUSION SET TO IMPROVE CARE IN T1D</Description2Txt>
        <Expenses2Amt>1500000</Expenses2Amt>
        <AllOtherProgramRltdInvstTotAmt referenceDocumentId="RetDoc2063500001">1999000</AllOtherProgramRltdInvstTotAmt>
        <TotalAmt>5056500</TotalAmt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>6710657638</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>122236254</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>126672</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>6833020564</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>6833020564</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>102495308</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>6730525256</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>336526263</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>336526263</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>9477512</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>9477512</TotalTaxAmt>
        <DistributableBeforeAdjAmt>327048751</DistributableBeforeAdjAmt>
        <RecoveriesQualfiedDistriAmt>1880763</RecoveriesQualfiedDistriAmt>
        <DistributableBeforeDedAmt>328929514</DistributableBeforeDedAmt>
        <DeductionFromDistributableAmt>0</DeductionFromDistributableAmt>
        <DistributableAsAdjustedAmt>328929514</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <QualifyingDistriPartXIIGrp>
        <ExpensesAndContributionsAmt>284708095</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>5056500</ProgramRelatedInvstTotalAmt>
        <CharitableAssetsAcquisPaidAmt>1769329</CharitableAssetsAcquisPaidAmt>
        <QualifyingDistributionsAmt>291533924</QualifyingDistributionsAmt>
        <PctSect4940eOrgNetInvstIncmAmt>0</PctSect4940eOrgNetInvstIncmAmt>
        <AdjustedQualifyingDistriAmt>291533924</AdjustedQualifyingDistriAmt>
      </QualifyingDistriPartXIIGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>328929514</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>83081151</UndistributedIncomePYAmt>
        <TotalForPriorYearsAmt>0</TotalForPriorYearsAmt>
        <TotalExcessDistributionCyovAmt>0</TotalExcessDistributionCyovAmt>
        <QualifyingDistributionsAmt>291533924</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>83081151</AppliedToYear1Amt>
        <AppliedToPriorYearsAmt>0</AppliedToPriorYearsAmt>
        <TreatedAsDistriFromCorpusAmt>0</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>208452773</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>0</RemainingDistriFromCorpusAmt>
        <ExcessDistriCyovAppCYCorpusAmt>0</ExcessDistriCyovAppCYCorpusAmt>
        <ExcessDistributionCyovAppCYAmt>0</ExcessDistributionCyovAppCYAmt>
        <TotalCorpusAmt>0</TotalCorpusAmt>
        <PriorYearUndistributedIncmAmt>0</PriorYearUndistributedIncmAmt>
        <PriorYearDeficiencyOrTaxAmt>0</PriorYearDeficiencyOrTaxAmt>
        <Taxable1Amt>0</Taxable1Amt>
        <Taxable2Amt>0</Taxable2Amt>
        <UndistributedIncomeCYAmt>120476741</UndistributedIncomeCYAmt>
        <CorpusDistri170b1EOr4942g3Amt>0</CorpusDistri170b1EOr4942g3Amt>
        <ExcessDistriCyovFromYr5Amt>0</ExcessDistriCyovFromYr5Amt>
        <ExcessDistriCyovToNextYrAmt>0</ExcessDistriCyovToNextYrAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>4YOUANDME</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2901 THIRD AVENUE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98121</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WEARABLES TO MEASURE STRESS AND FORECAST CROHN'S SYMPTOMS</GrantOrContributionPurposeTxt>
          <Amt>77000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>4YOUANDME</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2901 THIRD AVENUE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98121</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WEARABLES TO MEASURE STRESS AND FORECAST CROHN'S SYMPTOMS</GrantOrContributionPurposeTxt>
          <Amt>667500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>A GLIMMER OF HOPE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3600 N CAPITAL OF TEXAS HWY</AddressLine1Txt>
            <CityNm>AUSTIN</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78746</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PF</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>2783559</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ADVENTIST HEALTH SYSTEMSUNBELT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>601 E ROLLINS ST</AddressLine1Txt>
            <CityNm>ORLANDO</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32803</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DETERMINING WHETHER AGONISTS MIGHT PREVENT HYPOGLYCEMIA</GrantOrContributionPurposeTxt>
          <Amt>170340</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ADVENTIST HEALTH SYSTEMSUNBELT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>601 E ROLLINS ST</AddressLine1Txt>
            <CityNm>ORLANDO</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32803</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DETERMINING WHETHER AGONISTS MIGHT PREVENT HYPOGLYCEMIA IN T1D</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ADVENTIST HEALTH SYSTEMSUNBELT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>601 E ROLLINS ST</AddressLine1Txt>
            <CityNm>ORLANDO</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32803</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AGRICULTURAL RESEARCH ORGANIZATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>DERECH HAMACCABIM 68 RISHON</AddressLine1Txt>
            <AddressLine2Txt>LETSIYON</AddressLine2Txt>
            <CityNm>RISHON LETSIYON</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE HELMSLEY CENTER FOR AI IN AGRICULTURE AT THE VOLCANI CENTER</GrantOrContributionPurposeTxt>
          <Amt>2500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALBERT EINSTEIN COLLEGE OF MEDICINE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1300 MORRIS PARK AVE</AddressLine1Txt>
            <CityNm>BRONX</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>104611975</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALEH NEGEV FOR REHABILITATION AND DEVELOPMENT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MERHAVIM REGIONAL COUNCIL PO BOX</AddressLine1Txt>
            <AddressLine2Txt>331</AddressLine2Txt>
            <CityNm>OFAKIM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONSTRUCTION OF A NEW REHABILITATION HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>746031</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALEH NEGEV FOR REHABILITATION AND DEVELOPMENT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MERHAVIM REGIONAL COUNCIL PO BOX</AddressLine1Txt>
            <AddressLine2Txt>331</AddressLine2Txt>
            <CityNm>OFAKIM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONSTRUCTION OF A NEW REHABILITATION HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>638318</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALIMENTIV INC (FKA ROBARTS)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>100 DUNDAS STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>636012</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALIMENTIV INC (FKA ROBARTS)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>100 DUNDAS STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>291998</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALTRU HEALTH SYSTEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 6002</AddressLine1Txt>
            <CityNm>GRAND FORKS</CityNm>
            <StateAbbreviationCd>ND</StateAbbreviationCd>
            <ZIPCd>58206</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ALTRU HEALTH SYSTEM COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>247298</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALVIN AILEY DANCE FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>THE JOAN WEILL CENTER FOR DANCE 405</AddressLine1Txt>
            <AddressLine2Txt>WEST 55TH STREET</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10019</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>10000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMC MEDICAL RESEARCH BV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MEIBERGDREEF 9</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF AN EPIGENETIC BIOMARKER THAT PREDICTS SUCCESS</GrantOrContributionPurposeTxt>
          <Amt>580202</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMC MEDICAL RESEARCH BV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MEIBERGDREEF 9</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>835601</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN ASSOCIATES BEN-GURION UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1001 AVENUE OF THE AMERICAS 19TH</AddressLine1Txt>
            <AddressLine2Txt>FLOOR</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10018</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>7500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN CAMPING ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5000 STATE ROAD 67 NORTH</AddressLine1Txt>
            <CityNm>MARTINSVILLE</CityNm>
            <StateAbbreviationCd>IN</StateAbbreviationCd>
            <ZIPCd>46151</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ACA PROFESSIONAL DEVELOPMENT 2019-2021</GrantOrContributionPurposeTxt>
          <Amt>43275</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN DIABETES ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2451 CRYSTAL DRIVE SUITE 900</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2019-2021 TYPE 1 DIABETES CAMP INITIATIVE</GrantOrContributionPurposeTxt>
          <Amt>357500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN DIABETES ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2451 CRYSTAL DRIVE SUITE 900</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL PROJECTS</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN DIABETES ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2451 CRYSTAL DRIVE SUITE 900</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PATRON SUPPORT OF THE ASSOCIATION'S 79TH, 80TH, AND 81ST SESSIONS</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN HEART ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7272 GREENVILLE AVENUE</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>75231</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MISSION: LIFELINE STROKE SYSTEM OF CARE IN NEBRASKA</GrantOrContributionPurposeTxt>
          <Amt>1018534</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN HEART ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7272 GREENVILLE AVENUE</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>75231</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MISSION: LIFELINE STROKE AND POST-ACUTE STROKE CARE QUALITY STANDARDS</GrantOrContributionPurposeTxt>
          <Amt>1344150</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN HEART ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7272 GREENVILLE AVENUE</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>75231</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 RESPONSE: OXYGENATION AND VENTILATION TRAINING HUB</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICARES FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>88 HAMILTON AVE</AddressLine1Txt>
            <CityNm>STAMFORD</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06840</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPLIES FOR T1D CLINICS IN U.S.</GrantOrContributionPurposeTxt>
          <Amt>155338</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMICI DI ADWA ONLUS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>VIA GIACOMO MATTEOTTI 8</AddressLine1Txt>
            <CityNm>CENTO FERRARA</CityNm>
            <CountryCd>IT</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HOSPITAL FOR ADWA, ETHIOPIA IN TIGRAY REGION</GrantOrContributionPurposeTxt>
          <Amt>2026060</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ARIEL UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>KIRYAT HAMADA POB 3</AddressLine1Txt>
            <CityNm>ARIEL</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE ARIEL UNIVERSITY REGIONAL MEDICAL CENTER BUILDING</GrantOrContributionPurposeTxt>
          <Amt>1497915</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASIAN HEALTH CARE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>6-3-661 SOMAJIGUDA</AddressLine1Txt>
            <CityNm>HYDERABAD</CityNm>
            <CountryCd>IN</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ACCESS TO CROHN'S DIAGNOSTICS IN INDIA FOR PATIENTS LIVING IN POVERTY</GrantOrContributionPurposeTxt>
          <Amt>210221</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASSOCIATION FOR THE COMMUNITY IN RAMAT HANEGEV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>RAMAT HANEGEV</AddressLine1Txt>
            <CityNm>RAMAT HANEGEV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RAMAT HANEGEV REGIONAL COUNCIL MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>1620172</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASSOCIATION OF DIABETES CARE &amp; EDUCATION SPECIALISTS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>125 S WACKER DRIVE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60606</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS</GrantOrContributionPurposeTxt>
          <Amt>600000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASSOCIATION SANTE DIABETE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>17 AVENUE MALHERBE</AddressLine1Txt>
            <CityNm>GRENOBLE</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIABETES SUPPORT TO PEOPLE</GrantOrContributionPurposeTxt>
          <Amt>371654</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>55 VICTORIA PARADE LEVEL 2</AddressLine1Txt>
            <CityNm>FITZROY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY</GrantOrContributionPurposeTxt>
          <Amt>374589</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3900 W AVERA DR</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE TELE-PSYCHIATRY 24/7 CARE TEAM</GrantOrContributionPurposeTxt>
          <Amt>1252083</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3900 W AVERA DR</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TELEHEALTH EDUCATION PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>1354776</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3900 W AVERA DR</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>317515</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3900 W AVERA DR</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE TELE-PSYCHIATRY 24/7 CARE TEAM</GrantOrContributionPurposeTxt>
          <Amt>377000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN FOR THE AVERA MERRILL PIONEER HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1100 S 10TH AVE</AddressLine1Txt>
            <CityNm>ROCK RAPIDS</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51246</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY AT AVERA MERRILL PIONEER HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>49893</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1325 S CLIFF AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57105</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA BEHAVIORAL HEALTH CENTER EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>5000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BAR ILAN UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MAX VE-ANNA WEBB ST</AddressLine1Txt>
            <CityNm>RAMAT GAN</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPANDING AI RESEARCH AT BAR ILAN UNIVERSITY'S COMPUTER SCIENCE DEPT</GrantOrContributionPurposeTxt>
          <Amt>1836200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BARZILAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAHISTADROUT ST2</AddressLine1Txt>
            <CityNm>ASHKELON</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BAYLOR COLLEGE OF MEDICINE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH ONE BAYLOR PLAZA</AddressLine1Txt>
            <CityNm>HOUSTON</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>77030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BEARTOOTH BILLINGS CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2525 N BROADWAY</AddressLine1Txt>
            <CityNm>RED LODGE</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59068</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT BEARTOOTH BILLINGS CLINIC</GrantOrContributionPurposeTxt>
          <Amt>33956</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BEIT URI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ZUKIT 4</AddressLine1Txt>
            <CityNm>AFULA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 EMERGENCY FUND</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BEN-GURION UNIVERSITY OF THE NEGEV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BEN-GURION BLVD 1</AddressLine1Txt>
            <CityNm>BEER SHEVA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RANDOMIZED INTERVENTIONAL STUDY OF MINDFULNESS STRESS-REDUCTION</GrantOrContributionPurposeTxt>
          <Amt>154960</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BENNETT COUNTY HOSPITAL AND NURSING HOME</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>102 MAJOR ALLEN ST</AddressLine1Txt>
            <CityNm>MARTIN</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57551</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AND EEMERGENCY</GrantOrContributionPurposeTxt>
          <Amt>24673</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BETH ISRAEL DEACONESS MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>330 BROOKLINE AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022155491</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROACTIVE OPTIMIZATION OF INFLIXIMAB USING PHARMACOKINETIC DASHBOARD</GrantOrContributionPurposeTxt>
          <Amt>316515</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BIG HORN HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>17 N MILES AVE</AddressLine1Txt>
            <CityNm>HARDIN</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59034</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY</GrantOrContributionPurposeTxt>
          <Amt>62366</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BILLINGS CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2917 TENTH AVENUE NORTH</AddressLine1Txt>
            <CityNm>BILLINGS</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59102</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MONTANA PSYCHIATRY RESIDENCY PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>898186</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BILLINGS CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2917 TENTH AVENUE NORTH</AddressLine1Txt>
            <CityNm>BILLINGS</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59102</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BILLINGS CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2917 TENTH AVENUE NORTH</AddressLine1Txt>
            <CityNm>BILLINGS</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59102</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BILLINGS CLINIC COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>312899</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BIPARTISAN POLICY CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1225 I ST NW 1000</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RURAL HEALTH CARE TASK FORCE</GrantOrContributionPurposeTxt>
          <Amt>350800</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BOZEMAN DEACONESS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>931 HIGHLAND BLVD STE 3200</AddressLine1Txt>
            <CityNm>BOZEMAN</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59715</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BOZEMAN HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>62676</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIDGES TO PROSPERITY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1031 33RD STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>80205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ZAMBIA ASSESSMENT OF BRIDGE INFRASTRUCTURE</GrantOrContributionPurposeTxt>
          <Amt>147890</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIDGES TO PROSPERITY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1031 33RD STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>80205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ETHIOPIA ASSESSMENT OF BRIDGE INFRASTRUCTURE</GrantOrContributionPurposeTxt>
          <Amt>147890</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>75 FRANCIS STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PASSIVE WIRELESS MONITORING TO PREDICT AND TRACK CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>1305411</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>75 FRANCIS STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>35000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BURGESS HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1600 DIAMOND STREET</AddressLine1Txt>
            <CityNm>ONAWA</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51040</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY AT BURGESS HEALTH CENTER</GrantOrContributionPurposeTxt>
          <Amt>71508</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BUTLER COUNTY HEALTH CARE CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>372 S 9TH ST</AddressLine1Txt>
            <CityNm>DAVID CITY</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68632</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT BUTLER COUNTY HEALTH CARE CENTER</GrantOrContributionPurposeTxt>
          <Amt>6328</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CALLAWAY HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>211 EAST KIMBALL ST</AddressLine1Txt>
            <CityNm>CALLAWAY</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68825</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT CALLAWAY DISTRICT HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>11675</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE MEMORIAL HOSPITAL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1305 WEST HIGHWAY 6/34</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>69022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT TRI VALLEY HEALTH SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>14587</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HILLS ROAD</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS</GrantOrContributionPurposeTxt>
          <Amt>312018</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMPBELL COUNTY HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>501 SOUTH BURMA AVE</AddressLine1Txt>
            <CityNm>GILLETTE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82717</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>220434</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARBON COUNTY MEMORIAL HOSPITAL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2221 ELM ST</AddressLine1Txt>
            <CityNm>RAWLINS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>82301</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOIII FI</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>74812</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARE FOR THE HOMELESS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>30 EAST 33RD STREET 5TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 GRANT ASSISTANCE: HOMELESS HEALTHCARE IN NYC</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARE FOR THE HOMELESS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>30 EAST 33RD STREET 5TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARE FOR THE HOMELESS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>30 EAST 33RD STREET 5TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARE-FOR-RARE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>KINDERSPITAL KLINIKUM DER UNIVERSIT</AddressLine1Txt>
            <AddressLine2Txt>T MUNCHEN INDWURMSTRASSE 4</AddressLine2Txt>
            <CityNm>MUNICH</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD</GrantOrContributionPurposeTxt>
          <Amt>333298</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARE-FOR-RARE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>KINDERSPITAL KLINIKUM DER UNIVERSIT</AddressLine1Txt>
            <AddressLine2Txt>T MUNCHEN INDWURMSTRASSE 4</AddressLine2Txt>
            <CityNm>MUNICH</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD</GrantOrContributionPurposeTxt>
          <Amt>333298</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ADDRESSING MISSIONARIES OF CHARITY CRITICAL NEEDS</GrantOrContributionPurposeTxt>
          <Amt>669615</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT</GrantOrContributionPurposeTxt>
          <Amt>2500993</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BOUSSOUMA AND ZIGA, BURKINA FASO IMPROVED WASH INFRASTRUCTURE</GrantOrContributionPurposeTxt>
          <Amt>1105829</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOOD FOR ALL - ETHIOPIA 2.0</GrantOrContributionPurposeTxt>
          <Amt>835103</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELPING ZAMBIAN MOTHERS &amp; NEWBORNS SURVIVE &amp; THRIVE</GrantOrContributionPurposeTxt>
          <Amt>1784500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR DEVELOPMENT</GrantOrContributionPurposeTxt>
          <Amt>2224121</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO UNDERSTAND CD</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENE DISCOVERY TO CLINICAL UTILITY AND RELEVANCE TO ADULT IBD</GrantOrContributionPurposeTxt>
          <Amt>55631</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING MICROORGANISMS IN CREEPING FAT</GrantOrContributionPurposeTxt>
          <Amt>400218</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENE DISCOVERY TO CLINICAL UTILITY AND RELEVANCE TO ADULT IBD</GrantOrContributionPurposeTxt>
          <Amt>54368</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATION OF IBD COVID-19 REGISTRY AND SAMPLE DATABASE</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR DISASTER PHILANTHROPY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1201 CONNECTICUT AVE NW SUITE 300</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STATE OF DISASTER PHILANTHROPY REPORT 2020</GrantOrContributionPurposeTxt>
          <Amt>126155</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR EXCELLENCE IN HEALTH CARE JOURNALISM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>10 NEFF HALL</AddressLine1Txt>
            <CityNm>COLUMBIA</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>65211</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOII</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND REPORTING</GrantOrContributionPurposeTxt>
          <Amt>350000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR HEALTH CARE STRATEGIES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 AMERICAN METRO BLVD SUITE 119</AddressLine1Txt>
            <CityNm>TRENTON</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>08619</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING ACCESS TO CGMS FOR MEDICAID BENEFICIARIES</GrantOrContributionPurposeTxt>
          <Amt>106961</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR URBAN COMMUNITY SERVICES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>198 EAST 121ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10035</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE IN NYC</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR URBAN COMMUNITY SERVICES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>198 EAST 121ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10035</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR URBAN COMMUNITY SERVICES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>198 EAST 121ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10035</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTRACARE HEALTH SYSTEM FOR THE ST CLOUD HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1406 6TH AVE NORTH</AddressLine1Txt>
            <CityNm>ST CLOUD</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56303</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMPATH UNIT AT CENTRACARE HEALTH SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>1200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTRAL COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>901 DAVIDSON STREET NW</AddressLine1Txt>
            <CityNm>ELKADER</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52043</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT CENTRAL COMMUNITY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>6692</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTRAL MONTANA MEDICAL FACILITIES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>408 WENDELL AVE</AddressLine1Txt>
            <CityNm>LEWISTOWN</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59457</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT CENTRAL MONTANA MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>11060</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHASE COUNTY COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 WEST 12TH STREET</AddressLine1Txt>
            <CityNm>IMPERIAL</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>69033</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>96332</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHEYENNE REGIONAL MEDICAL CENTER FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>214 EAST 23RD STREET</AddressLine1Txt>
            <CityNm>CHEYENNE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>99082</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN OF THE LIGHT INTERNATIONAL MINISTRIES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1171 E 95TH STREET</AddressLine1Txt>
            <CityNm>BROOKLYN</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11236</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>960683</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD: BOSTON</GrantOrContributionPurposeTxt>
          <Amt>270512</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLUCOSE-RESPONSIVE APPROACHES TO INSULIN AND GLUCAGON DELIVERY</GrantOrContributionPurposeTxt>
          <Amt>377425</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD</GrantOrContributionPurposeTxt>
          <Amt>270512</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLUCOSE-RESPONSIVE APPROACHES TO INSULIN AND GLUCAGON DELIVERY</GrantOrContributionPurposeTxt>
          <Amt>377425</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL LOS ANGELES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>SABAN RESEARCH INSTITUTE 4650</AddressLine1Txt>
            <AddressLine2Txt>SUNSET BOULEVARD MS 142</AddressLine2Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90027</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TEAM CLINIC: EXPANSION OF A CARE MODEL FOR ADOLESCENTS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>85199</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL LOS ANGELES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>SABAN RESEARCH INSTITUTE 4650</AddressLine1Txt>
            <AddressLine2Txt>SUNSET BOULEVARD MS 142</AddressLine2Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90027</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 BURNET AVENUE</AddressLine1Txt>
            <CityNm>CINCINNATI</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>45229</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>49713</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 BURNET AVENUE</AddressLine1Txt>
            <CityNm>CINCINNATI</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>45229</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>40000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL OF ORANGE COUNTY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1201 W LA VETA AVE</AddressLine1Txt>
            <CityNm>ORANGE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92868</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL OF PHILADELPHIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2716 SOUTH STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191462305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S DISEASE EPITHELIAL STEM CELL ATLAS</GrantOrContributionPurposeTxt>
          <Amt>426038</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL OF PHILADELPHIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2716 SOUTH STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191462305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HUNGER FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>13931 BALBOA BLVD</AddressLine1Txt>
            <CityNm>SYLMAR</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>91342</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOOD SUPPORT IN ETHIOPIA AND ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>134970</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S MERCY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2401 GILLHAM ROAD</AddressLine1Txt>
            <CityNm>KANSAS CITY</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>64108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TYPE 1 DIABETES RAPID LEARNING LAB</GrantOrContributionPurposeTxt>
          <Amt>1425523</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S MERCY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2401 GILLHAM ROAD</AddressLine1Txt>
            <CityNm>KANSAS CITY</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>64108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>30000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S MERCY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2401 GILLHAM ROAD</AddressLine1Txt>
            <CityNm>KANSAS CITY</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>64108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TYPE 1 DIABETES RAPID LEARNING LAB</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CITY PARKS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>830 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NYC GREEN RELIEF &amp; RECOVERY FUND</GrantOrContributionPurposeTxt>
          <Amt>518000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CITY PARKS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>830 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NYC GREEN RELIEF &amp; RECOVERY FUND</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD</GrantOrContributionPurposeTxt>
          <Amt>166130</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS</GrantOrContributionPurposeTxt>
          <Amt>582660</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PEDIATRIC REHAB DEPT AND HYDROTHERAPY POOLS</GrantOrContributionPurposeTxt>
          <Amt>3131101</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>475863</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL &amp; PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>219751</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMEK MEDICAL CENTER - NEW OPERATING SUITES</GrantOrContributionPurposeTxt>
          <Amt>374087</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMEK MEDICAL CENTER - NEW OPERATING SUITES</GrantOrContributionPurposeTxt>
          <Amt>659275</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ISRAELI IBD RESEARCH NUCLEUS (IIRN): CONSORTIUM MANAGEMENT</GrantOrContributionPurposeTxt>
          <Amt>71050</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S DISEASE: UNDERSTANDING PATHOGENESIS, BEHAVIOR, RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>285221</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS</GrantOrContributionPurposeTxt>
          <Amt>573675</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>YOSEFTAL HOSPITAL ADDITION</GrantOrContributionPurposeTxt>
          <Amt>1094286</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PEDIATRIC REHAB DEPT AND HYDROTHERAPY POOLS</GrantOrContributionPurposeTxt>
          <Amt>514830</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>5000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLARINDA REGIONAL HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>220 ESSIE DAVISON DRIVE</AddressLine1Txt>
            <CityNm>CLARINDA</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51632</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT CLARINDA REGIONAL HEALTH CENTER</GrantOrContributionPurposeTxt>
          <Amt>40614</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>401 WEST 15TH STREET SUITE 800</AddressLine1Txt>
            <CityNm>AUSTIN</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78701</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CDISC STANDARDS DEVELOPMENT PROJECT FOR CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>395077</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>401 WEST 15TH STREET SUITE 800</AddressLine1Txt>
            <CityNm>AUSTIN</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78701</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CDISC STANDARDS DEVELOPMENT PROJECT FOR TYPE 1 DIABETES</GrantOrContributionPurposeTxt>
          <Amt>343353</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COLUMBIA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>615 WEST 131ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100273922</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE ROLE OF GAMMA-DELTA T CELLS IN HUMAN EARLY LIFE IMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>106706</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COLUMBIA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>615 WEST 131ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100273922</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL SPATIALLY RESOLVED GENOMIC PROFILING OF CROHN'S TISSUE</GrantOrContributionPurposeTxt>
          <Amt>146453</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COMMUNITY MEMORIAL HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2731 HEALTHCARE DRIVE</AddressLine1Txt>
            <CityNm>SYRACUSE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68446</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE EMERGENCY AT SYRACUSE AREA HEALTH</GrantOrContributionPurposeTxt>
          <Amt>117772</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COUNCIL ON FOUNDATIONS INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1255 23RD ST NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20037</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>33500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COUNCIL ON THE ENVIRONMENT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>100 GOLD ST SUITE 3300</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY GRANT ASSISTANCE</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COUNCIL ON THE ENVIRONMENT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>100 GOLD ST SUITE 3300</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTER-GENERATIONAL, VIABLE GREENSPACE IN NYCHA COMMUNITIES</GrantOrContributionPurposeTxt>
          <Amt>257703</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COZAD HOSPITAL DISTRICT NO 2</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 EAST 12TH STREET</AddressLine1Txt>
            <CityNm>COZAD</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>69130</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT COZAD COMMUNITY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>8480</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CRITICAL PATH INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1730 E RIVER RD</AddressLine1Txt>
            <CityNm>TUCSON</CityNm>
            <StateAbbreviationCd>AZ</StateAbbreviationCd>
            <ZIPCd>85719</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>T1D BIOMARKER CONSORTIUM - SUPPLEMENTATION</GrantOrContributionPurposeTxt>
          <Amt>160500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 SUPPORT FOR THE IBD HELP CENTER</GrantOrContributionPurposeTxt>
          <Amt>143195</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>USE OF FMT FOR POST SURGICAL RECURRENCE</GrantOrContributionPurposeTxt>
          <Amt>55597</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 SUPPORT FOR THE IBD HELP CENTER</GrantOrContributionPurposeTxt>
          <Amt>156805</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S AND COLITIS CANADA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>60 ST CLAIR AVE EAST SUITE 600</AddressLine1Txt>
            <CityNm>TORONTO</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORT FOR CROHN'S &amp; COLITIS CANADA 2020- 21 PATIENT PROGRAMS</GrantOrContributionPurposeTxt>
          <Amt>65990</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S AND COLITIS CANADA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>60 ST CLAIR AVE EAST SUITE 600</AddressLine1Txt>
            <CityNm>TORONTO</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORT FOR CROHN'S &amp; COLITIS CANADA 2020- 21 PATIENT PROGRAMS</GrantOrContributionPurposeTxt>
          <Amt>65990</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S COLITIS CURE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 OCONNELL STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE</GrantOrContributionPurposeTxt>
          <Amt>133983</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DAHL MEMORIAL HEALTHCARE ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>215 SANDY ST</AddressLine1Txt>
            <CityNm>EKALAKA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59324</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CT SCANNER AT DAHL MEMORIAL HEALTHCARE ASSOCIATION INC</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DALLAS COUNTY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>610 10TH STREET</AddressLine1Txt>
            <CityNm>PERRY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50220</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY AT DALLAS COUNTY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>19089</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DALY HOSPITAL FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1200 WESTWOOD DRIVE</AddressLine1Txt>
            <CityNm>HAMILTON</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59840</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MARCUS DALY MEMORIAL HOSPITAL COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>50541</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DE LA SALLE SOLIDARIET INTERNAZIONALE ONLUS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>VIA AUREALIA 476</AddressLine1Txt>
            <CityNm>ROME</CityNm>
            <CountryCd>IT</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESTABLISHING A ROBUST MEDICAL EDUCATION CENTER - ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>74334</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DELAWARE COUNTY MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>709 W MAIN ST</AddressLine1Txt>
            <CityNm>MANCHESTER</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52057</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY</GrantOrContributionPurposeTxt>
          <Amt>72983</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DIABETES EDUCATION AND CAMPING ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1138 SPRING COVE ROAD</AddressLine1Txt>
            <CityNm>FLORENCE</CityNm>
            <StateAbbreviationCd>AL</StateAbbreviationCd>
            <ZIPCd>35634</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DECA 2021 INTERNATIONAL DIABETES CAMPING CONFERENCE</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DIABETES NSW</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>26 ARUNDEL ST</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ENHANCE CAPACITY TO EXPAND THE EVIDENCE BASE ON DIABETES</GrantOrContributionPurposeTxt>
          <Amt>2602266</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ELLSWORTH MUNICIPAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>920 SOUTH OAK STREET</AddressLine1Txt>
            <CityNm>IOWA FALLS</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50126</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT HANSEN FAMILY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>21233</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>END FUND INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2 PARK AVENUE 18TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ADDRESSING TRACHOMA SURGERY GAPS IN ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>1812084</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ENDOCRINE SOCIETY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2055 L STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ENDOCRINE FELLOWS SERIES: T1D CARE AND MANAGEMENT (2018-2020)</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ENDOCRINE SOCIETY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2055 L STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ENDO SCIENTIFIC SESSIONS AND SCIENTIFIC ABSTRACT AWARDS</GrantOrContributionPurposeTxt>
          <Amt>40000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ENGINEERING MINISTRIES INTERNATIONAL USA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>130 EAST KIOWA</AddressLine1Txt>
            <CityNm>COLORADO SPRINGS</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80903</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ALASKA WASH PROJECT</GrantOrContributionPurposeTxt>
          <Amt>6733535</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ENGINEERING MINISTRIES INTERNATIONAL USA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>130 EAST KIOWA</AddressLine1Txt>
            <CityNm>COLORADO SPRINGS</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80903</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMI GLOBAL LEADERSHIP INITIATIVE</GrantOrContributionPurposeTxt>
          <Amt>55000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>EZRATH NASHIM SARAH HERZOG MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>92 GIVAT SHAUL ST</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORT FOR NEW COMPREHENSIVE REHABILITATION CENTER</GrantOrContributionPurposeTxt>
          <Amt>850000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FALL RIVER HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1201 HIGHWAY 71 S</AddressLine1Txt>
            <CityNm>HOT SPRINGS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57747</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT FALL RIVER HEALTH SERVICES</GrantOrContributionPurposeTxt>
          <Amt>43309</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FEDERAL INSTITUTE OF TECHNOLOGY ZURICH ETHZ</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>RAMISTRASSE 101</AddressLine1Txt>
            <CityNm>ZURICH</CityNm>
            <CountryCd>SZ</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SPHERE-SEQUENCING TO STUDY ABERRANT CELLULAR INTERACTIONS IN CROHN'S.</GrantOrContributionPurposeTxt>
          <Amt>608166</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FEEDING SOUTH DAKOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4701 N WESTPORT AVE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>571070123</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>58 ZHONGSHAN II ROAD</AddressLine1Txt>
            <CityNm>GUANGZHOU</CityNm>
            <CountryCd>CH</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INDUSTRIALIZATION ENVIRONMENTAL CHANGES &amp; MICROBIOME ALTERATIONS</GrantOrContributionPurposeTxt>
          <Amt>12292</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FLORESTA USA INCORPORATED</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4747 MORENA BLVD STE 100</AddressLine1Txt>
            <CityNm>SAN DIEGO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92117</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EQUIPPING RURAL FAMILIES IN THE AMHARA REGION OF ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>20919</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FLORESTA USA INCORPORATED</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4747 MORENA BLVD STE 100</AddressLine1Txt>
            <CityNm>SAN DIEGO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92117</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EQUIPPING RURAL FAMILIES IN THE AMHARA REGION OF ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>175400</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FLOYD VALLEY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>714 LINCOLN STREET NE</AddressLine1Txt>
            <CityNm>LE MARS</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51031</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT FLOYD VALLEY HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>37092</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 BEDFORD STREET</AddressLine1Txt>
            <CityNm>MANCHESTER</CityNm>
            <StateAbbreviationCd>NH</StateAbbreviationCd>
            <ZIPCd>03101</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FORSCHERGRUPPE DIABETES EV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FR1DA-PLUS COHORT STUDY</GrantOrContributionPurposeTxt>
          <Amt>437691</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FORT ATKINSON FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>201 S 7TH ST</AddressLine1Txt>
            <CityNm>FORT CALHOUN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68023</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FORT ATKINSON STATE HISTORICAL PARK RESTORATION/CENTER REMODEL</GrantOrContributionPurposeTxt>
          <Amt>492500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FOUNDATION CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>32 OLD SLIP 24TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>28751</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FOUNDATION FOR MORRISTOWN MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>475 SOUTH STREET</AddressLine1Txt>
            <CityNm>MORRISTOWN</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07960</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FOUNDATION FOR THE DEFENSE OF DEMOCRACIES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1800 M ST NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NATIONAL SECURITY FELLOWS VIRTUAL ISRAEL TRIP TO ISRAEL</GrantOrContributionPurposeTxt>
          <Amt>35747</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FRIENDS OF CRAWFORD PARK INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7 RYE RIDGE PLAZA</AddressLine1Txt>
            <CityNm>RYE BROOK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10573</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>7500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FRIENDS OF TEL AVIV SOURASKY MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1461 FIRST AVENUE BOX 150</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10075</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBATTING THE CORONAVIRUS PANDEMIC IN ISRAEL</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FRIENDS OF THE ISRAEL DEFENSE FORCES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>60 EAST 42 STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10165</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPACT! SCHOLARSHIP PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>268000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FUENTE LATINA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7300 BISCAYNE BLVD SUITE 200</AddressLine1Txt>
            <CityNm>MIAMI</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33138</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HISPANIC ISRAEL MEDIA PANDEMIC PROGRAMMING (HIMP)</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GALILEE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>GALILEE MEDICAL CENTER BEN ZVI BLVD</AddressLine1Txt>
            <AddressLine2Txt>POB 21</AddressLine2Txt>
            <CityNm>NAHARYIA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOBILE X-RAY MACHINES FOR CORONAVIRUS ISOLATION WARDS</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GEOSCIENCE AUSTRALIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 JERRABOMBERRA AVE</AddressLine1Txt>
            <CityNm>SYMONSTON</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIGITAL EARTH AFRICA: PHASE 2 (OPERATIONAL BUILD)</GrantOrContributionPurposeTxt>
          <Amt>2500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GLOBAL SOLIDARITY FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>425 LEXINGTON AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONSORTIUM TO MAXIMIZE SERVICES FOR REFUGEES, MIGRANTS &amp; IDPS - ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GORDON MEMORIAL HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 E 8TH ST</AddressLine1Txt>
            <CityNm>GORDON</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>69343</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT GORDON MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>38111</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>27 KINGS COLLEGE CIRCLE</AddressLine1Txt>
            <CityNm>TORONTO</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLUCOSE RESPONSIVE GLUCAGON MICRONEEDLE-HYPOGLYCEMIA PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>351560</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GRAND CANYON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3300 WEST CAMELBACK ROAD</AddressLine1Txt>
            <CityNm>PHOENIX</CityNm>
            <StateAbbreviationCd>AZ</StateAbbreviationCd>
            <ZIPCd>85017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>673774</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GRANITE FALLS MUNICIPAL HOSPITAL AND MANOR</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>345 10TH AVE</AddressLine1Txt>
            <CityNm>GRANITE FALLS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56241</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT GRANITE FALLS HEALTH</GrantOrContributionPurposeTxt>
          <Amt>8064</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GRANTMAKERS FOR EFFECTIVE ORGANIZATIONS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1310 L STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>18920</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GRANTMAKERS IN HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1100 CONNECTICUT AVENUE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>23760</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GUTTENBERG MUNICIPAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 MAIN ST</AddressLine1Txt>
            <CityNm>GUTTENBERG</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52052</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY AT GUTTENBERG MUNICIPAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>67301</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HACKENSACK UNIVERSITY MEDICAL CENTER FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>160 ESSEX STREET</AddressLine1Txt>
            <CityNm>LODI</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07644</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HACKENSACK UNIVERSITY MEDICAL CENTER FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>160 ESSEX STREET</AddressLine1Txt>
            <CityNm>LODI</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07644</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HADASSAH MEDICAL ORGANIZATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>POB 12000</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EQUIP A WARD TO TREAT VENTILATED &amp; NON-VENTILATED COVID PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HAMILTON COUNTY PUBLIC HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2350 HOSPITAL DRIVE</AddressLine1Txt>
            <CityNm>WEBSTER CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50595</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT VAN DIEST MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>15199</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTH ADVOCACY SUMMIT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1962 DOCKSIDE DRIVE</AddressLine1Txt>
            <CityNm>GREENWOOD</CityNm>
            <StateAbbreviationCd>IN</StateAbbreviationCd>
            <ZIPCd>46143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORT FOR THE HEALTH ADVOCACY SUMMIT AND CCYAN</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTH FINANCE INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1690 NORTH QUINN STREET</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22209</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CATALYZE FINANCE &amp; PARTNERS TO ADDRESS BURDEN OF CHRONIC DISEASE</GrantOrContributionPurposeTxt>
          <Amt>761650</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTH RESEARCH ALLIANCE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>65 TW ALEXANDER DRIVE</AddressLine1Txt>
            <CityNm>RESEARCH TRIANGLE PARK</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27709</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>22150</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTHPARTNERS INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 1309</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55440</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIRECT INTEGRATION OF CGM DATA INTO THE EMR</GrantOrContributionPurposeTxt>
          <Amt>257534</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEBREW UNIVERSITY OF JERUSALEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>THE HEBREW UNIVERSITY OF JERUSALEM</AddressLine1Txt>
            <AddressLine2Txt>MOUNT SCOPUS</AddressLine2Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>METHYLATION PATTERNS OF CELL-FREE DNA AS A BIOMARKER IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>271601</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELEN KELLER INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE DAG HAMMARSKJOLD PLAZA</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVE HEALTH, NUTRITION AND LIVELIHOODS IN SISSILI PROVINCE</GrantOrContributionPurposeTxt>
          <Amt>1398422</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>1744911</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>3166777</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>3500407</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT</GrantOrContributionPurposeTxt>
          <Amt>166791</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>3131887</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>3075103</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HENRY FORD HEALTH SYSTEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE FORD PLACE - 5F</AddressLine1Txt>
            <CityNm>DETROIT</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>48202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HERLEV OG GENTOFTE HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HERLEV RINGVEJ 75 OPG 115</AddressLine1Txt>
            <CityNm>HERLEV</CityNm>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING GIP/GLP RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D</GrantOrContributionPurposeTxt>
          <Amt>220005</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IBD PASSPORT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>48 CAMBERLY HOUSE</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IBD-PASSPORT: A WEB-BASED SUPPORT PLATFORM FOR TRAVELERS WITH IBD</GrantOrContributionPurposeTxt>
          <Amt>201695</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATIVE NETWORK APPROACHES FOR VEO-IBD GENE IDENTIFICATION</GrantOrContributionPurposeTxt>
          <Amt>110000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>322263</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>462745</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATIVE NETWORK APPROACHES FOR VEO-IBD TARGET GENE IDENTIFICATION</GrantOrContributionPurposeTxt>
          <Amt>110000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MODULATING MICROBIOME THROUGH DIETARY INTERVENTION IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>383087</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IDA COUNTY IOWA COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>701 EAST SECOND STREET</AddressLine1Txt>
            <CityNm>IDA GROVE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51445</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE PHARMACY AT HORN MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>162363</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INNOVIS HEALTH LLC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3000 32ND AVE</AddressLine1Txt>
            <CityNm>FARGO</CityNm>
            <StateAbbreviationCd>ND</StateAbbreviationCd>
            <ZIPCd>58103</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESSENTIA HEALTH FARGO COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>123352</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSTITUT D'INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ROSSELLO 149</AddressLine1Txt>
            <CityNm>BARCELONA</CityNm>
            <CountryCd>SP</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY DETECTION OF PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>267204</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>86 RUE REGNAULT</AddressLine1Txt>
            <CityNm>PARIS</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BENIGN ISLET AUTOIMMUNITY TO T1D: T-CELL BIOMARKERS OF PROGRESSION</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSULIN FOR LIFE USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5745 SW 75TH STREET 116</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STRENGTHENING ORGANIZATIONAL CAPACITY</GrantOrContributionPurposeTxt>
          <Amt>193050</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSULIN FOR LIFE USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5745 SW 75TH STREET 116</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIABETES DEVICES FOR CLINICS IN THE U.S. DURING THE COVID-19 PANDEMIC</GrantOrContributionPurposeTxt>
          <Amt>199273</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSULIN FOR LIFE USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5745 SW 75TH STREET 116</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIABETES DEVICES FOR CLINICS IN THE U.S. DURING COVID-19</GrantOrContributionPurposeTxt>
          <Amt>784533</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSULIN FOR LIFE USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5745 SW 75TH STREET 116</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIABETES DEVICES FOR HOSPITALS IN THE U.S. DURING THE COVID-19</GrantOrContributionPurposeTxt>
          <Amt>90088</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTEGRATED BIOBANK OF LUXEMBOURG (IBBL)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 RUE LOUIS RECH</AddressLine1Txt>
            <CityNm>DUDELANGE</CityNm>
            <CountryCd>LU</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>48128</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTEGRATED BIOBANK OF LUXEMBOURG (IBBL)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 RUE LOUIS RECH</AddressLine1Txt>
            <CityNm>DUDELANGE</CityNm>
            <CountryCd>LU</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>26690</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERMOUNTAIN HEALTHCARE FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>36 S STATE ST STE 2200</AddressLine1Txt>
            <CityNm>SALT LAKE CITY</CityNm>
            <StateAbbreviationCd>UT</StateAbbreviationCd>
            <ZIPCd>84111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>30000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERNATIONAL BOWEL ULTRASOUND GROUP EV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HARKORTSTR 1 1ST FLOOR</AddressLine1Txt>
            <CityNm>MUNSTER</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND</GrantOrContributionPurposeTxt>
          <Amt>1016631</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERNATIONAL DEVELOPMENT ENTERPRISES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1031 33RD STREET STE 270</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80210</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLOSING THE GAP ON IMPROVED SANITATION IN NORTHERN GHANA</GrantOrContributionPurposeTxt>
          <Amt>183193</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IOWA DEPARTMENT OF PUBLIC HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>321 EAST 12TH</AddressLine1Txt>
            <CityNm>DES MOINES</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50319</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IOWA FIRST RESPONDER AED INITIATIVE</GrantOrContributionPurposeTxt>
          <Amt>4586841</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY</GrantOrContributionPurposeTxt>
          <Amt>263371</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIRTUAL DIABETES SPECIALTY CLINIC STUDY EVALUATING REMOTE CGM</GrantOrContributionPurposeTxt>
          <Amt>2265996</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM</GrantOrContributionPurposeTxt>
          <Amt>161537</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM</GrantOrContributionPurposeTxt>
          <Amt>34905</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE WITH TYPE 1 DIABETES INITIATIVE: PILOT PHASE</GrantOrContributionPurposeTxt>
          <Amt>340704</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF AUSTRALIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>80-84 CHANDOS STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ENDIA FOLLOW UP 2020-2022</GrantOrContributionPurposeTxt>
          <Amt>1345269</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF AUSTRALIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>80-84 CHANDOS STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ENDIA SCIENTIFIC DIRECTIONS 2018-2021</GrantOrContributionPurposeTxt>
          <Amt>287210</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF AUSTRALIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>80-84 CHANDOS STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATING AN ANALYTICAL METHOD FOR T1D PROGRESSION</GrantOrContributionPurposeTxt>
          <Amt>365926</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF NOVEL INSULIN INFUSION SET</GrantOrContributionPurposeTxt>
          <Amt>149008</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ADDITIONAL SIGNALS TO IMPROVE GLUCOSE CONTROL SURROUNDING EXERCISE</GrantOrContributionPurposeTxt>
          <Amt>167907</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ADDITIONAL SIGNALS FOR GLUCOSE CONTROL</GrantOrContributionPurposeTxt>
          <Amt>200663</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELMSLEY AND JDRF CO-FUNDED WORKSHOPS</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JENNIE M MELHAM MEMORIAL MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>145 MEMORIAL DRIVE</AddressLine1Txt>
            <CityNm>BROKEN BOW</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68822</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT JENNIE M MELHAM MEMORIAL MEDICAL CENTER, INC.</GrantOrContributionPurposeTxt>
          <Amt>28400</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JERUSALEM COLLEGE OF TECHNOLOGY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>21 HAVAAD HALEUMI ST</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING</GrantOrContributionPurposeTxt>
          <Amt>676000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOHNS HOPKINS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3400 NORTH CHARLES STREET</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21218</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A MULTIDISCIPLINARY BIOENGINEERING APPROACH TO FISTULA-IN-ANO</GrantOrContributionPurposeTxt>
          <Amt>239373</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOHNS HOPKINS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3400 NORTH CHARLES STREET</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21218</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A MULTIDISCIPLINARY APPROACH TO FISTULA-IN-ANO IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>236110</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOSLIN DIABETES CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE JOSLIN PLACE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02215</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOSLIN DIABETES CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE JOSLIN PLACE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02215</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREDICTIVE SEROLOGICAL BIOMARKER SIGNATURES FOR RESPONSE TO ANTI-TNFS</GrantOrContributionPurposeTxt>
          <Amt>435842</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INNODIA HARVEST</GrantOrContributionPurposeTxt>
          <Amt>259027</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INNODIA - CONTINUED SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>1467112</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT</GrantOrContributionPurposeTxt>
          <Amt>248850</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD</GrantOrContributionPurposeTxt>
          <Amt>486399</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INNODIA HARVEST</GrantOrContributionPurposeTxt>
          <Amt>497878</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREDICTIVE SEROLOGICAL BIOMARKER SIGNATURES FOR RESPONSE ANTI-TNFS</GrantOrContributionPurposeTxt>
          <Amt>95814</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>1413293</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UNDERSTANDING EXTREMELY EARLY-ONSET TYPE 1 DIABETES</GrantOrContributionPurposeTxt>
          <Amt>124739</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>294698</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER &amp; TECHNOLOGY</GrantOrContributionPurposeTxt>
          <Amt>201418</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING BETA CELLS BY GENERATING HIGH AFFINITY T CELL RECEPTORS</GrantOrContributionPurposeTxt>
          <Amt>92994</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE II</GrantOrContributionPurposeTxt>
          <Amt>683167</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KMR ADVANCEMENT OF MEDICAL CENTERS LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>8 HAALIYAH ST</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESTABLISHMENT OF THE HEALTH DISCOVERY TOWER</GrantOrContributionPurposeTxt>
          <Amt>4019770</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KNOXVILLE COMMUNITY HOSPITAL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1002 SOUTH LINCOLN</AddressLine1Txt>
            <CityNm>KNOXVILLE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50138</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT KNOXVILLE HOSPITAL &amp; CLINICS</GrantOrContributionPurposeTxt>
          <Amt>8423</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LAKES REGIONAL HEALTHCARE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>HIGHWAY 71 SOUTH</AddressLine1Txt>
            <CityNm>SPIRIT LAKE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51360</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE PHARMACY AT LAKES REGIONAL HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>65880</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LIVING WATER INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4001 GREENBRIAR DRIVE</AddressLine1Txt>
            <CityNm>STAFFORD</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>77477</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>1775354</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>CAMPUS GROBHADERN MARCHIONINISTRABE</AddressLine1Txt>
            <AddressLine2Txt>1581377</AddressLine2Txt>
            <CityNm>MUNICH</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FMT FOR MAINTENANCE OF REMISSION IN PEDIATRIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>416756</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LUNDS UNIVERSITET</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PARADISGATAN 2</AddressLine1Txt>
            <CityNm>LUND</CityNm>
            <CountryCd>SW</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VALIDATION OF PCR-BASED ISLET AUTOANTIBODY DETECTION</GrantOrContributionPurposeTxt>
          <Amt>377744</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LUTHERAN CHARITY ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2422 20TH STREET SW</AddressLine1Txt>
            <CityNm>JAMESTOWN</CityNm>
            <StateAbbreviationCd>ND</StateAbbreviationCd>
            <ZIPCd>58401</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>JRMC CANCER CENTER</GrantOrContributionPurposeTxt>
          <Amt>13500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MANNING REGIONAL HEALTHCARE CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3034 INWOOD AVE</AddressLine1Txt>
            <CityNm>MANNING</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT MANNING REGIONAL HEALTHCARE CENTER</GrantOrContributionPurposeTxt>
          <Amt>11771</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MARY C WHEELER SCHOOL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>216 HOPE STREET</AddressLine1Txt>
            <CityNm>PROVIDENCE</CityNm>
            <StateAbbreviationCd>RI</StateAbbreviationCd>
            <ZIPCd>02906</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>10000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD.</GrantOrContributionPurposeTxt>
          <Amt>893605</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF FAST ON/OFF INSULIN RECEPTOR ACTIVATORS</GrantOrContributionPurposeTxt>
          <Amt>313795</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENOMIC RESEARCH ON BIOLOGICS FOR INFLAMMATORY DISEASE AND COVID</GrantOrContributionPurposeTxt>
          <Amt>150449</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STUDYING RAPID ACTING ANALOG DIFFERENCE ON GLUCOSE CONTROL</GrantOrContributionPurposeTxt>
          <Amt>254915</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEFINING DISEASE BIOLOGY FOR PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>211564</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF FAST ON/OFF INSULIN RECEPTOR ACTIVATORS</GrantOrContributionPurposeTxt>
          <Amt>70916</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS INSTITUTE OF TECHNOLOGY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>77 MASSACHUSETTS AVE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02139</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPLANTABLE DEPOTS FOR DETECTION OF PERI-ANASTOMOTIC INFLAMMATION</GrantOrContributionPurposeTxt>
          <Amt>462050</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>254489</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>OFF-SITE REMOTE ROBOTIC PERCUTANEOUS CORONARY INTERVENTIONS</GrantOrContributionPurposeTxt>
          <Amt>156527</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2019-2021 MILITARY SCIENCES MEDICAL TRAINING/SUPPORT PROJECT</GrantOrContributionPurposeTxt>
          <Amt>243059</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MEDIZINISCHE HOCHSCHULE HANNOVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>CARL NEUBERG STREET 1</AddressLine1Txt>
            <CityNm>HANNOVER</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATING T1D-SPECIFIC ANTIGEN RECEPTORS FOR REGULATORY T-CELLS</GrantOrContributionPurposeTxt>
          <Amt>89605</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MEEKER MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>612 S SIBLEY AVE</AddressLine1Txt>
            <CityNm>LITCHFIELD</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55355</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT MEEKER MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>43633</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MEEKER MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>612 S SIBLEY AVE</AddressLine1Txt>
            <CityNm>LITCHFIELD</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55355</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT MEEKER MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>120176</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MEMORIAL HOSPITAL OF SWEETWATER COUNTY FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1200 COLLEGE DRIVE</AddressLine1Txt>
            <CityNm>ROCK SPRINGS</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82901</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>50541</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MERCY MEDICAL CENTER NEW HAMPTON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>308 NORTH MAPLE AVENUE</AddressLine1Txt>
            <CityNm>NEW HAMPTON</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50659</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT MERCYONE NEW HAMPTON MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>39103</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 27837</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IRAN STUDIES PROJECT</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONASH UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>26 SPORTS WALK LEVEL 1 CHANCELLERY</AddressLine1Txt>
            <AddressLine2Txt>BUILDING D</AddressLine2Txt>
            <CityNm>CLAYTON</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DOSE OPTIMIZATION AND CLINICAL TESTING FOR IVERMECTIN</GrantOrContributionPurposeTxt>
          <Amt>1328837</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONASH UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>26 SPORTS WALK LEVEL 1 CHANCELLERY</AddressLine1Txt>
            <AddressLine2Txt>BUILDING D</AddressLine2Txt>
            <CityNm>CLAYTON</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DOSE OPTIMIZATION AND CLINICAL TESTING FOR IVERMECTIN</GrantOrContributionPurposeTxt>
          <Amt>466285</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONTANA STATE PARKS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>400 W BROADWAY SUITE 100-424</AddressLine1Txt>
            <CityNm>MISSOULA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59802</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FORT OWEN STATE PARK RESTORATION AND SITE IMPROVEMENTS</GrantOrContributionPurposeTxt>
          <Amt>507500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONTEFIORE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>111 EAST 210TH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10467</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONUMENT HEALTH NETWORK INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>353 FAIRMONT BLVD</AddressLine1Txt>
            <CityNm>RAPID CITY</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57701</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MONUMENT HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>196164</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONUMENT HEALTH NETWORK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>353 FAIRMONT BOULEVARD</AddressLine1Txt>
            <CityNm>RAPID CITY</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57701</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATURAL AREAS CONSERVANCY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1234 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FORMALIZING A NEW YORK CITY TRAIL SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATURE CONSERVANCY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4245 NORTH FAIRFAX DRIVE SUITE 100</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FUTURE FOREST NEW YORK CITY PHASE II</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NCD ALLIANCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>31-33 AVENUE GIUSEPPE MOTTA</AddressLine1Txt>
            <CityNm>GENEVA</CityNm>
            <CountryCd>SZ</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>42500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEIGHBOR TO NEIGHBOR INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>248 EAST PUTNAM AVENUE</AddressLine1Txt>
            <CityNm>GREENWICH</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06830</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEMOURS CHILDREN'S CLINIC INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>807 CHILDRENS WAY</AddressLine1Txt>
            <CityNm>JACKSONVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32207</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW VENTURE FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1201 CONNECTICUT AVE NW SUITE 300</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TYPE 1 DIABETES CAMPS PROJECT (2019-2021)</GrantOrContributionPurposeTxt>
          <Amt>1375225</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW VENTURE FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1201 CONNECTICUT AVE NW SUITE 300</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>15000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK CITY BALLET INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DAVID H KOCH THEATER 20 LINCOLN</AddressLine1Txt>
            <AddressLine2Txt>CENTER PLAZA</AddressLine2Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10023</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>15000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK CITY HEALTH AND HOSPITALS CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>125 WORTH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPRESSCARE PLATFORM UPDATE AND SERVICE DELIVERY TO HOMELESS</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK COMMON PANTRY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8 EAST 109TH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>550 1ST AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVALUATION OF PILOT ENDOCRINOLOGY TELEECHO CLINIC IN NEW MEXICO</GrantOrContributionPurposeTxt>
          <Amt>30912</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK-PRESBYTERIAN FUND INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>850 THIRD AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING CARE FOR UNDERSERVED CHILDREN WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK-PRESBYTERIAN FUND INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>850 THIRD AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NORTH BIG HORN HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1115 LANE 12</AddressLine1Txt>
            <CityNm>LOVELL</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82431</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT NORTH BIG HORN HOSPITAL DISTRICT</GrantOrContributionPurposeTxt>
          <Amt>7346</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NORTHERN MONTANA HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>30 13TH STREET</AddressLine1Txt>
            <CityNm>HAVRE</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>13349</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NORTHWESTERN UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>750 N LAKE SHORE DRIVE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60611</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NURU INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2020 PENNSYLVANIA AVE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NURU ETHIOPIA: SUSTAINING IMPACT THROUGH 2021 AND BEYOND</GrantOrContributionPurposeTxt>
          <Amt>550893</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OREGON HEALTH &amp; SCIENCE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3181 SW SAM JACKSON PARK RD MAIL</AddressLine1Txt>
            <AddressLine2Txt>CODE L101</AddressLine2Txt>
            <CityNm>PORTLAND</CityNm>
            <StateAbbreviationCd>OR</StateAbbreviationCd>
            <ZIPCd>972393098</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DESIGN AND EVALUATION OF A MDI DECISION SUPPORT SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>281554</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OREGON HEALTH &amp; SCIENCE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3181 SW SAM JACKSON PARK RD MAIL</AddressLine1Txt>
            <AddressLine2Txt>CODE L101</AddressLine2Txt>
            <CityNm>PORTLAND</CityNm>
            <StateAbbreviationCd>OR</StateAbbreviationCd>
            <ZIPCd>972393098</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE IMPLEMENTATION OF NICH IN ANOTHER HEALTHCARE SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>967386</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OREGON HEALTH &amp; SCIENCE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3181 SW SAM JACKSON PARK RD MAIL</AddressLine1Txt>
            <AddressLine2Txt>CODE L101</AddressLine2Txt>
            <CityNm>PORTLAND</CityNm>
            <StateAbbreviationCd>OR</StateAbbreviationCd>
            <ZIPCd>972393098</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE IMPLEMENTATION OF NICH IN ANOTHER HEALTHCARE SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>322463</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OREGON HEALTH &amp; SCIENCE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3181 SW SAM JACKSON PARK RD MAIL</AddressLine1Txt>
            <AddressLine2Txt>CODE L101</AddressLine2Txt>
            <CityNm>PORTLAND</CityNm>
            <StateAbbreviationCd>OR</StateAbbreviationCd>
            <ZIPCd>972393098</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE IMPLEMENTATION OF NICH IN ANOTHER HEALTHCARE SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>49863</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OREGON HEALTH &amp; SCIENCE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3181 SW SAM JACKSON PARK RD MAIL</AddressLine1Txt>
            <AddressLine2Txt>CODE L101</AddressLine2Txt>
            <CityNm>PORTLAND</CityNm>
            <StateAbbreviationCd>OR</StateAbbreviationCd>
            <ZIPCd>972393098</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DESIGN AND EVALUATION OF A MDI DECISION SUPPORT SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>50515</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OREGON HEALTH &amp; SCIENCE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3181 SW SAM JACKSON PARK RD MAIL</AddressLine1Txt>
            <AddressLine2Txt>CODE L101</AddressLine2Txt>
            <CityNm>PORTLAND</CityNm>
            <StateAbbreviationCd>OR</StateAbbreviationCd>
            <ZIPCd>972393098</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>30000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PALO ALTO VETERANS INSTITUTE FOR RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3801 MIRANDA AVENUE</AddressLine1Txt>
            <CityNm>PALO ALTO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>943040038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>496425</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PALO ALTO VETERANS INSTITUTE FOR RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3801 MIRANDA AVENUE</AddressLine1Txt>
            <CityNm>PALO ALTO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>943040038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>503575</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARK NICOLLET INSTITUTE DBA INTERNATIONAL DIABETES CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3800 PARK NICOLLET BLVD</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55416</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>30000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 LETTERMAN DRIVE</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94129</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STUDYING AUTOIMMUNE T1D FOLLOWING CANCER IMMUNOTHERAPIES</GrantOrContributionPurposeTxt>
          <Amt>1106748</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARTNERS IN HEALTH A NONPROFIT CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>800 BOYLSTON STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02219</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UNIVERSAL ACCESS TO TYPE 1 DIABETES CARE</GrantOrContributionPurposeTxt>
          <Amt>2950411</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PATH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2201 WESTLAKE AVENUE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98121</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>17750</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PATH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2201 WESTLAKE AVENUE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98121</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>17750</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PAWNEE COUNTY MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 I STREET</AddressLine1Txt>
            <CityNm>PAWNEE CITY</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68420</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT PAWNEE COUNTY MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>29679</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PHILANTHROPY NEW YORK INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>320 EAST 43RD STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>39250</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRESIDENT AND FELLOWS OF HARVARD COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>25 SHATTUCK STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MICRONEEDLE-BASED SENSOR TO ENHANCE AUTOMATED INSULIN DELIVERY</GrantOrContributionPurposeTxt>
          <Amt>86804</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT HOSPITALITY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>100 PARK AVENUE</AddressLine1Txt>
            <CityNm>STATEN ISLAND</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10302</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT NYAME NSA LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>33 WILLETS LANE</AddressLine1Txt>
            <CityNm>MANHASSET</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROJECT NYAME NSA ZAMBIA EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>280750</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT NYAME NSA LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>33 WILLETS LANE</AddressLine1Txt>
            <CityNm>MANHASSET</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING VULNERABLE CHILDREN IN EASTERN GHANA</GrantOrContributionPurposeTxt>
          <Amt>152810</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT RENEWAL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VARICK STREET SUITE 900</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE IN NYC</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT RENEWAL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VARICK STREET SUITE 900</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT RENEWAL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VARICK STREET SUITE 900</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY ASSISTANCE: HOMELESS HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROVIDENCE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1200 PROVIDENCE ROAD</AddressLine1Txt>
            <CityNm>WAYNE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68787</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT PROVIDENCE MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>41340</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROVIDENCE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1200 PROVIDENCE ROAD</AddressLine1Txt>
            <CityNm>WAYNE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68787</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT PROVIDENCE MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>214145</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PUBLIC HEALTH SOLUTIONS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>40 WORTH STREET 5TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS</GrantOrContributionPurposeTxt>
          <Amt>854669</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PUBLIC HEALTH SOLUTIONS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>40 WORTH STREET 5TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>1015000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RADY CHILDREN'S HOSPITAL - SAN DIEGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3020 CHILDRENS WAY</AddressLine1Txt>
            <CityNm>SAN DIEGO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92123</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RAMBAM HEALTH CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAALIA HASNIA 8</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>POINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES</GrantOrContributionPurposeTxt>
          <Amt>133355</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RAMBAM HEALTH CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAALIA HASNIA 8</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREDICTING AND OPTIMIZING DRUG THERAPY IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>208850</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RAMBAM HEALTH CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAALIA HASNIA 8</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID 19 PANDEMIC RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RECTOR &amp; VISITORS OF THE UNIVERSITY OF VIRGINIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROGRAMS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>400195</AddressLine2Txt>
            <CityNm>CHARLOTTESVILLE</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>229044195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>40000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF CALIFORNIA SANTA BARBARA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ENGINEERING SCIENCE BUILDING ROOM</AddressLine1Txt>
            <AddressLine2Txt>3231 C</AddressLine2Txt>
            <CityNm>SANTA BARBARA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>93117</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL PATCH PUMP MECHANISM</GrantOrContributionPurposeTxt>
          <Amt>180000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MICHIGAN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3003 S STATE ST</AddressLine1Txt>
            <CityNm>ANN ARBOR</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>48109</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MINNESOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>401 EAST RIVER ROAD</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>REDEFINING THE FUTURE OF EMERGENCY MEDICINE</GrantOrContributionPurposeTxt>
          <Amt>4220398</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MINNESOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>401 EAST RIVER ROAD</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D</GrantOrContributionPurposeTxt>
          <Amt>350000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGIONAL HEALTH SERVICES OF HOWARD COUNTY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>235 8TH AVE WEST</AddressLine1Txt>
            <CityNm>CRESCO</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52136</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT REGIONAL HEALTH SERVICES OF HOWARD COUNTY</GrantOrContributionPurposeTxt>
          <Amt>9922</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RESEARCH INSTITUTE AT NATIONWIDE CHILDRENS HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>700 CHILDRENS DR</AddressLine1Txt>
            <CityNm>COLUMBUS</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>43205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>40000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RIVER FUND NEW YORK INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>89-11 LEFFERTS BLVD</AddressLine1Txt>
            <CityNm>RICHMOND HILL</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11418</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ROCK COUNTY COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>102 E SOUTH STREET</AddressLine1Txt>
            <CityNm>BASSETT</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68714</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT ROCK COUNTY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>8200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ROSEBUD COMMUNITY HOSPITAL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>383 NORTH 17TH AVENUE</AddressLine1Txt>
            <CityNm>FORSYTH</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AND ADM AT ROSEBUD HEALTH CARE CENTER</GrantOrContributionPurposeTxt>
          <Amt>28152</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ROUNDABOUT THEATRE COMPANY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>231 W 39TH STREET 1200</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10018</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>10000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ROUNDUP MEMORIAL HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1202 3RD STREET WEST</AddressLine1Txt>
            <CityNm>ROUNDUP</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59072</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT ROUNDUP MEMORIAL HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>8842</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RUTGERS THE STATE UNIVERSITY OF NEW JERSEY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>110 BERGEN STREET</AddressLine1Txt>
            <CityNm>NEWARK</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07103</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-1 FOR TREATMENT</GrantOrContributionPurposeTxt>
          <Amt>162601</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RUTGERS THE STATE UNIVERSITY OF NEW JERSEY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>110 BERGEN STREET</AddressLine1Txt>
            <CityNm>NEWARK</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07103</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING LYMPHOCYTE FUNCTION ANTIGEN-1 FOR TREATMENT OF CD</GrantOrContributionPurposeTxt>
          <Amt>155671</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SAGE BIONETWORKS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2901 THIRD AVE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981213014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXTENDING IMPACT OF VEOIBD CONSORTIUM THROUGH RESOURCE SHARING</GrantOrContributionPurposeTxt>
          <Amt>66720</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SAGE BIONETWORKS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2901 THIRD AVE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981213014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXTENDING VEOIBD CONSORTIUM THROUGH RESOURCE SHARING</GrantOrContributionPurposeTxt>
          <Amt>66720</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SAGE BIONETWORKS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2901 THIRD AVE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981213014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING SCIENTIFIC INSIGHTS THROUGH COMMUNITY-BASED RESEARCH</GrantOrContributionPurposeTxt>
          <Amt>888278</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SAINT LOUIS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>221 NORTH GRAND BOULEVARD</AddressLine1Txt>
            <CityNm>SAINT LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>631032006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL TARGET TO FIGHT ALPHA CELL DYSFUNCTION STOP HYPOGLYCEMIA IN T1D</GrantOrContributionPurposeTxt>
          <Amt>341798</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SALVATION ARMY WORLD SERVICE OFFICE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>615 SLATERS LANE</AddressLine1Txt>
            <CityNm>ALEXANDRIA</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22314</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOI</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVE PRIMARY HEALTH CARE SERVICES IN CHIKANKATA, ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>183266</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SANFORD HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1305 W 18TH ST</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57117</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOII</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SANFORD HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>620895</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SANFORD RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2301 E 60TH STREET N</AddressLine1Txt>
            <CityNm>SIOUX FALL</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>571040569</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SANFORD PLEDGE: PHASES 1 AND 2</GrantOrContributionPurposeTxt>
          <Amt>491115</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SAPIR ACADEMIC COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>DN HOF ASHKELON</AddressLine1Txt>
            <CityNm>SHAAR HANEGEV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MECHINA COLLEGE PREPARATORY COMPLEX - RENOVATION &amp; CONSTRUCTION</GrantOrContributionPurposeTxt>
          <Amt>2908773</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SCHWARTZREISMAN SCIENCE EDUCATION CENTER REHOVOT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HERZL ST 234</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT</GrantOrContributionPurposeTxt>
          <Amt>605811</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SCRIPPS HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>10140 CAMPUS POINT DR</AddressLine1Txt>
            <CityNm>SAN DIEGO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92121</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SEATTLE CHILDREN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 5731 M/S S-200</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981455005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF ANTIGEN-SPECIFIC ETREG THERAPY IN T1D</GrantOrContributionPurposeTxt>
          <Amt>1487551</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TASTY &amp; HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>513193</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK</GrantOrContributionPurposeTxt>
          <Amt>235980</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>POPULATION-BASED ANALYSES OF IBD USING ADMINISTRATIVE DATABASE</GrantOrContributionPurposeTxt>
          <Amt>214337</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 EMERGENCY MEDICAL RESPONSE PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHENANDOAH MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 PERSHING AVE</AddressLine1Txt>
            <CityNm>SHENANDOAH</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SHENANDOAH MEDICAL CENTER EEMERGENCY IMPLEMENTATION PROJECT</GrantOrContributionPurposeTxt>
          <Amt>119381</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHERIDAN COUNTY MEMORIAL HOSPITAL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1401 WEST 5TH ST</AddressLine1Txt>
            <CityNm>SHERIDAN</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82801</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>26270</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIMULATION IN MOTION MONTANA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MONTANA MEDICAL ASSOCIATION 2021</AddressLine1Txt>
            <AddressLine2Txt>11TH AVE SUITE 1</AddressLine2Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA</GrantOrContributionPurposeTxt>
          <Amt>612500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIMULATION IN MOTION MONTANA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MONTANA MEDICAL ASSOCIATION 2021</AddressLine1Txt>
            <AddressLine2Txt>11TH AVE SUITE 1</AddressLine2Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA</GrantOrContributionPurposeTxt>
          <Amt>253174</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIMULATION IN MOTION MONTANA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MONTANA MEDICAL ASSOCIATION 2021</AddressLine1Txt>
            <AddressLine2Txt>11TH AVE SUITE 1</AddressLine2Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA</GrantOrContributionPurposeTxt>
          <Amt>145636</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIMULATION IN MOTION MONTANA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MONTANA MEDICAL ASSOCIATION 2021</AddressLine1Txt>
            <AddressLine2Txt>11TH AVE SUITE 1</AddressLine2Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA</GrantOrContributionPurposeTxt>
          <Amt>253173</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIMULATION IN MOTION MONTANA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MONTANA MEDICAL ASSOCIATION 2021</AddressLine1Txt>
            <AddressLine2Txt>11TH AVE SUITE 1</AddressLine2Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA</GrantOrContributionPurposeTxt>
          <Amt>253173</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIOUX EMPIRE TRIAGE CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>132 NORTH DAKOTA AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57104</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SIOUX EMPIRE TRIAGE CENTER</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIOUX VALLEY MEMORIAL HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 SIOUX VALLEY DRIVE</AddressLine1Txt>
            <CityNm>CHEROKEE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51012</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>121396</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SISTERS OF CHARITY OF LEAVENWORTH HEALTH SYSTEM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>500 ELDORADO BLVD STE 4300</AddressLine1Txt>
            <CityNm>BROOMFIELD</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>80021</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SCL HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>99082</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOCIAL SCIENCE RESEARCH COUNCIL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE PIERREPONT PLAZA 15TH FLOOR</AddressLine1Txt>
            <CityNm>BROOKLYN</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA2GO.NYC: HEALTH</GrantOrContributionPurposeTxt>
          <Amt>70000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOS CHILDREN'S VILLAGES-USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1620 I STREET NW SUITE 220</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EDUCATION &amp; EMPOWERMENT IN DEBRE MARKOS &amp; WOLDIYA, ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>1292968</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOS CHILDREN'S VILLAGES-USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1620 I STREET NW SUITE 220</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>2111648</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTH DAKOTA BROADCASTERS ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>106 WEST CAPITOL AVE</AddressLine1Txt>
            <CityNm>PIERRE</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PUBLIC AWARENESS AND BEHAVIOR</GrantOrContributionPurposeTxt>
          <Amt>1110000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTH DAKOTA DIVISION OF PARKS AND RECREATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>523 E CAPITOL AVE</AddressLine1Txt>
            <CityNm>PIERRE</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CUSTER STATE PARK LEGION LAKE FIRE REHABILITATION PROJECT</GrantOrContributionPurposeTxt>
          <Amt>240625</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTH DAKOTA PARKS &amp; WILDLIFE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>523 E CAPITOL</AddressLine1Txt>
            <CityNm>PIERRE</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOIII FI</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CUSTER STATE PARK BISON CENTER</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTH SHORE CONSERVATORY OF MUSIC INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>135 WEBSTER STREET</AddressLine1Txt>
            <CityNm>HANOVER</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02339</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>30000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST VINCENT HEALTHCARE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1233 N 30TH STREET</AddressLine1Txt>
            <CityNm>BILLINGS</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59101</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST ALEXIUS MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>900 EAST BROADWAY AVE</AddressLine1Txt>
            <CityNm>BISMARCK</CityNm>
            <StateAbbreviationCd>ND</StateAbbreviationCd>
            <ZIPCd>585065510</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ST ALEXIUS HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>135487</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST JOHN'S BREAD &amp; LIFE PROGRAM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>795 LEXINGTON AVENUE</AddressLine1Txt>
            <CityNm>BROOKLYN</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11221</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST JOHN'S HOSPITAL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>555 E BROADWAY</AddressLine1Txt>
            <CityNm>JACKSON</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>83001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>50541</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST JOSEPH'S HOSPITAL AND MEDICAL CENTER FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>703 MAIN STREET</AddressLine1Txt>
            <CityNm>PATERSON</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>07503</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST PATRICK HOSPITAL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>502 W SPRUCE ST</AddressLine1Txt>
            <CityNm>MISSOULA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59802</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROVIDENCE HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>50541</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ST PETER'S COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2475 BROADWAY</AddressLine1Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ST. PETER'S HEALTH COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>62676</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>376108</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIABETESWISE-PRO: INCREASING DIABETES DEVICE UPTAKE</GrantOrContributionPurposeTxt>
          <Amt>704175</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>709794</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPANSION &amp; EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT</GrantOrContributionPurposeTxt>
          <Amt>2203369</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>20000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING CAR-EXPRESSING REGULATORY T CELLS TO PANCREATIC ISLETS</GrantOrContributionPurposeTxt>
          <Amt>90459</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>LONGITUDINAL STUDY OF MYOELECTRIC GUTPRINT OF CROHN'S PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>291563</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>OPTIMIZING UPTAKE &amp; SUSTAINED USE OF DIABETES DEVICES WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>48051</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>225000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE EDUCATION AT NEW ONSET OF T1D</GrantOrContributionPurposeTxt>
          <Amt>195947</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STATE OF SOUTH DAKOTA UNIFIED JUDICIAL SYSTEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>500 E CAPITOL AVE</AddressLine1Txt>
            <CityNm>PIERRE</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UNIFIED JUDICIAL SYSTEM CRIMINAL JUSTICE RESPONSES TO MENTAL ILLNESS</GrantOrContributionPurposeTxt>
          <Amt>418840</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STATE OF SOUTH DAKOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 E CAPITOL AVENUE</AddressLine1Txt>
            <CityNm>PIERRE</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SOUTH DAKOTA FIRST RESPONDER AUTOMATED EXTERNAL DEFIBRILLATOR PROJECT</GrantOrContributionPurposeTxt>
          <Amt>294000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STICHTING HEALTH ACTION INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>OVERTOOM 60/II</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SOLVING PROBLEMS OF INSULIN SOURCES AND SUPPLY STUDY</GrantOrContributionPurposeTxt>
          <Amt>1099311</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STICHTING PHARMACCESS INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>AHTC TOWER C4 PAASHEUVELWEG 25</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INVESTING IN QUALITY HEALTHCARE THROUGH SAFECARE</GrantOrContributionPurposeTxt>
          <Amt>397018</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STICHTING PHARMACCESS INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>AHTC TOWER C4 PAASHEUVELWEG 25</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING MEDICINE QUALITY THROUGH DIGITAL PROCUREMENT</GrantOrContributionPurposeTxt>
          <Amt>822634</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SUNY HEALTH SCIENCE CENTER AT SYRACUSE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>750 E ADAMS ST</AddressLine1Txt>
            <CityNm>SYRACUSE</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>13210</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SYNERGOS INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3 EAST 54TH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS</GrantOrContributionPurposeTxt>
          <Amt>1485316</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR T1D</GrantOrContributionPurposeTxt>
          <Amt>655806</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA APPROACH TO IMPROVE OUTCOMES FOR INDIVIDUALS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>354000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR T1D</GrantOrContributionPurposeTxt>
          <Amt>752710</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR T1D</GrantOrContributionPurposeTxt>
          <Amt>3386424</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TALLAHASSEE MEMORIAL HEALTHCARE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1300 MICCOSUKEE RD</AddressLine1Txt>
            <CityNm>TALLAHASSEE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>32303</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TAMPERE UNIVERSITY FOUNDATION SR</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>KALEVANTIE 4</AddressLine1Txt>
            <CityNm>TAMPERE</CityNm>
            <CountryCd>FI</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIRUSES AND ANTIVIRAL IMMUNE MARKERS IN TWO ENDOTYPES OF T1D</GrantOrContributionPurposeTxt>
          <Amt>235290</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TECHNISCHE UNIVERSITAET MUENCHEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ARCISSTRABE 21</AddressLine1Txt>
            <CityNm>MUNCHEN</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FMT FOR MAINTENANCE OF REMISSION IN PEDIATRIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>177980</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE ACADEMIC COLLEGE AT TEL-HAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>TEL-HAI COLLEGE</AddressLine1Txt>
            <CityNm>UPPER GALILEE</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SCIENCE BUILDING FOR HEALTH, ENVIRONMENT, AND BIOTECH STUDIES</GrantOrContributionPurposeTxt>
          <Amt>1984100</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BARUCH PADEH MEDICAL CENTER PORIYA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>DOV HOZ 0</AddressLine1Txt>
            <CityNm>TIBERIAS</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONSTRUCTION OF THE 12-BED INTENSIVE CARE AND RESPIRATION UNIT</GrantOrContributionPurposeTxt>
          <Amt>1077334</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>239643</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>1387769</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>100868</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CENTER FOR EFFECTIVE PHILANTHROPY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>675 MASSACHUSETTS AVENUE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02139</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>41500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHILDREN'S HOSPITAL FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>234 E GRAY STREET</AddressLine1Txt>
            <CityNm>LOUISVILLE</CityNm>
            <StateAbbreviationCd>KY</StateAbbreviationCd>
            <ZIPCd>40202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE</GrantOrContributionPurposeTxt>
          <Amt>533765</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN</GrantOrContributionPurposeTxt>
          <Amt>400533</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>304248</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS</GrantOrContributionPurposeTxt>
          <Amt>573271</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOMARKER OF INNATE IMMUNITY PERTURBATION CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>11893</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE COMMUNICATIONS NETWORK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>777 6TH STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>12000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE DIATRIBE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>804 HAIGHT ST</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94117</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIATRIBE LEARN</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE HARDING FORD VISION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>157-22 TUSKEGEE AIRMEN WAY</AddressLine1Txt>
            <CityNm>JAMAICA</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11433</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE HEALTH &amp; HOUSING CONSORTIUM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>STADIUM STATION PO BOX 524022</AddressLine1Txt>
            <CityNm>BRONX</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10452</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STRATEGY BUILDING FOR HEALTH AND HOUSING CONSORTIUM EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>240000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE HOLE IN THE WALL GANG FUND INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>555 LONG WHARF DRIVE</AddressLine1Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06511</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE HOSPITAL FOR SICK CHILDREN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>555 UNIVERSITY AVE</AddressLine1Txt>
            <CityNm>TORONTO</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD</GrantOrContributionPurposeTxt>
          <Amt>271920</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE HOSPITAL FOR SICK CHILDREN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>555 UNIVERSITY AVE</AddressLine1Txt>
            <CityNm>TORONTO</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEFINING AND DEVELOPING THE THERAPEUTIC PIPELINE FOR VEO-IBD</GrantOrContributionPurposeTxt>
          <Amt>262028</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE LEGATUM INSTITUTE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>11 CHARLES STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UNITED STATES PROSPERITY INDEX</GrantOrContributionPurposeTxt>
          <Amt>236923</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TETHERED CAPSULE ENDOMICROSCOPY VISUALIZATION OF THE CROHN'S BOWEL WALL</GrantOrContributionPurposeTxt>
          <Amt>794394</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>YEZREEL VALLEY</AddressLine1Txt>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AUGMENT EQUIPMENT AND SYSTEMS AT NURSING SCHOOL SIMULATION CENTER</GrantOrContributionPurposeTxt>
          <Amt>183251</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>YEZREEL VALLEY</AddressLine1Txt>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SCHOLARSHIP AND AID FOR ETHIOPIAN-ISRAELIS SEEKING NURSING DEGREES</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MAYORS FUND TO ADVANCE NEW YORK CITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>253 BROADWAY 6TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10007</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A CONCEPTUAL PLAN FOR NYC NEIGHBORHOOD GREENWAYS</GrantOrContributionPurposeTxt>
          <Amt>550000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MAYORS FUND TO ADVANCE NEW YORK CITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>253 BROADWAY 6TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10007</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STRENGTHENING THE NYC EMERGENCY FOOD SYSTEM DURING COVID</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MILKEN INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1250 FOURTH STREET</AddressLine1Txt>
            <CityNm>SANTA MONICA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90401</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CURES FOR LIFE: PATIENT ACCESS TO CELL AND GENE THERAPY</GrantOrContributionPurposeTxt>
          <Amt>325002</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MOUNT SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE GUSTAVE L LEVY PLACE BOX 1049</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE ONE LOVE FOUNDATION IN HONOR OF YEARDLEY LOVE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>44 PONDFIELD ROAD SUITE 12</AddressLine1Txt>
            <CityNm>BRONXVILLE</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10708</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING PROJECT SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>120 THEORY SUITE 200</AddressLine1Txt>
            <CityNm>IRVINE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>926971050</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>945841</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 GILMAN DRIVE - MAIL CODE 0934</AddressLine1Txt>
            <CityNm>LA JOLLA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92093</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PERSONALIZING CROHN'S DISEASE THERAPEUTICS</GrantOrContributionPurposeTxt>
          <Amt>593026</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 GILMAN DRIVE - MAIL CODE 0934</AddressLine1Txt>
            <CityNm>LA JOLLA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92093</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>3D MEDICAL IMAGING PILOT TO IMPROVE CROHN'S SURGICAL OUTCOMES</GrantOrContributionPurposeTxt>
          <Amt>428180</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 GILMAN DRIVE - MAIL CODE 0934</AddressLine1Txt>
            <CityNm>LA JOLLA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92093</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PERSONALIZING CROHN'S DISEASE THERAPEUTICS</GrantOrContributionPurposeTxt>
          <Amt>575441</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 GILMAN DRIVE - MAIL CODE 0934</AddressLine1Txt>
            <CityNm>LA JOLLA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92093</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>3D MEDICAL IMAGING PILOT TO IMPROVE CROHN'S SURGICAL OUTCOMES</GrantOrContributionPurposeTxt>
          <Amt>295887</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 GILMAN DRIVE - MAIL CODE 0934</AddressLine1Txt>
            <CityNm>LA JOLLA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92093</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>490 ILLINOIS STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94158</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ID ANALYSIS OF EXTREME FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY</GrantOrContributionPurposeTxt>
          <Amt>433333</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>490 ILLINOIS STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94158</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FEASIBILITY EVAL OF AID IN PRIMARY CARE AND THROUGH TELEHEALTH</GrantOrContributionPurposeTxt>
          <Amt>620366</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ASK - REMOTE SCREENING AND MONITORING</GrantOrContributionPurposeTxt>
          <Amt>153959</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONTINUOUS GLUCOSE : WHAT FAMILY DOCS AND EDUCATORS NEED TO KNOW</GrantOrContributionPurposeTxt>
          <Amt>90839</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FEASIBILITY EVAL OF AID IN PRIMARY CARE AND THROUGH TELEHEALTH</GrantOrContributionPurposeTxt>
          <Amt>283726</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CULTURALLY SENSITIVE GROUP CLINIC MODEL FOR LATINO PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>574167</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE</GrantOrContributionPurposeTxt>
          <Amt>167721</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONTINUOUS GLUCOSE : WHAT FAMILY DOCS AND EDUCATORS NEED TO KNOW</GrantOrContributionPurposeTxt>
          <Amt>81726</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SDEROT DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>6 BAR LEV STREET</AddressLine1Txt>
            <CityNm>SDEROT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SDEROT MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>715938</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SDEROT DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>6 BAR LEV STREET</AddressLine1Txt>
            <CityNm>SDEROT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESILIENCE COMPLEX, RESILIENCE CENTER AND PARENTHOOD HOUSE</GrantOrContributionPurposeTxt>
          <Amt>1415714</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>TEL-HASHOMER</AddressLine1Txt>
            <CityNm>RAMAT GAN</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>"MSR ON WHEELS" TO SERVE NORTHERN ISRAEL'S HEALTH CARE SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>120544</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>TEL-HASHOMER</AddressLine1Txt>
            <CityNm>RAMAT GAN</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTESTINAL RESPONSE TO MICROBIAL SIGNALS IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>33400</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>TEL-HASHOMER</AddressLine1Txt>
            <CityNm>RAMAT GAN</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMPREHENSIVE INDIVIDUALIZED PROACTIVE THERAPY OF CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>255306</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>TEL-HASHOMER</AddressLine1Txt>
            <CityNm>RAMAT GAN</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CRITICAL CORONA CARE INTENSIVE CARE UNIT</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SONIA NABETA FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 2222</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100082222</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROJECT BODA-BODA</GrantOrContributionPurposeTxt>
          <Amt>270054</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE TEL AVIV JAFFA ACADEMIC COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>RABENU YERUHAM ST POB 8401</AddressLine1Txt>
            <CityNm>TEL AVIV YAFFO</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SCHOLARSHIPS FOR ULTRA-ORTHODOX MEN PURSUING NURSING DEGREES</GrantOrContributionPurposeTxt>
          <Amt>573359</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS</GrantOrContributionPurposeTxt>
          <Amt>411939</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE CONNECTOME OF THE HUMAN ENTERIC SYSTEM IN HEALTH AND CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>223430</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>487806</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS</GrantOrContributionPurposeTxt>
          <Amt>411939</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>788086</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DECIPHERING FACTORS DRIVING INCREASED INCIDENCE OF CROHN'S IN CHINA</GrantOrContributionPurposeTxt>
          <Amt>107892</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>788085</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE WEIZMANN QUANTUM NANO-PHYSICS INITIATIVE</GrantOrContributionPurposeTxt>
          <Amt>159809</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TIDEPOOL PROJECT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>555 BRYANT ST 429</AddressLine1Txt>
            <CityNm>PALO ALTO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94301</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPANDING THE AVAILABILITY OF THE LOOP AID SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>1010231</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TOWNSEND HEALTH SYSTEMS INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>110 NORTH OAK</AddressLine1Txt>
            <CityNm>TOWNSEND</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59644</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT BROADWATER HEALTH CENTER</GrantOrContributionPurposeTxt>
          <Amt>32329</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRICKLE UP PROGRAM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 WEST 27TH STREET 12TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRINITY HOSPITALS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 BURDICK EXPRESSWAY WEST</AddressLine1Txt>
            <CityNm>MINOT</CityNm>
            <StateAbbreviationCd>ND</StateAbbreviationCd>
            <ZIPCd>58701</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TRINITY HOSPITALS COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>86947</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF INDIANA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>509 E 3RD ST</AddressLine1Txt>
            <CityNm>BLOOMINGTON</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>474013654</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF REGULATORY ROADMAP FOR BOWEL PREP FOR CD</GrantOrContributionPurposeTxt>
          <Amt>353894</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF INDIANA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>509 E 3RD ST</AddressLine1Txt>
            <CityNm>BLOOMINGTON</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>474013654</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING FAMILY MANAGEMENT AND GLYCEMIC CONTROL IN YOUTH W T1D</GrantOrContributionPurposeTxt>
          <Amt>20273</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF INDIANA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>509 E 3RD ST</AddressLine1Txt>
            <CityNm>BLOOMINGTON</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>474013654</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DURABLE ISLET TRANSPLANT BY ADMINISTRATING ENGINEERED T CELLS</GrantOrContributionPurposeTxt>
          <Amt>478518</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>40000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED HOSPITAL FUND OF NEW YORK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1411 BROADWAY</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10018</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK STATE MEDICAL RESPITE PILOT PROGRAM DESIGN</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED OSTOMY ASSOCIATIONS OF AMERICA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 525</AddressLine1Txt>
            <CityNm>KENNEBUNK</CityNm>
            <StateAbbreviationCd>ME</StateAbbreviationCd>
            <ZIPCd>040430525</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF CROHN'S DISEASE CONTENT AND AWARENESS</GrantOrContributionPurposeTxt>
          <Amt>29882</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED OSTOMY ASSOCIATIONS OF AMERICA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 525</AddressLine1Txt>
            <CityNm>KENNEBUNK</CityNm>
            <StateAbbreviationCd>ME</StateAbbreviationCd>
            <ZIPCd>040430525</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF CROHN'S DISEASE CONTENT AND AWARENESS</GrantOrContributionPurposeTxt>
          <Amt>29883</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED STATES AFRICAN DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1400 I STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>LIVELIHOOD IMPROVEMENT PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>1436892</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITE CATHOLIQUE DE LOUVAIN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PLACE DE LUNIVERSITE 1</AddressLine1Txt>
            <CityNm>LOUVAINLANEUVE</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIRECT AND INDIRECT CAUSES FOR THE IMPAIRED GLUCAGON SECRETION IN T1D</GrantOrContributionPurposeTxt>
          <Amt>243257</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1001 MAIN ST</AddressLine1Txt>
            <CityNm>BUFFALO</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>14203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>GOWER STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SPIT-C: USING SALIVA TO PREDICT CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>63267</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY HOSPITALS HEALTH SYSTEM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11100 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44106</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>40000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF CAMBRIDGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>THE OLD SCHOOLS TRINITY LANE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>170680</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF EXETER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>NORTHCOTE HOUSE THE QUEENS DRIVE</AddressLine1Txt>
            <CityNm>EXETER</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D</GrantOrContributionPurposeTxt>
          <Amt>324520</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER &amp; TECHNOLOGY</GrantOrContributionPurposeTxt>
          <Amt>50085</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>1208349</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>379382</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF GLASGOW COURT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY AVENUE</AddressLine1Txt>
            <CityNm>GLASGOW</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE CLINICAL EFFECTIVENESS OF CD-TREAT IN PATIENTS WITH ACTIVE CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>260860</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF IOWA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DIVISION OF SPONSORED PROGRAMS 2</AddressLine1Txt>
            <AddressLine2Txt>GILMORE HALL</AddressLine2Txt>
            <CityNm>IOWA CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52442</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RUPRI HEALTH PANEL SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>167554</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF IOWA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DIVISION OF SPONSORED PROGRAMS 2</AddressLine1Txt>
            <AddressLine2Txt>GILMORE HALL</AddressLine2Txt>
            <CityNm>IOWA CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52442</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SIMULATION IN MOTION IOWA (SIM-IA)</GrantOrContributionPurposeTxt>
          <Amt>3770195</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF IOWA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DIVISION OF SPONSORED PROGRAMS 2</AddressLine1Txt>
            <AddressLine2Txt>GILMORE HALL</AddressLine2Txt>
            <CityNm>IOWA CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52442</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 LAKE AVENUE NORTH</AddressLine1Txt>
            <CityNm>WORCESTER</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01655</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MELBOURNE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ALAN GILBERT BUILDING 161 BARRY</AddressLine1Txt>
            <AddressLine2Txt>STREET LEVEL 4</AddressLine2Txt>
            <CityNm>CARLTON</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>549121</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MELBOURNE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ALAN GILBERT BUILDING 161 BARRY</AddressLine1Txt>
            <AddressLine2Txt>STREET LEVEL 4</AddressLine2Txt>
            <CityNm>CARLTON</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT AND EVALUATION OF A CONTINUOUS KETONE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>82000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1320 SOUTH DIXIE HIGHWAY SUITE 650</AddressLine1Txt>
            <CityNm>CORAL GABLES</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33146</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A HOLISTIC DIET INTERVENTION FOR PEOPLE WITH CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>374435</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1320 SOUTH DIXIE HIGHWAY SUITE 650</AddressLine1Txt>
            <CityNm>CORAL GABLES</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33146</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOP A METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICE</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NEBRASKA FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1010 LINCOLN MALL</AddressLine1Txt>
            <CityNm>LINCOLN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOBILE RURAL HEALTHCARE PROVIDER TRAINING</GrantOrContributionPurposeTxt>
          <Amt>592963</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NEBRASKA FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1010 LINCOLN MALL</AddressLine1Txt>
            <CityNm>LINCOLN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEBRASKA COVID-19 CARDIAC PREPAREDNESS AND SIMULATION IN MOTION</GrantOrContributionPurposeTxt>
          <Amt>1496078</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SURVEILLANCE EPIDEMIOLOGY OF CORONAVIRUS UNDER RESEARCH FOR IBD</GrantOrContributionPurposeTxt>
          <Amt>157946</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>472065</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFYING MOLECULAR PROFILES OF POST-OPERATIVE CD OUTCOMES</GrantOrContributionPurposeTxt>
          <Amt>581625</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANTI-TNF COMBINATION CLINICAL TRIAL IN PEDIATRIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>91810</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SURVEILLANCE EPIDEMIOLOGY OF COVID UNDER RESEARCH EXCLUSION IBD</GrantOrContributionPurposeTxt>
          <Amt>152143</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1100 N LINDSAY</AddressLine1Txt>
            <CityNm>OKLAHOMA CITY</CityNm>
            <StateAbbreviationCd>OK</StateAbbreviationCd>
            <ZIPCd>731260901</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INNATE AND ADAPTIVE THERAPEUTIC TARGETS OF VEO IBD</GrantOrContributionPurposeTxt>
          <Amt>110000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 ANTIBODY RESPONSE UNDER SUSTAINED IMMUNE SUPPRESSION</GrantOrContributionPurposeTxt>
          <Amt>608272</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PHARMACOLOGICAL MODULATION TO ADDRESS GLUCAGON SECRETION IN T1D</GrantOrContributionPurposeTxt>
          <Amt>18215</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INNATE AND ADAPTIVE THERAPEUTIC TARGETS OF VEO-IBD - OXFORD STUDIES</GrantOrContributionPurposeTxt>
          <Amt>110000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF SOUTH FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3702 SPECTRUM BLVD SUITE 165</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33612</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF SOUTHERN CALIFORNIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>SPONSORED PROJECTS ACCOUNTING</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>900742095</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF TEXAS SYSTEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1616 GUADALUPE STREET</AddressLine1Txt>
            <CityNm>AUSTIN</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78701</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MAPPING THE CROSSTALK IN THE EPITHELIUM-MICROBIOME-IMMUNE AXIS</GrantOrContributionPurposeTxt>
          <Amt>378343</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF TEXAS SYSTEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1616 GUADALUPE STREET</AddressLine1Txt>
            <CityNm>AUSTIN</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78701</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MAPPING THE CROSSTALK IN THE EPITHELIUM-MICROBIOME-IMMUNE AXIS</GrantOrContributionPurposeTxt>
          <Amt>487302</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF UTAH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>201 S PRESIDENTS CIRCLE</AddressLine1Txt>
            <CityNm>SALT LAKE CITY</CityNm>
            <StateAbbreviationCd>UT</StateAbbreviationCd>
            <ZIPCd>84112</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANTI-PHAGE ANTIBODIES: CROHNS DISEASE DIAGNOSIS AND TREATMENT</GrantOrContributionPurposeTxt>
          <Amt>245583</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF VIRGINIA LAW SCHOOL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>580 MASSIE ROAD</AddressLine1Txt>
            <CityNm>CHARLOTTESVILLE</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22903</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF WASHINGTON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4333 BROOKLYN AVE NE BOX 359472</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981959472</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMPUTATIONAL DESIGN OF GLUCOSE RESPONSIVE CYCLIC PEPTIDES</GrantOrContributionPurposeTxt>
          <Amt>274851</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF WASHINGTON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4333 BROOKLYN AVE NE BOX 359472</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981959472</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SKIN PATHOLOGY IN PEOPLE WITH T1D: IMPACT OF INSULIN INFUSION VIA PUMP</GrantOrContributionPurposeTxt>
          <Amt>323566</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF WASHINGTON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4333 BROOKLYN AVE NE BOX 359472</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981959472</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY PHYSICIAN GROUP</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>400 MACK AVE</AddressLine1Txt>
            <CityNm>DETROIT</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>48201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORTING INDIVIDUALS IN NEED WITH T1D IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVESITAIR MEDISCH CENTRUM UTRECHT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HEIDELBERGLAAN 100</AddressLine1Txt>
            <CityNm>UTRECHT</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPITHELIAL BASED DIAGNOSTICS FOR VEO-IBD</GrantOrContributionPurposeTxt>
          <Amt>82500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVESITAIR MEDISCH CENTRUM UTRECHT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HEIDELBERGLAAN 100</AddressLine1Txt>
            <CityNm>UTRECHT</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPITHELIAL BASED DIAGNOSTICS FOR VEO-IBD</GrantOrContributionPurposeTxt>
          <Amt>82500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UPPSALA UNIVERSITET</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BOX 256</AddressLine1Txt>
            <CityNm>UPPSALA</CityNm>
            <CountryCd>SW</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION</GrantOrContributionPurposeTxt>
          <Amt>72756</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VAN BUREN COUNTY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>304 FRANKLIN STREET</AddressLine1Txt>
            <CityNm>KEOSAUQUA</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52565</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT VAN BUREN COUNTY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>44413</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3319 WEST END AVENUE SUITE 970</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S DISEASE GUT CELL ATLAS</GrantOrContributionPurposeTxt>
          <Amt>509159</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3319 WEST END AVENUE SUITE 970</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPING AN ISLET MODEL THAT MIMICS T1D</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2201 WEST END AVE</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37235</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UNDERSTANDING CALCIUM SIGNALING IN ALPHA CELLS IN T1D</GrantOrContributionPurposeTxt>
          <Amt>225833</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VILLAGES OF HOPE AFRICA SOCIETY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>2450 MILLTOWER COURT</AddressLine1Txt>
            <CityNm>MISSISSAUGA</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ZAMBIA DEVELOPMENT: FOOD PRODUCTION, WATER SUPPLY, EDUCATION</GrantOrContributionPurposeTxt>
          <Amt>655350</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VIVLI INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>14 STORY STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02138</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIVLI GLOBAL PLATFORM FOR OPEN REPRODUCIBLE CLINICAL RESEARCH</GrantOrContributionPurposeTxt>
          <Amt>200918</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VIVLI INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>14 STORY STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02138</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIVLI GLOBAL PLATFORM FOR OPEN REPRODUCIBLE CLINICAL RESEARCH</GrantOrContributionPurposeTxt>
          <Amt>78000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>660 S EUCLID AVE</AddressLine1Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>63110</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VACCINE SAFETY AND EFFICACY</GrantOrContributionPurposeTxt>
          <Amt>473975</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>660 S EUCLID AVE</AddressLine1Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>63110</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MANIPULATING ALPHA CELL SIGNALING TO RESTORE NORMAL GLUCAGON SECRETORY</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>660 S EUCLID AVE</AddressLine1Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>63110</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING GLUCAGON ASSAYS FOR STUDIES TO PREVENT HYPOGLYCEMIA IN T1D</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WATERAID AMERICA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>233 BROADWAY</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10279</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>1933789</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1300 YORK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100654805</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING THE MYCOBIOME IN CROHNS DISEASE</GrantOrContributionPurposeTxt>
          <Amt>283902</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WEST PARK HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>707 SHERIDAN AVENUE</AddressLine1Txt>
            <CityNm>CODY</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82414</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CODY CARDIOLOGY CENTER CATHETERIZATION LABORATORY PROJECT</GrantOrContributionPurposeTxt>
          <Amt>95674</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WEST SIDE CENTER FOR COMMUNITY LIFE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>263 WEST 86TH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10024</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 PANDEMIC EMERGENCY ASSISTANCE: FOOD SECURITY IN NYC</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WILDLIFE CONSERVATION SOCIETY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2300 SOUTHERN BOULEVARD</AddressLine1Txt>
            <CityNm>BRONX</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10460</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>10000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WNET FOR THE WLIW-21 PUBLIC BROADCASTING</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>825 EIGHTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100197435</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>5000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WORLD AFFAIRS COUNCIL OF NORTHERN CALIFORNIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>312 SUTTER STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>33000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WORLD VISION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>34834 WEYERHAEUSER WAY SOUTH</AddressLine1Txt>
            <CityNm>FEDERAL WAY</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FLOOD MITIGATION AND COMMUNITY RESILIENCE PHASE 2</GrantOrContributionPurposeTxt>
          <Amt>615413</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING COMMUNITY FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1472 NORTH 5TH STREET</AddressLine1Txt>
            <CityNm>LARAMIE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82072</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WYOMING COVID CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>120138</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING DEPARTMENT OF HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6101 YELLOWSTONE RD SUITE 400</AddressLine1Txt>
            <CityNm>CHEYENNE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82009</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WYOMING FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>3731196</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING MEDICAL CENTER FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1233 E SECOND ST</AddressLine1Txt>
            <CityNm>CASPER</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOI</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WYOMING MEDICAL CENTER COVID-19 CARDIAC PREPAREDNESS PROJECT</GrantOrContributionPurposeTxt>
          <Amt>196164</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING STATE PARKS AND CULTURAL RESOURCES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2301 CENTRAL AVENUE</AddressLine1Txt>
            <CityNm>CHEYENNE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82002</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE</GrantOrContributionPurposeTxt>
          <Amt>185000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YAD SARAH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>124 HERZL BLVD</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOBILE DENTAL CLINICS FOR ISRAEL'S PERIPHERY</GrantOrContributionPurposeTxt>
          <Amt>136850</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROJECTS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>208327</AddressLine2Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>065208327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS</GrantOrContributionPurposeTxt>
          <Amt>330246</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROJECTS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>208327</AddressLine2Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>065208327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS</GrantOrContributionPurposeTxt>
          <Amt>330798</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROJECTS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>208327</AddressLine2Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>065208327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EMERGENCY SUPPORT FOR T1D POPULATIONS IMPACTED BY COVID-19</GrantOrContributionPurposeTxt>
          <Amt>50000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YITZHAK SHAMIR MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ZERIFIN</AddressLine1Txt>
            <CityNm>BEER YAAKOV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID 19 PANDEMIC RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YOUNG MEN'S CHRISTIAN ASSOCIATION OF GREATER NEW YORK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5 WEST 63RD STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10023</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>5000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YOUNG MEN'S CHRISTIAN ASSOCIATION RETIREMENT FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>120 BROADWAY</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10271</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOI</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>10000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YOUTH DEVELOPMENT ORGANIZATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15 UNION STREET 563</AddressLine1Txt>
            <CityNm>LAWRENCE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01840</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EDUCATION AND CHARACTER DEVELOPMENT FOR LOCAL YOUTH</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ZEFAT ACADEMIC COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>11 JERUSALEM STREET POB 160</AddressLine1Txt>
            <CityNm>ZEFAT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EQUIPPING THE MEDICAL SIMULATION &amp; TRAINING CENTER</GrantOrContributionPurposeTxt>
          <Amt>1103914</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>262300602</TotalGrantOrContriPdDurYrAmt>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>4YOUANDME</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2901 THIRD AVENUE</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>98121</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WEARABLES TO MEASURE STRESS AND FORECAST CROHN'S SYMPTOMS</GrantOrContributionPurposeTxt>
          <Amt>84107</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>A GLIMMER OF HOPE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3600 N CAPITAL OF TEXAS HWY</AddressLine1Txt>
            <CityNm>AUSTIN</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78746</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PF</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>2579190</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AGRICULTURAL RESEARCH ORGANIZATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>DERECH HAMACCABIM 68 RISHON</AddressLine1Txt>
            <AddressLine2Txt>LETSIYON</AddressLine2Txt>
            <CityNm>RISHON LETSIYON</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE HELMSLEY CENTER FOR AI IN AGRICULTURE AT THE VOLCANI CENTER</GrantOrContributionPurposeTxt>
          <Amt>1591900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALIMENTIV INC (FKA ROBARTS)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>100 DUNDAS STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>542299</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ALIMENTIV INC (FKA ROBARTS)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>100 DUNDAS STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>522727</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMC MEDICAL RESEARCH BV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MEIBERGDREEF 9</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>50570</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMC MEDICAL RESEARCH BV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MEIBERGDREEF 9</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>942690</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMC MEDICAL RESEARCH BV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MEIBERGDREEF 9</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>50570</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMC MEDICAL RESEARCH BV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>MEIBERGDREEF 9</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>610817</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN DIABETES ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2451 CRYSTAL DRIVE SUITE 900</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PATRON SUPPORT OF THE ASSOCIATION'S 79TH, 80TH, AND 81ST SESSIONS</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN DIABETES ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2451 CRYSTAL DRIVE SUITE 900</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL PROJECTS</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN DIABETES ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2451 CRYSTAL DRIVE SUITE 900</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL PROJECTS</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN HEART ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7272 GREENVILLE AVENUE</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>75231</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MISSION: LIFELINE STROKE SYSTEM OF CARE IN NEBRASKA</GrantOrContributionPurposeTxt>
          <Amt>1034941</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN HEART ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7272 GREENVILLE AVENUE</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>75231</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MISSION: LIFELINE STROKE AND POST-ACUTE STROKE CARE STANDARDS</GrantOrContributionPurposeTxt>
          <Amt>1835938</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN HEART ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>7272 GREENVILLE AVENUE</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>75231</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MISSION: LIFELINE STROKE AND POST-ACUTE STROKE CARE QUALITY STANDARDS</GrantOrContributionPurposeTxt>
          <Amt>1654728</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>APHP ST ANTOINE HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>184 RUE DU FAUBOURG SAINT-ANTOINE</AddressLine1Txt>
            <CityNm>PARIS</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>474464</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>APHP ST ANTOINE HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>184 RUE DU FAUBOURG SAINT-ANTOINE</AddressLine1Txt>
            <CityNm>PARIS</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>474464</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>APHP ST ANTOINE HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>184 RUE DU FAUBOURG SAINT-ANTOINE</AddressLine1Txt>
            <CityNm>PARIS</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>367130</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>APHP ST ANTOINE HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>184 RUE DU FAUBOURG SAINT-ANTOINE</AddressLine1Txt>
            <CityNm>PARIS</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>421680</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASIAN HEALTH CARE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>6-3-661 SOMAJIGUDA</AddressLine1Txt>
            <CityNm>HYDERABAD</CityNm>
            <CountryCd>IN</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ACCESS TO CROHN'S DIAGNOSTICS IN INDIA FOR PATIENTS LIVING IN POVERTY</GrantOrContributionPurposeTxt>
          <Amt>210551</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASSOCIATION OF DIABETES CARE &amp; EDUCATION SPECIALISTS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>125 S WACKER DRIVE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60606</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS</GrantOrContributionPurposeTxt>
          <Amt>216544</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASSOCIATION SANTE DIABETE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>17 AVENUE MALHERBE</AddressLine1Txt>
            <CityNm>GRENOBLE</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIABETES SUPPORT IN BURKINA FASO, MALI AND UNION OF COMOROS</GrantOrContributionPurposeTxt>
          <Amt>272362</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ASSOCIATION SANTE DIABETE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>17 AVENUE MALHERBE</AddressLine1Txt>
            <CityNm>GRENOBLE</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIABETES SUPPORT TO BURKINA FASO, MALI AND UNION OF COMOROS</GrantOrContributionPurposeTxt>
          <Amt>205984</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>55 VICTORIA PARADE LEVEL 2</AddressLine1Txt>
            <CityNm>FITZROY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>285429</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>55 VICTORIA PARADE LEVEL 2</AddressLine1Txt>
            <CityNm>FITZROY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>907233</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>55 VICTORIA PARADE LEVEL 2</AddressLine1Txt>
            <CityNm>FITZROY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>456536</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>55 VICTORIA PARADE LEVEL 2</AddressLine1Txt>
            <CityNm>FITZROY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>285429</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3900 W AVERA DR</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TELEHEALTH EDUCATION PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>1346286</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1325 S CLIFF AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57105</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA BEHAVIORAL HEALTH CENTER EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1325 S CLIFF AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57105</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA BEHAVIORAL HEALTH CENTER EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>3000000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1325 S CLIFF AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57105</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA BEHAVIORAL HEALTH CENTER EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1325 S CLIFF AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57105</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA BEHAVIORAL HEALTH CENTER EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1325 S CLIFF AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57105</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA BEHAVIORAL HEALTH CENTER EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1325 S CLIFF AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57105</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AVERA BEHAVIORAL HEALTH CENTER EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AVERA MERRILL PIONEER HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1100 S 10TH AVE</AddressLine1Txt>
            <CityNm>ROCK RAPIDS</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51246</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY AT AVERA MERRILL PIONEER HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>19959</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BARZILAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAHISTADROUT ST 2</AddressLine1Txt>
            <CityNm>ASHKELON</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BUILD-OUT OF NEW FORTIFIED SURGICAL DEPARTMENT</GrantOrContributionPurposeTxt>
          <Amt>1586700</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BARZILAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAHISTADROUT ST 2</AddressLine1Txt>
            <CityNm>ASHKELON</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BUILD-OUT OF NEW FORTIFIED SURGICAL DEPARTMENT</GrantOrContributionPurposeTxt>
          <Amt>1519500</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BETH ISRAEL DEACONESS MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>330 BROOKLINE AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022155491</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROACTIVE OPTIMIZATION USING A PHARMACOKINETIC DASHBOARD</GrantOrContributionPurposeTxt>
          <Amt>519550</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BETH ISRAEL DEACONESS MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>330 BROOKLINE AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022155491</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROACTIVE OPTIMIZATION USING A PHARMACOKINETIC DASHBOARD</GrantOrContributionPurposeTxt>
          <Amt>519548</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BETH ISRAEL DEACONESS MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>330 BROOKLINE AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022155491</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A DASHBOARD</GrantOrContributionPurposeTxt>
          <Amt>538077</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BETH ISRAEL DEACONESS MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>330 BROOKLINE AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022155491</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROACTIVE OPTIMIZATION OF USING A PHARMACOKINETIC DASHBOARD</GrantOrContributionPurposeTxt>
          <Amt>538077</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BETH ISRAEL DEACONESS MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>330 BROOKLINE AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>022155491</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROACTIVE OPTIMIZATION USING A PHARMACOKINETIC DASHBOARD</GrantOrContributionPurposeTxt>
          <Amt>526637</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BIG HORN HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>17 N MILES AVE</AddressLine1Txt>
            <CityNm>HARDIN</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59034</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY</GrantOrContributionPurposeTxt>
          <Amt>24948</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BIPARTISAN POLICY CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1225 I ST NW 1000</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RURAL HEALTH CARE TASK FORCE</GrantOrContributionPurposeTxt>
          <Amt>149200</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BOSTON MEDICAL CENTER CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE BOSTON MEDICAL PLACE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02118</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STAGING CROHN'S DISEASE USING MUCOSAL EXOSOMES</GrantOrContributionPurposeTxt>
          <Amt>82998</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BOSTON MEDICAL CENTER CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE BOSTON MEDICAL PLACE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02118</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STAGING CROHN'S DISEASE USING MUCOSAL EXOSOMES</GrantOrContributionPurposeTxt>
          <Amt>51814</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIDGES TO PROSPERITY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1031 33RD STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ZAMBIA ASSESSMENT OF BRIDGE INFRASTRUCTURE</GrantOrContributionPurposeTxt>
          <Amt>142110</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIDGES TO PROSPERITY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1031 33RD STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ETHIOPIA ASSESSMENT OF BRIDGE INFRASTRUCTURE</GrantOrContributionPurposeTxt>
          <Amt>142110</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>75 FRANCIS STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS</GrantOrContributionPurposeTxt>
          <Amt>3031033</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>75 FRANCIS STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS</GrantOrContributionPurposeTxt>
          <Amt>1544914</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRIGHAM AND WOMEN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>75 FRANCIS STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS</GrantOrContributionPurposeTxt>
          <Amt>940787</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BURGESS HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1600 DIAMOND STREET</AddressLine1Txt>
            <CityNm>ONAWA</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51040</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY AT BURGESS HEALTH CENTER</GrantOrContributionPurposeTxt>
          <Amt>33587</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HILLS ROAD</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS</GrantOrContributionPurposeTxt>
          <Amt>312018</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HILLS ROAD</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS</GrantOrContributionPurposeTxt>
          <Amt>292476</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HILLS ROAD</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS</GrantOrContributionPurposeTxt>
          <Amt>268528</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HILLS ROAD</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS</GrantOrContributionPurposeTxt>
          <Amt>313576</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HILLS ROAD</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UK IBD BIORESOURCE: TRANSLATING TODAY'S SCIENCE INTO CD TREATMENTS</GrantOrContributionPurposeTxt>
          <Amt>313576</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARILION MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1906 BELLEVIEW AVENUE</AddressLine1Txt>
            <CityNm>ROANOKE</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>24014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESTABLISHING NEW PARADIGMS IN PRE-CLINICAL CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>388860</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARILION MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1906 BELLEVIEW AVENUE</AddressLine1Txt>
            <CityNm>ROANOKE</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>24014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESTABLISHING NEW PARADIGMS IN PRE-CLINICAL CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>181208</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CARILION MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1906 BELLEVIEW AVENUE</AddressLine1Txt>
            <CityNm>ROANOKE</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>24014</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESTABLISHING NEW PARADIGMS IN PRE-CLINICAL CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>207652</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMMUNITY RECOVERY AND RESILIENCE IN EASTERN ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>2752636</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR DEVELOPMENT</GrantOrContributionPurposeTxt>
          <Amt>1597757</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELPING ZAMBIAN MOTHERS &amp; NEWBORNS SURVIVE &amp; THRIVE</GrantOrContributionPurposeTxt>
          <Amt>1066649</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVED WASH INFRASTRUCTURE &amp; SERVICES</GrantOrContributionPurposeTxt>
          <Amt>2045026</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT</GrantOrContributionPurposeTxt>
          <Amt>2589304</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RURAL EMERGENCY HEALTH SERVICE AND TRANSPORT</GrantOrContributionPurposeTxt>
          <Amt>1344542</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELPING ZAMBIAN MOTHERS &amp; NEWBORNS SURVIVE &amp; THRIVE</GrantOrContributionPurposeTxt>
          <Amt>1100098</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT</GrantOrContributionPurposeTxt>
          <Amt>1556214</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CATHOLIC RELIEF SERVICES-USCCB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>228 W LEXINGTON ST</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21201</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVED WASH INFRASTRUCTURE &amp; SERVICES</GrantOrContributionPurposeTxt>
          <Amt>749145</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING MICROORGANISMS IN CREEPING FAT</GrantOrContributionPurposeTxt>
          <Amt>393039</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING MICROORGANISMS IN CREEPING FAT</GrantOrContributionPurposeTxt>
          <Amt>375747</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATING GENOMIC AND IMAGING DATA TO UNDERSTAND CD</GrantOrContributionPurposeTxt>
          <Amt>268151</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CEDARS-SINAI MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>8700 BEVERLY BLVD</AddressLine1Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90048</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATING GENOMIC AND IMAGING DATA TO UNDERSTAND CD</GrantOrContributionPurposeTxt>
          <Amt>231849</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR EXCELLENCE IN HEALTH CARE JOURNALISM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>10 NEFF HALL</AddressLine1Txt>
            <CityNm>COLUMBIA</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>65211</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOII</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND REPORTING</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTER FOR EXCELLENCE IN HEALTH CARE JOURNALISM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>10 NEFF HALL</AddressLine1Txt>
            <CityNm>COLUMBIA</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>65211</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOII</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND REPORTING</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHASE COUNTY COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 WEST 12TH STREET</AddressLine1Txt>
            <CityNm>IMPERIAL</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>69033</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>29056</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHASE COUNTY COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 WEST 12TH STREET</AddressLine1Txt>
            <CityNm>IMPERIAL</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>69033</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>12656</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLUCOSE-RESPONSIVE APPROACHES TO INSULIN AND GLUCAGON DELIVERY</GrantOrContributionPurposeTxt>
          <Amt>567507</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>374591</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>374591</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>374591</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 414413 ATTN RESEARCH FINANCE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>022414413</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>374591</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL LOS ANGELES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>SABAN RESEARCH INSTITUTE 4650</AddressLine1Txt>
            <AddressLine2Txt>SUNSET BOULEVARD MS 142</AddressLine2Txt>
            <CityNm>LOS ANGELES</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90027</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TEAM CLINIC: EXPANSION OF A CARE MODEL FOR ADOLESCENTS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>360832</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 BURNET AVENUE</AddressLine1Txt>
            <CityNm>CINCINNATI</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>45229</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PRECISION CROHN'S DISEASE MANAGEMENT UTILIZING PREDICTIVE PROTEIN</GrantOrContributionPurposeTxt>
          <Amt>560860</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 BURNET AVENUE</AddressLine1Txt>
            <CityNm>CINCINNATI</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>45229</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>692740</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 BURNET AVENUE</AddressLine1Txt>
            <CityNm>CINCINNATI</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>45229</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PRECISION CROHN'S MANAGEMENT UTILIZING PREDICTIVE PROTEIN PANELS</GrantOrContributionPurposeTxt>
          <Amt>222483</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 BURNET AVENUE</AddressLine1Txt>
            <CityNm>CINCINNATI</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>45229</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>282554</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL OF PHILADELPHIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2716 SOUTH STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191462305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S DISEASE STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM</GrantOrContributionPurposeTxt>
          <Amt>424937</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL OF PHILADELPHIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2716 SOUTH STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191462305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM</GrantOrContributionPurposeTxt>
          <Amt>281734</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HOSPITAL OF PHILADELPHIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2716 SOUTH STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191462305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM</GrantOrContributionPurposeTxt>
          <Amt>272676</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S HUNGER FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>13931 BALBOA BLVD</AddressLine1Txt>
            <CityNm>SYLMAR</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>91342</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOOD SUPPORT IN ETHIOPIA AND ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>151800</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S MERCY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2401 GILLHAM ROAD</AddressLine1Txt>
            <CityNm>KANSAS CITY</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>64108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TYPE 1 DIABETES RAPID LEARNING LAB</GrantOrContributionPurposeTxt>
          <Amt>1387611</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S MERCY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2401 GILLHAM ROAD</AddressLine1Txt>
            <CityNm>KANSAS CITY</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>64108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TYPE 1 DIABETES RAPID LEARNING LAB</GrantOrContributionPurposeTxt>
          <Amt>1387612</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S MERCY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2401 GILLHAM ROAD</AddressLine1Txt>
            <CityNm>KANSAS CITY</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>64108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TYPE 1 DIABETES RAPID LEARNING LAB</GrantOrContributionPurposeTxt>
          <Amt>1399623</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CHILDREN'S MERCY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2401 GILLHAM ROAD</AddressLine1Txt>
            <CityNm>KANSAS CITY</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>64108</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TYPE 1 DIABETES RAPID LEARNING LAB</GrantOrContributionPurposeTxt>
          <Amt>1399624</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CITY PARKS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>830 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NYC GREEN RELIEF &amp; RECOVERY FUND</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CITY PARKS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>830 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES</GrantOrContributionPurposeTxt>
          <Amt>479444</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CITY PARKS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>830 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES</GrantOrContributionPurposeTxt>
          <Amt>491131</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CITY PARKS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>830 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10065</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NYC GREEN RELIEF &amp; RECOVERY FUND</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>KIRYAT SHMONA MEDICAL CLINIC</GrantOrContributionPurposeTxt>
          <Amt>1405714</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>YOSEFTAL HOSPITAL ADDITION</GrantOrContributionPurposeTxt>
          <Amt>2058214</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL &amp; PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>209642</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS</GrantOrContributionPurposeTxt>
          <Amt>582660</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY CROHN'S: UNDERSTANDING PATHOGENESIS, BEHAVIOR, RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>112000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ISRAELI IBD RESEARCH NUCLEUS (IIRN): CONSORTIUM MANAGEMENT</GrantOrContributionPurposeTxt>
          <Amt>32000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>552715</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD</GrantOrContributionPurposeTxt>
          <Amt>165855</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD</GrantOrContributionPurposeTxt>
          <Amt>242153</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>552715</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>KIRYAT SHMONA MEDICAL CLINIC</GrantOrContributionPurposeTxt>
          <Amt>1118393</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>YOSEFTAL HOSPITAL ADDITION</GrantOrContributionPurposeTxt>
          <Amt>3847500</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD</GrantOrContributionPurposeTxt>
          <Amt>177281</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL &amp; PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>242153</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>919309</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL &amp; PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>243216</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>919308</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLALIT HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>101 ARLOZOROV STREET</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL &amp; PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>243216</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CLARINDA REGIONAL HEALTH CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>220 ESSIE DAVISON DRIVE</AddressLine1Txt>
            <CityNm>CLARINDA</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51632</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT CLARINDA REGIONAL HEALTH CENTER</GrantOrContributionPurposeTxt>
          <Amt>16247</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COLUMBIA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>615 WEST 131ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100273922</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>POVERTY SURVEY: HEALTHCARE NEEDS &amp; USE OF LOW-INCOME NEW YORKERS</GrantOrContributionPurposeTxt>
          <Amt>110040</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COLUMBIA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>615 WEST 131ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100273922</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL SPATIALLY RESOLVED GENOMIC PROFILING OF CROHN'S DISEASE TISSUE</GrantOrContributionPurposeTxt>
          <Amt>146811</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COLUMBIA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>615 WEST 131ST STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100273922</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>POVERTY TRACKER: HEALTHCARE NEEDS &amp; USE OF LOW-INCOME NEW YORKERS</GrantOrContributionPurposeTxt>
          <Amt>81367</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COMMUNITY MEMORIAL HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2731 HEALTHCARE DRIVE</AddressLine1Txt>
            <CityNm>SYRACUSE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68446</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE EMERGENCY AT SYRACUSE AREA HEALTH</GrantOrContributionPurposeTxt>
          <Amt>33296</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COMMUNITY MEMORIAL HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2731 HEALTHCARE DRIVE</AddressLine1Txt>
            <CityNm>SYRACUSE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68446</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE EMERGENCY AT SYRACUSE AREA HEALTH</GrantOrContributionPurposeTxt>
          <Amt>13320</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ROSSELLO 149</AddressLine1Txt>
            <CityNm>BARCELONA</CityNm>
            <CountryCd>SP</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY DETECTION OF PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>262204</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ROSSELLO 149</AddressLine1Txt>
            <CityNm>BARCELONA</CityNm>
            <CountryCd>SP</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY DETECTION OF PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>270828</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ROSSELLO 149</AddressLine1Txt>
            <CityNm>BARCELONA</CityNm>
            <CountryCd>SP</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY DETECTION OF PERIANAL FISTULIZING DISEASE</GrantOrContributionPurposeTxt>
          <Amt>261948</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>COUNCIL ON THE ENVIRONMENT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>100 GOLD ST SUITE 3300</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTER-GENERATIONAL, VIABLE GREENSPACE IN NYCHA COMMUNITIES</GrantOrContributionPurposeTxt>
          <Amt>116600</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SYSTEMATIZING INTERVENTIONS OF CARE MANAGEMENT IN CD</GrantOrContributionPurposeTxt>
          <Amt>494615</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE IN CD</GrantOrContributionPurposeTxt>
          <Amt>544115</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SYSTEMATIZING INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD</GrantOrContributionPurposeTxt>
          <Amt>570831</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD</GrantOrContributionPurposeTxt>
          <Amt>570830</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SYSTEMATIZING INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD</GrantOrContributionPurposeTxt>
          <Amt>588266</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S &amp; COLITIS FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>733 THIRD AVENUE SUITE 510</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SYSTEMATIZING INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD</GrantOrContributionPurposeTxt>
          <Amt>588266</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S AND COLITIS CANADA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>60 ST CLAIR AVE EAST SUITE 600</AddressLine1Txt>
            <CityNm>TORONTO</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPORT FOR CROHN'S &amp; COLITIS CANADA 2020- 21 PATIENT PROGRAMS</GrantOrContributionPurposeTxt>
          <Amt>65990</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S AND COLITIS UK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 BISHOPS SQUARE</AddressLine1Txt>
            <CityNm>HATFIELD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK</GrantOrContributionPurposeTxt>
          <Amt>75900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S AND COLITIS UK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 BISHOPS SQUARE</AddressLine1Txt>
            <CityNm>HATFIELD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK</GrantOrContributionPurposeTxt>
          <Amt>75900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S AND COLITIS UK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 BISHOPS SQUARE</AddressLine1Txt>
            <CityNm>HATFIELD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK</GrantOrContributionPurposeTxt>
          <Amt>75900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S AND COLITIS UK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 BISHOPS SQUARE</AddressLine1Txt>
            <CityNm>HATFIELD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT FOR CROHN'S AND COLITIS UK</GrantOrContributionPurposeTxt>
          <Amt>75900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S COLITIS CURE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 OCONNELL STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE</GrantOrContributionPurposeTxt>
          <Amt>175233</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S COLITIS CURE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 OCONNELL STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE</GrantOrContributionPurposeTxt>
          <Amt>68358</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S COLITIS CURE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 OCONNELL STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE</GrantOrContributionPurposeTxt>
          <Amt>99842</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S COLITIS CURE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 OCONNELL STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE</GrantOrContributionPurposeTxt>
          <Amt>90467</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CROHN'S COLITIS CURE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 OCONNELL STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE</GrantOrContributionPurposeTxt>
          <Amt>66267</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DARTMOUTH- HITCHCOCK CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE MEDICAL CENTER DRIVE</AddressLine1Txt>
            <CityNm>LEBANON</CityNm>
            <StateAbbreviationCd>NH</StateAbbreviationCd>
            <ZIPCd>03756</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING FOR VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>195140</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DARTMOUTH- HITCHCOCK CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE MEDICAL CENTER DRIVE</AddressLine1Txt>
            <CityNm>LEBANON</CityNm>
            <StateAbbreviationCd>NH</StateAbbreviationCd>
            <ZIPCd>03756</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING FOR VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>197461</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>DELAWARE COUNTY MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>709 W MAIN ST</AddressLine1Txt>
            <CityNm>MANCHESTER</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52057</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY</GrantOrContributionPurposeTxt>
          <Amt>29195</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ELLSWORTH MUNICIPAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>920 SOUTH OAK STREET</AddressLine1Txt>
            <CityNm>IOWA FALLS</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50126</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT HANSEN FAMILY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>8493</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ENGINEERING MINISTRIES INTERNATIONAL USA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>130 EAST KIOWA</AddressLine1Txt>
            <CityNm>COLORADO SPRINGS</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80903</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ALASKA WASH PROJECT</GrantOrContributionPurposeTxt>
          <Amt>6680429</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ENGINEERING MINISTRIES INTERNATIONAL USA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>130 EAST KIOWA</AddressLine1Txt>
            <CityNm>COLORADO SPRINGS</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80903</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ALASKA WASH PROJECT</GrantOrContributionPurposeTxt>
          <Amt>7020410</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FALL RIVER HEALTH SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1201 HIGHWAY 71 S</AddressLine1Txt>
            <CityNm>HOT SPRINGS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57747</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT FALL RIVER HEALTH SERVICES</GrantOrContributionPurposeTxt>
          <Amt>17325</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FLOYD VALLEY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>714 LINCOLN STREET NE</AddressLine1Txt>
            <CityNm>LE MARS</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51031</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT FLOYD VALLEY HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>14837</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 BEDFORD STREET</AddressLine1Txt>
            <CityNm>MANCHESTER</CityNm>
            <StateAbbreviationCd>NH</StateAbbreviationCd>
            <ZIPCd>03101</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FOR INSPIRATION AND RECOGNITION OF SCIENCE AND TECHNOLOGY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 BEDFORD STREET</AddressLine1Txt>
            <CityNm>MANCHESTER</CityNm>
            <StateAbbreviationCd>NH</StateAbbreviationCd>
            <ZIPCd>03101</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FORSCHERGRUPPE DIABETES EV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FR1DA-PLUS COHORT STUDY</GrantOrContributionPurposeTxt>
          <Amt>467844</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GALILEE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>GALILEE MEDICAL CENTER BEN ZVI BLVD</AddressLine1Txt>
            <AddressLine2Txt>POB 21</AddressLine2Txt>
            <CityNm>NAHARYIA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING</GrantOrContributionPurposeTxt>
          <Amt>2200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GALILEE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>GALILEE MEDICAL CENTER BEN ZVI BLVD</AddressLine1Txt>
            <AddressLine2Txt>POB 21</AddressLine2Txt>
            <CityNm>NAHARYIA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING</GrantOrContributionPurposeTxt>
          <Amt>2200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GIRLS WITH GUTS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6024 RIDGE STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19128</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.</GrantOrContributionPurposeTxt>
          <Amt>9862</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GIRLS WITH GUTS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6024 RIDGE STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19128</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.</GrantOrContributionPurposeTxt>
          <Amt>9862</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GIRLS WITH GUTS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6024 RIDGE STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19128</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.</GrantOrContributionPurposeTxt>
          <Amt>11100</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GIRLS WITH GUTS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6024 RIDGE STREET</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19128</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 &amp; 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.</GrantOrContributionPurposeTxt>
          <Amt>11100</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GORDON MEMORIAL HOSPITAL DISTRICT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 E 8TH ST</AddressLine1Txt>
            <CityNm>GORDON</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>69343</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT GORDON MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>14384</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>27 KINGS COLLEGE CIRCLE</AddressLine1Txt>
            <CityNm>TORONTO</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RESPONSIVE GLUCAGON MICRONEEDLE PATCH - HYPOGLYCEMIA PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>185460</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GRAND CANYON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3300 WEST CAMELBACK ROAD</AddressLine1Txt>
            <CityNm>PHOENIX</CityNm>
            <StateAbbreviationCd>AZ</StateAbbreviationCd>
            <ZIPCd>85017</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>766986</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GRANTMAKERS IN HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1100 CONNECTICUT AVENUE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GRANTMAKERS IN HEALTH EFFECTIVE PHILANTHROPY FUND</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GUTTENBERG MUNICIPAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 MAIN ST</AddressLine1Txt>
            <CityNm>GUTTENBERG</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52052</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AND EPHARMACY AT GUTTENBERG MUNICIPAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>26922</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HARLAN COUNTY HEALTH SYSTEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>717 NORTH BROWN</AddressLine1Txt>
            <CityNm>ALMA</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>689200836</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT HARLAN COUNTY HEALTH SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>9737</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTH ADVOCACY SUMMIT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1962 DOCKSIDE DRIVE</AddressLine1Txt>
            <CityNm>GREENWOOD</CityNm>
            <StateAbbreviationCd>ID</StateAbbreviationCd>
            <ZIPCd>46143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 OPERATING SUPPORT FOR HEALTH ADVOCACY SUMMIT AND THE CCYAN</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTH ADVOCACY SUMMIT INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1962 DOCKSIDE DRIVE</AddressLine1Txt>
            <CityNm>GREENWOOD</CityNm>
            <StateAbbreviationCd>ID</StateAbbreviationCd>
            <ZIPCd>46143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2021 OPERATING SUPPORT FOR HEALTH ADVOCACY SUMMIT</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTH FINANCE INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1690 NORTH QUINN STREET</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22209</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CATALYZE FINANCE &amp; PARTNERS TO ADDRESS GLOBAL BURDEN OF CHRONIC DISEASE</GrantOrContributionPurposeTxt>
          <Amt>1633848</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEALTHPARTNERS INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 1309</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55440</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIRECT INTEGRATION OF CGM DATA INTO THE EMR</GrantOrContributionPurposeTxt>
          <Amt>258500</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HEBREW UNIVERSITY OF JERUSALEM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>THE HEBREW UNIVERSITY OF JERUSALEM</AddressLine1Txt>
            <AddressLine2Txt>MOUNT SCOPUS</AddressLine2Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>METHYLATION PATTERNS OF CELL-FREE DNA AS A BIOMARKER IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>249301</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>2705330</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>5085075</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT</GrantOrContributionPurposeTxt>
          <Amt>361753</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONTINUATION OF THE GPPAD-02-STUDY</GrantOrContributionPurposeTxt>
          <Amt>2428367</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>668907</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>3337054</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT</GrantOrContributionPurposeTxt>
          <Amt>361752</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>668906</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1277602</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONTINUATION OF THE GPPAD-02-STUDY</GrantOrContributionPurposeTxt>
          <Amt>2428367</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>3337054</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1277602</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>2234555</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONTINUATION OF THE GPPAD-02-STUDY</GrantOrContributionPurposeTxt>
          <Amt>2451335</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>847748</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>847748</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1454620</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>2234554</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONTINUATION OF THE GPPAD-02-STUDY</GrantOrContributionPurposeTxt>
          <Amt>2451335</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1454619</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>2200346</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONTINUATION OF THE GPPAD-02-STUDY</GrantOrContributionPurposeTxt>
          <Amt>2440023</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>870315</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>870314</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1339873</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>2200346</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1339873</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>830769</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1482901</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GPPAD COORDINATION CENTER CONTINUATION</GrantOrContributionPurposeTxt>
          <Amt>830769</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1482900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1410856</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1410856</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1301918</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1301917</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HELMHOLTZ ZENTRUM MUNCHEN (GMBH)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INGOLSTADTER LANDSTRABE 1</AddressLine1Txt>
            <CityNm>NEUHERBERG</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF T1D AUTOIMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>522291</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HERLEV OG GENTOFTE HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HERLEV RINGVEJ 75 OPG 115</AddressLine1Txt>
            <CityNm>HERLEV</CityNm>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D</GrantOrContributionPurposeTxt>
          <Amt>402594</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HERLEV OG GENTOFTE HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HERLEV RINGVEJ 75 OPG 115</AddressLine1Txt>
            <CityNm>HERLEV</CityNm>
            <CountryCd>DA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D</GrantOrContributionPurposeTxt>
          <Amt>241665</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>375235</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>492812</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>267814</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>479190</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 GUSTAVE L LEVY PL</AddressLine1Txt>
            <CityNm>NEW YORK CITY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MODULATING EARLY LIFE MICROBIOME THROUGH DIET IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>409388</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IDA COUNTY IOWA COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>701 EAST SECOND STREET</AddressLine1Txt>
            <CityNm>IDA GROVE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51445</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE PHARMACY AT HORN MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>24192</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IDA COUNTY IOWA COMMUNITY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>701 EAST SECOND STREET</AddressLine1Txt>
            <CityNm>IDA GROVE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51445</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE PHARMACY AT HORN MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>9677</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INDIANA UNIVERSITY (AMPATH PROJECT)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>702 ROTARY CIRCLE</AddressLine1Txt>
            <CityNm>INDIANAPOLIS</CityNm>
            <StateAbbreviationCd>ID</StateAbbreviationCd>
            <ZIPCd>46202</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AMPATH MODEL REPLICATION IN GHANA</GrantOrContributionPurposeTxt>
          <Amt>3474440</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>86 RUE REGNAULT</AddressLine1Txt>
            <CityNm>PARIS</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BENIGN ISLET AUTOIMMUNITY TO T1D: CELL BIOMARKERS OF PROGRESSION</GrantOrContributionPurposeTxt>
          <Amt>227975</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>86 RUE REGNAULT</AddressLine1Txt>
            <CityNm>PARIS</CityNm>
            <CountryCd>FR</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BENIGN ISLET AUTOIMMUNITY TO T1D: T-CELL BIOMARKERS OF PROGRESSION</GrantOrContributionPurposeTxt>
          <Amt>426271</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTEGRATED BIOBANK OF LUXEMBOURG (IBBL)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 RUE LOUIS RECH</AddressLine1Txt>
            <CityNm>DUDELANGE</CityNm>
            <CountryCd>LU</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>82380</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTEGRATED BIOBANK OF LUXEMBOURG (IBBL)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 RUE LOUIS RECH</AddressLine1Txt>
            <CityNm>DUDELANGE</CityNm>
            <CountryCd>LU</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>90190</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTEGRATED BIOBANK OF LUXEMBOURG (IBBL)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>1 RUE LOUIS RECH</AddressLine1Txt>
            <CityNm>DUDELANGE</CityNm>
            <CountryCd>LU</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>NC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL</GrantOrContributionPurposeTxt>
          <Amt>148458</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERNATIONAL BOWEL ULTRASOUND GROUP EV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HARKORTSTR 1 1ST FLOOR</AddressLine1Txt>
            <CityNm>MUNSTER</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE DEVELOPMENT OF A DISEASE INDEX FOR INTESTINAL ULTRASOUND</GrantOrContributionPurposeTxt>
          <Amt>693935</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERNATIONAL BOWEL ULTRASOUND GROUP EV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HARKORTSTR 1 1ST FLOOR</AddressLine1Txt>
            <CityNm>MUNSTER</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE DEVELOPMENT OF A DISEASE INDEX FOR INTESTINAL ULTRASOUND</GrantOrContributionPurposeTxt>
          <Amt>779377</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERNATIONAL BOWEL ULTRASOUND GROUP EV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HARKORTSTR 1 1ST FLOOR</AddressLine1Txt>
            <CityNm>MUNSTER</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND</GrantOrContributionPurposeTxt>
          <Amt>718578</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERNATIONAL BOWEL ULTRASOUND GROUP EV</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HARKORTSTR 1 1ST FLOOR</AddressLine1Txt>
            <CityNm>MUNSTER</CityNm>
            <CountryCd>GM</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND</GrantOrContributionPurposeTxt>
          <Amt>375221</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>INTERNATIONAL WATER MANAGEMENT INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>127 SUNIL MAWATHA</AddressLine1Txt>
            <CityNm>BATTARAMULLA</CityNm>
            <CountryCd>CE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WATER SECURE AFRICA INITIATIVE: OPEN DATA CUBE EXTENSION</GrantOrContributionPurposeTxt>
          <Amt>942226</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IOWA DEPARTMENT OF PUBLIC HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>321 EAST 12TH</AddressLine1Txt>
            <CityNm>DES MOINES</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50319</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IOWA FIRST RESPONDER AED INITIATIVE</GrantOrContributionPurposeTxt>
          <Amt>5283804</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IOWA DEPARTMENT OF PUBLIC HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>321 EAST 12TH</AddressLine1Txt>
            <CityNm>DES MOINES</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50319</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IOWA FIRST RESPONDER AED INITIATIVE</GrantOrContributionPurposeTxt>
          <Amt>186944</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>IOWA DEPARTMENT OF PUBLIC HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>321 EAST 12TH</AddressLine1Txt>
            <CityNm>DES MOINES</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50319</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IOWA FIRST RESPONDER AED INITIATIVE</GrantOrContributionPurposeTxt>
          <Amt>58968</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CGM MONITORING OF MATERNAL DYSGLYCEMIA</GrantOrContributionPurposeTxt>
          <Amt>878930</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY</GrantOrContributionPurposeTxt>
          <Amt>600000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE IN DIABETES INITIATIVE: LARGE ADULT STUDY</GrantOrContributionPurposeTxt>
          <Amt>159838</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIRTUAL DIABETES CLINIC STUDY EVALUATING REMOTE INITIATION CGM</GrantOrContributionPurposeTxt>
          <Amt>724198</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY</GrantOrContributionPurposeTxt>
          <Amt>400000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM RETINOPATHY</GrantOrContributionPurposeTxt>
          <Amt>286747</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY</GrantOrContributionPurposeTxt>
          <Amt>625000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY</GrantOrContributionPurposeTxt>
          <Amt>283542</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVAL OF THE RELATIONSHIP OF GLUCOSE VIA CGM W/DIAB. RETINOPATHY</GrantOrContributionPurposeTxt>
          <Amt>384845</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM</GrantOrContributionPurposeTxt>
          <Amt>387943</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W/DIAB. RETINOPATHY</GrantOrContributionPurposeTxt>
          <Amt>331671</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15310 AMBERLY DRIVE SUITE 350</AddressLine1Txt>
            <CityNm>TAMPA</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33647</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVAL OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W/DIAB. RETINOPATHY</GrantOrContributionPurposeTxt>
          <Amt>218347</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF AUSTRALIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>80-84 CHANDOS STREET</AddressLine1Txt>
            <CityNm>SYDNEY</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ENDIA FOLLOW UP 2020-2022</GrantOrContributionPurposeTxt>
          <Amt>1133601</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AUTOIMMUNITY SCREENING IN KIDS (ASK) RENEWAL</GrantOrContributionPurposeTxt>
          <Amt>400000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF NOVEL INSULIN INFUSION SET</GrantOrContributionPurposeTxt>
          <Amt>432631</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELMSLEY AND JDRF CO-FUNDED WORKSHOPS</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 VESEY STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10281</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELMSLEY AND JDRF CO-FUNDED WORKSHOPS</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JENNIE M MELHAM MEMORIAL MEDICAL CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>145 MEMORIAL DRIVE</AddressLine1Txt>
            <CityNm>BROKEN BOW</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68822</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT JENNIE M MELHAM MEMORIAL MEDICAL CENTER, INC.</GrantOrContributionPurposeTxt>
          <Amt>11360</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JERUSALEM COLLEGE OF TECHNOLOGY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>21 HAVAAD HALEUMI ST</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING</GrantOrContributionPurposeTxt>
          <Amt>2859000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JERUSALEM COLLEGE OF TECHNOLOGY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>21 HAVAAD HALEUMI ST</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING</GrantOrContributionPurposeTxt>
          <Amt>5465000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>JOHNS HOPKINS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3400 NORTH CHARLES STREET</AddressLine1Txt>
            <CityNm>BALTIMORE</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21218</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A MULTIDISCIPLINARY APPROACH TO FISTULA-IN-ANO IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>239373</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT</GrantOrContributionPurposeTxt>
          <Amt>497699</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT</GrantOrContributionPurposeTxt>
          <Amt>530355</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD</GrantOrContributionPurposeTxt>
          <Amt>297898</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INNODIA HARVEST</GrantOrContributionPurposeTxt>
          <Amt>481994</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>AN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT</GrantOrContributionPurposeTxt>
          <Amt>530354</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD</GrantOrContributionPurposeTxt>
          <Amt>358644</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD</GrantOrContributionPurposeTxt>
          <Amt>408046</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KATHOLIEKE UNIVERSITEIT LEUVEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>WAAISTRAAT 6 BOX 5105</AddressLine1Txt>
            <CityNm>LEUVEN</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD</GrantOrContributionPurposeTxt>
          <Amt>362770</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVALUATE THE BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA</GrantOrContributionPurposeTxt>
          <Amt>177354</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>400000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>493562</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EVALUATE THE BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA</GrantOrContributionPurposeTxt>
          <Amt>177354</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>700333</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>307619</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER &amp; TECHNOLOGY</GrantOrContributionPurposeTxt>
          <Amt>115097</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>209247</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>257531</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>797447</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>858213</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>1061247</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>390821</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>301927</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KING'S COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>150 STAMFORD STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KITTSON MEMORIAL HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1010 SOUTH BIRCH AVENUE</AddressLine1Txt>
            <CityNm>HALLOCK</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56728</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT KITTSON HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>29321</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KITTSON MEMORIAL HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1010 SOUTH BIRCH AVENUE</AddressLine1Txt>
            <CityNm>HALLOCK</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56728</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT KITTSON HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>11729</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KMR ADVANCEMENT OF MEDICAL CENTERS LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>8 HAALIYAH ST</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ESTABLISHMENT OF THE HEALTH DISCOVERY TOWER</GrantOrContributionPurposeTxt>
          <Amt>2950750</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LAKES REGIONAL HEALTHCARE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>HIGHWAY 71 SOUTH</AddressLine1Txt>
            <CityNm>SPIRIT LAKE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51360</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE PHARMACY AT LAKES REGIONAL HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>27140</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LAKES REGIONAL HEALTHCARE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>HIGHWAY 71 SOUTH</AddressLine1Txt>
            <CityNm>SPIRIT LAKE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51360</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE PHARMACY AT LAKES REGIONAL HEALTHCARE</GrantOrContributionPurposeTxt>
          <Amt>10856</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LIVING WATER INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4001 GREENBRIAR DRIVE</AddressLine1Txt>
            <CityNm>STAFFORD</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>77477</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>1369113</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>LIVING WATER INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4001 GREENBRIAR DRIVE</AddressLine1Txt>
            <CityNm>STAFFORD</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>77477</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>1251684</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>350279</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD</GrantOrContributionPurposeTxt>
          <Amt>843986</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>350278</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>352645</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD.</GrantOrContributionPurposeTxt>
          <Amt>752326</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>021142696</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION</GrantOrContributionPurposeTxt>
          <Amt>353249</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2019-2021 MILITARY SCIENCES MEDICAL TRAINING/SUPPORT PROJECT</GrantOrContributionPurposeTxt>
          <Amt>124891</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>OFF-SITE REMOTE CONTROL ROBOTIC CORONARY INTERVENTIONS</GrantOrContributionPurposeTxt>
          <Amt>385906</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 FIRST STREET SW</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>103827</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MEEKER MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>612 S SIBLEY AVE</AddressLine1Txt>
            <CityNm>LITCHFIELD</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55355</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT MEEKER MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>30671</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MEEKER MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>612 S SIBLEY AVE</AddressLine1Txt>
            <CityNm>LITCHFIELD</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55355</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT MEEKER MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>18524</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MEEKER MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>612 S SIBLEY AVE</AddressLine1Txt>
            <CityNm>LITCHFIELD</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55355</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT MEEKER MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>12269</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MERCY MEDICAL CENTER NEW HAMPTON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>308 NORTH MAPLE AVENUE</AddressLine1Txt>
            <CityNm>NEW HAMPTON</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50659</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT MERCYONE NEW HAMPTON MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>15178</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONTANA DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 202951</AddressLine1Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59620</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MONTANA FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>219190</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MONTANA DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 202951</AddressLine1Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59620</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MONTANA FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>191663</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATIONAL ACADEMY OF SCIENCES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>500 5TH STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STRENGTHENING MINORITY SERVING INSTITUTIONS</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATIONAL PARK FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1110 VERMONT AVE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER</GrantOrContributionPurposeTxt>
          <Amt>1100000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATIONAL PARK FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1110 VERMONT AVE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>LITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER</GrantOrContributionPurposeTxt>
          <Amt>1400000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATIONAL PARK FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1110 VERMONT AVE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>LITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER</GrantOrContributionPurposeTxt>
          <Amt>1750000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATIONAL PARK FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1110 VERMONT AVE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>BADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER</GrantOrContributionPurposeTxt>
          <Amt>750000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATURAL AREAS CONSERVANCY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1234 FIFTH AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10029</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FORMALIZING A NEW YORK CITY TRAIL SYSTEM</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATURE CONSERVANCY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4245 NORTH FAIRFAX DRIVE SUITE 100</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FUTURE FOREST NEW YORK CITY PHASE II</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NCD ALLIANCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>31-33 AVENUE GIUSEPPE MOTTA</AddressLine1Txt>
            <CityNm>GENEVA</CityNm>
            <CountryCd>SZ</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NCDS FIRST: DRIVING ADVOCACY, CHANGE, IMPROVING CARE</GrantOrContributionPurposeTxt>
          <Amt>1055700</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NCD ALLIANCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>31-33 AVENUE GIUSEPPE MOTTA</AddressLine1Txt>
            <CityNm>GENEVA</CityNm>
            <CountryCd>SZ</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>42500</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NCD ALLIANCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>31-33 AVENUE GIUSEPPE MOTTA</AddressLine1Txt>
            <CityNm>GENEVA</CityNm>
            <CountryCd>SZ</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PUTTING PEOPLE WITH NCDS FIRST: ADVOCACY, CHANGE, IMPROVING CARE</GrantOrContributionPurposeTxt>
          <Amt>1015450</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEBRASKA DEPARTMENT OF HEALTH &amp; HUMAN SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>301 CENTENNIAL MALL SOUTH</AddressLine1Txt>
            <CityNm>LINCOLN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68508</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEBRASKA FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>5608814</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEBRASKA DEPARTMENT OF HEALTH &amp; HUMAN SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>301 CENTENNIAL MALL SOUTH</AddressLine1Txt>
            <CityNm>LINCOLN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68508</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEBRASKA FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>545083</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEBRASKA DEPARTMENT OF HEALTH &amp; HUMAN SERVICES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>301 CENTENNIAL MALL SOUTH</AddressLine1Txt>
            <CityNm>LINCOLN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68508</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEBRASKA FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>309887</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK CITY HEALTH AND HOSPITALS CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>125 WORTH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPRESSCARE PLATFORM UPDATE AND SERVICE DELIVERY TO HOMELESS</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>550 1ST AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>969747</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>550 1ST AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>772565</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK-PRESBYTERIAN FUND INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>850 THIRD AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING CARE FOR UNDERSERVED CHILDREN WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NORTH DAKOTA DEPARTMENT OF HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 E BOULEVARD AVENUE</AddressLine1Txt>
            <CityNm>BISMARCK</CityNm>
            <StateAbbreviationCd>ND</StateAbbreviationCd>
            <ZIPCd>585050200</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NORTH DAKOTA LAW ENFORCEMENT AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>153789</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NORTH DAKOTA DEPARTMENT OF HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 E BOULEVARD AVENUE</AddressLine1Txt>
            <CityNm>BISMARCK</CityNm>
            <StateAbbreviationCd>ND</StateAbbreviationCd>
            <ZIPCd>585050200</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NORTH DAKOTA LAW ENFORCEMENT AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>173689</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NURU INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2020 PENNSYLVANIA AVE NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NURU ETHIOPIA: SUSTAINING IMPACT THROUGH 2021 AND BEYOND</GrantOrContributionPurposeTxt>
          <Amt>550893</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PALO ALTO VETERANS INSTITUTE FOR RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3801 MIRANDA AVENUE</AddressLine1Txt>
            <CityNm>PALO ALTO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>943040038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>500825</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PALO ALTO VETERANS INSTITUTE FOR RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3801 MIRANDA AVENUE</AddressLine1Txt>
            <CityNm>PALO ALTO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>943040038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>499175</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PALO ALTO VETERANS INSTITUTE FOR RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3801 MIRANDA AVENUE</AddressLine1Txt>
            <CityNm>PALO ALTO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>943040038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>500825</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PALO ALTO VETERANS INSTITUTE FOR RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3801 MIRANDA AVENUE</AddressLine1Txt>
            <CityNm>PALO ALTO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>943040038</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>499175</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1 LETTERMAN DRIVE</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94129</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STUDYING AUTOIMMUNE T1D FOLLOWING CANCER IMMUNOTHERAPIES.</GrantOrContributionPurposeTxt>
          <Amt>1108140</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARTNERS IN HEALTH A NONPROFIT CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>800 BOYLSTON STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02219</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS</GrantOrContributionPurposeTxt>
          <Amt>1544914</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARTNERS IN HEALTH A NONPROFIT CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>800 BOYLSTON STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02219</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS</GrantOrContributionPurposeTxt>
          <Amt>940787</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PAWNEE COUNTY MEMORIAL HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 I STREET</AddressLine1Txt>
            <CityNm>PAWNEE CITY</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68420</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT PAWNEE COUNTY MEMORIAL HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>11936</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PHILIP HEALTH SERVICES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>503 W PINE STREET</AddressLine1Txt>
            <CityNm>PHILIP</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57567</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPLEMENTATION OF AVERA EEMERGENCY AT PHILIP HEALTH SERVICES</GrantOrContributionPurposeTxt>
          <Amt>29491</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PHILIP HEALTH SERVICES INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>503 W PINE STREET</AddressLine1Txt>
            <CityNm>PHILIP</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57567</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPLEMENTATION OF AVERA EEMERGENCY AT PHILIP HEALTH SERVICES</GrantOrContributionPurposeTxt>
          <Amt>12317</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRESIDENT AND FELLOWS OF HARVARD COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>25 SHATTUCK STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATING MICRONEEDLE-BASED SENSOR TO AUTOMATED INSULIN DELIVERY</GrantOrContributionPurposeTxt>
          <Amt>462154</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRESIDENT AND FELLOWS OF HARVARD COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>25 SHATTUCK STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATING MICRONEEDLE-BASED SENSOR TO AUTOMATED INSULIN DELIVERY</GrantOrContributionPurposeTxt>
          <Amt>462155</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT NYAME NSA LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>33 WILLETS LANE</AddressLine1Txt>
            <CityNm>MANHASSET</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROJECT NYAME NSA ZAMBIA EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>277650</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROJECT NYAME NSA LTD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>33 WILLETS LANE</AddressLine1Txt>
            <CityNm>MANHASSET</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROJECT NYAME NSA ZAMBIA EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>241600</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROVIDENCE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1200 PROVIDENCE ROAD</AddressLine1Txt>
            <CityNm>WAYNE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68787</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT PROVIDENCE MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>21140</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROVIDENCE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1200 PROVIDENCE ROAD</AddressLine1Txt>
            <CityNm>WAYNE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68787</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT PROVIDENCE MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>16407</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROVIDENCE MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1200 PROVIDENCE ROAD</AddressLine1Txt>
            <CityNm>WAYNE</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68787</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AT PROVIDENCE MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>8457</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PUBLIC HEALTH SOLUTIONS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>40 WORTH STREET 5TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS</GrantOrContributionPurposeTxt>
          <Amt>262335</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RAMBAM HEALTH CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAALIA HASNIA 8</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>POINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES</GrantOrContributionPurposeTxt>
          <Amt>120355</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RAMBAM HEALTH CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAALIA HASNIA 8</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREDICTING AND OPTIMIZING DRUG THERAPY IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>350000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RAMBAM HEALTH CORPORATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HAALIA HASNIA 8</AddressLine1Txt>
            <CityNm>HAIFA</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>POINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES</GrantOrContributionPurposeTxt>
          <Amt>78850</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MICHIGAN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3003 S STATE ST</AddressLine1Txt>
            <CityNm>ANN ARBOR</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>48109</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>USE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS.</GrantOrContributionPurposeTxt>
          <Amt>381754</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MICHIGAN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3003 S STATE ST</AddressLine1Txt>
            <CityNm>ANN ARBOR</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>48109</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>USE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS.</GrantOrContributionPurposeTxt>
          <Amt>385780</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MICHIGAN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3003 S STATE ST</AddressLine1Txt>
            <CityNm>ANN ARBOR</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>48109</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>USE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS.</GrantOrContributionPurposeTxt>
          <Amt>369880</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MINNESOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>401 EAST RIVER ROAD</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>REDEFINING THE FUTURE OF EMERGENCY MEDICINE</GrantOrContributionPurposeTxt>
          <Amt>6779053</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MINNESOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>401 EAST RIVER ROAD</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D</GrantOrContributionPurposeTxt>
          <Amt>350000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>REGENTS OF THE UNIVERSITY OF MINNESOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>401 EAST RIVER ROAD</AddressLine1Txt>
            <CityNm>MINNEAPOLIS</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ROSEBUD COMMUNITY HOSPITAL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>383 NORTH 17TH AVENUE</AddressLine1Txt>
            <CityNm>FORSYTH</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EPHARMACY AND ADM AT ROSEBUD HEALTH CARE CENTER</GrantOrContributionPurposeTxt>
          <Amt>11262</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SAINT LOUIS UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>221 NORTH GRAND BOULEVARD</AddressLine1Txt>
            <CityNm>SAINT LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>631032006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL TARGET TO FIGHT ALPHA CELL DYSFUNCTION STOP HYPOGLYCEMIA IN T1D</GrantOrContributionPurposeTxt>
          <Amt>260774</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SANFORD RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2301 E 60TH STREET N</AddressLine1Txt>
            <CityNm>SIOUX FALL</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>571040569</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SANFORD PLEDGE: PHASES 1 AND 2</GrantOrContributionPurposeTxt>
          <Amt>625757</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SANFORD RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2301 E 60TH STREET N</AddressLine1Txt>
            <CityNm>SIOUX FALL</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>571040569</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SANFORD PLEDGE: PHASES 1 AND 2</GrantOrContributionPurposeTxt>
          <Amt>190503</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SCHWARTZREISMAN SCIENCE EDUCATION CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HERZL ST 234</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT</GrantOrContributionPurposeTxt>
          <Amt>2540089</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SCHWARTZREISMAN SCIENCE EDUCATION CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>HERZL ST 234</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT</GrantOrContributionPurposeTxt>
          <Amt>1982305</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SEATTLE CHILDREN'S HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 5731 M/S S-200</AddressLine1Txt>
            <CityNm>SEATTLE</CityNm>
            <StateAbbreviationCd>WA</StateAbbreviationCd>
            <ZIPCd>981455005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF ANTIGEN-SPECIFIC ETREG THERAPY IN T1D</GrantOrContributionPurposeTxt>
          <Amt>1224949</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EQUIPMENT PURCHASES FOR THE NEW RADIOTHERAPY CENTER</GrantOrContributionPurposeTxt>
          <Amt>791105</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK</GrantOrContributionPurposeTxt>
          <Amt>413468</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RCT OF TASTY &amp; HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>415669</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>POPULATION-BASED ANALYSES OF IBD USING ADMINISTRATIVE DATABASE</GrantOrContributionPurposeTxt>
          <Amt>137000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK</GrantOrContributionPurposeTxt>
          <Amt>379439</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RCT OF TASTY &amp; HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>666492</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK</GrantOrContributionPurposeTxt>
          <Amt>355916</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHAARE ZEDEK MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>12 SHMUEL BAIT STREET</AddressLine1Txt>
            <CityNm>JERUSALEM</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RCT OF TASTY &amp; HEALTHY DIETARY APPROACH FOR REMISSION IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>527468</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHATTERPROOF A NONPROFIT CORP</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>101 MERRITT 7 CORPORATE PARK</AddressLine1Txt>
            <CityNm>NORWALK</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06851</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHATTERPROOF A NONPROFIT CORP</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>101 MERRITT 7 CORPORATE PARK</AddressLine1Txt>
            <CityNm>NORWALK</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06851</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHENANDOAH MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 PERSHING AVE</AddressLine1Txt>
            <CityNm>SHENANDOAH</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY IMPLEMENTATION PROJECT</GrantOrContributionPurposeTxt>
          <Amt>38299</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SHENANDOAH MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 PERSHING AVE</AddressLine1Txt>
            <CityNm>SHENANDOAH</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY IMPLEMENTATION PROJECT</GrantOrContributionPurposeTxt>
          <Amt>15320</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIMULATION IN MOTION MONTANA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>MONTANA MEDICAL ASSOCIATION 2021</AddressLine1Txt>
            <AddressLine2Txt>11TH AVE SUITE 1</AddressLine2Txt>
            <CityNm>HELENA</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59601</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA</GrantOrContributionPurposeTxt>
          <Amt>204364</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIOUX COUNCIL BOY SCOUTS OF AMERICA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>800 N WEST AVENUE</AddressLine1Txt>
            <CityNm>SIOUX FALLS</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57104</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WETLAND\NATURE STUDY AREA DEVELOPMENT</GrantOrContributionPurposeTxt>
          <Amt>75000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIOUX VALLEY MEMORIAL HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 SIOUX VALLEY DRIVE</AddressLine1Txt>
            <CityNm>CHEROKEE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51012</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>34691</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SIOUX VALLEY MEMORIAL HOSPITAL ASSOCIATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 SIOUX VALLEY DRIVE</AddressLine1Txt>
            <CityNm>CHEROKEE</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>51012</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>13877</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOS CHILDREN'S VILLAGES-USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1620 I STREET NW SUITE 220</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>2401776</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOS CHILDREN'S VILLAGES-USA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1620 I STREET NW SUITE 220</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA</GrantOrContributionPurposeTxt>
          <Amt>1386577</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTH DAKOTA HALL OF FAME</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1480 S MAIN ST</AddressLine1Txt>
            <CityNm>CHAMBERLAIN</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57325</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GENERAL OPERATING SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>20000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTH DAKOTA PARKS &amp; WILDLIFE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>523 E CAPITOL</AddressLine1Txt>
            <CityNm>PIERRE</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>SOIII FI</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CUSTER STATE PARK BISON CENTER</GrantOrContributionPurposeTxt>
          <Amt>3000000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTHCENTRAL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4501 DIPLOMACY DR</AddressLine1Txt>
            <CityNm>ANCHORAGE</CityNm>
            <StateAbbreviationCd>AK</StateAbbreviationCd>
            <ZIPCd>99508</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>1425805</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTHCENTRAL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4501 DIPLOMACY DR</AddressLine1Txt>
            <CityNm>ANCHORAGE</CityNm>
            <StateAbbreviationCd>AK</StateAbbreviationCd>
            <ZIPCd>99508</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>903283</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SOUTHCENTRAL FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4501 DIPLOMACY DR</AddressLine1Txt>
            <CityNm>ANCHORAGE</CityNm>
            <StateAbbreviationCd>AK</StateAbbreviationCd>
            <ZIPCd>99508</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>818171</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>758929</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>334722</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE EDUCATION AT NEW ONSET OF T1D</GrantOrContributionPurposeTxt>
          <Amt>183151</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPANSION &amp; EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT</GrantOrContributionPurposeTxt>
          <Amt>1296812</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>690953</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>331803</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPANSION &amp; EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT</GrantOrContributionPurposeTxt>
          <Amt>1296812</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INCREASING DIABETES DEVICE UPTAKE IN PEOPLE DIABETES</GrantOrContributionPurposeTxt>
          <Amt>817475</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>836979</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXERCISE EDUCATION AT NEW ONSET OF T1D</GrantOrContributionPurposeTxt>
          <Amt>176497</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>443 VIA ORTEGA</AddressLine1Txt>
            <CityNm>STANFORD</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94305</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPANSION &amp; EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT</GrantOrContributionPurposeTxt>
          <Amt>330000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STATE OF SOUTH DAKOTA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 E CAPITOL AVENUE</AddressLine1Txt>
            <CityNm>PIERRE</CityNm>
            <StateAbbreviationCd>SD</StateAbbreviationCd>
            <ZIPCd>57501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SOUTH DAKOTA FIRST RESPONDER AUTOMATED DEFIBRILLATOR PROJECT</GrantOrContributionPurposeTxt>
          <Amt>178000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STICHTING PHARMACCESS INTERNATIONAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>AHTC TOWER C4 PAASHEUVELWEG 25</AddressLine1Txt>
            <CityNm>AMSTERDAM</CityNm>
            <CountryCd>NL</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INVESTING IN QUALITY HEALTHCARE THROUGH SAFECARE</GrantOrContributionPurposeTxt>
          <Amt>254457</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SYNERGOS INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3 EAST 54TH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS</GrantOrContributionPurposeTxt>
          <Amt>1485316</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SYNERGOS INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3 EAST 54TH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS</GrantOrContributionPurposeTxt>
          <Amt>998553</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SYNERGOS INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3 EAST 54TH STREET</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS</GrantOrContributionPurposeTxt>
          <Amt>1063518</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA APPROACH TO IMPROVE QUALITY AND OUTCOMES WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>354000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>3686424</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>354000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>354000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>T1D EXCHANGE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>11 AVENUE DE LAFAYETTE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02111</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DATA TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>261908</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TAMPERE UNIVERSITY FOUNDATION SR</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>KALEVANTIE 4</AddressLine1Txt>
            <CityNm>TAMPERE</CityNm>
            <CountryCd>FI</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VIRUSES AND ANTIVIRAL IMMUNE MARKERS IN TWO ENDOTYPES OF T1D</GrantOrContributionPurposeTxt>
          <Amt>305030</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE ACADEMIC COLLEGE AT TEL-HAI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>TEL-HAI COLLEGE</AddressLine1Txt>
            <CityNm>UPPER GALILEE</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HELMSLEY SCIENCE BUILDING FOR HEALTH, ENVIRONMENT, AND BIOTECH</GrantOrContributionPurposeTxt>
          <Amt>634900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BARUCH PADEH MEDICAL CENTER PORIYA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>DOV HOZ 0</AddressLine1Txt>
            <CityNm>TIBERIAS</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CONSTRUCTION OF THE 12-BED INTENSIVE CARE AND RESPIRATION UNIT</GrantOrContributionPurposeTxt>
          <Amt>2321666</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>3000000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>719309</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>476319</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>463751</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>463755</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE BROAD INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02142</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NOVEL THERAPEUTIC APPROACHES FOR CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN</GrantOrContributionPurposeTxt>
          <Amt>239672</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE</GrantOrContributionPurposeTxt>
          <Amt>481225</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES</GrantOrContributionPurposeTxt>
          <Amt>423667</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE</GrantOrContributionPurposeTxt>
          <Amt>506838</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES</GrantOrContributionPurposeTxt>
          <Amt>251789</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE</GrantOrContributionPurposeTxt>
          <Amt>492017</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES</GrantOrContributionPurposeTxt>
          <Amt>430508</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CHINESE UNIVERSITY OF HONG KONG</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PI CHIU BUILDING</AddressLine1Txt>
            <CityNm>SHATIN</CityNm>
            <CountryCd>HK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES</GrantOrContributionPurposeTxt>
          <Amt>249337</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS</GrantOrContributionPurposeTxt>
          <Amt>573271</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM</GrantOrContributionPurposeTxt>
          <Amt>155544</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS</GrantOrContributionPurposeTxt>
          <Amt>573271</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE CLEVELAND CLINIC FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 EUCLID AVENUE</AddressLine1Txt>
            <CityNm>CLEVELAND</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>44195</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CROHN'S FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS</GrantOrContributionPurposeTxt>
          <Amt>573271</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE DIATRIBE FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>804 HAIGHT ST</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94117</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIATRIBE LEARN</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE GOVERNORS OF THE UNIVERSITY OF CALGARY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>2500 UNIVERSITY DRIVE NW</AddressLine1Txt>
            <CityNm>CALGARY</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD</GrantOrContributionPurposeTxt>
          <Amt>188736</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE GOVERNORS OF THE UNIVERSITY OF CALGARY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>2500 UNIVERSITY DRIVE NW</AddressLine1Txt>
            <CityNm>CALGARY</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD</GrantOrContributionPurposeTxt>
          <Amt>186777</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE GOVERNORS OF THE UNIVERSITY OF CALGARY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>2500 UNIVERSITY DRIVE NW</AddressLine1Txt>
            <CityNm>CALGARY</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD</GrantOrContributionPurposeTxt>
          <Amt>191883</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE GOVERNORS OF THE UNIVERSITY OF CALGARY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>2500 UNIVERSITY DRIVE NW</AddressLine1Txt>
            <CityNm>CALGARY</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE CHANGING EPIDEMIOLOGY OF CROHN'S IN THE WESTERN WORLD</GrantOrContributionPurposeTxt>
          <Amt>121036</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE HEALTH &amp; HOUSING CONSORTIUM INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>STADIUM STATION PO BOX 524022</AddressLine1Txt>
            <CityNm>BRONX</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10452</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STRATEGY BUILDING FOR HEALTH AND HOUSING CONSORTIUM EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>290000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE ISRAEL CROHN'S DISEASE AND ULCERATIVE COLITIS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>YOKNEAM 5</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2020 OPERATING SUPPORT FOR CCFI'S EMERGENCY TRANSPORTATION PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>59407</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE ISRAEL CROHN'S DISEASE AND ULCERATIVE COLITIS FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>YOKNEAM 5</AddressLine1Txt>
            <CityNm>TEL AVIV</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>2020 OPERATING SUPPORT FOR CCFI'S EMERGENCY TRANSPORTATION PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>57428</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE MILKEN INSTITUTE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1250 FOURTH STREET</AddressLine1Txt>
            <CityNm>SANTA MONICA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>90401</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CURES FOR LIFE: PATIENT ACCESS TO CELL AND GENE THERAPY</GrantOrContributionPurposeTxt>
          <Amt>174998</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>120 THEORY SUITE 200</AddressLine1Txt>
            <CityNm>IRVINE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>926971050</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>851633</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>120 THEORY SUITE 200</AddressLine1Txt>
            <CityNm>IRVINE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>926971050</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>837543</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>120 THEORY SUITE 200</AddressLine1Txt>
            <CityNm>IRVINE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>926971050</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>837542</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>9500 GILMAN DRIVE - MAIL CODE 0934</AddressLine1Txt>
            <CityNm>LA JOLLA</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>92093</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PERSONALIZING CROHN'S DISEASE THERAPEUTICS</GrantOrContributionPurposeTxt>
          <Amt>593024</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 CALIFORNIA STREET SUITE 315</AddressLine1Txt>
            <AddressLine2Txt>BOX 0962</AddressLine2Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VALIDATING A CLASS OF DRUGS THAT MAY PROTECT BETA CELLS IN T1D</GrantOrContributionPurposeTxt>
          <Amt>108185</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 CALIFORNIA STREET SUITE 315</AddressLine1Txt>
            <AddressLine2Txt>BOX 0962</AddressLine2Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RITUXIMAB FOLLOWED BY ABATACEPT FOR PREVENTION OR REVERSAL OF T1D</GrantOrContributionPurposeTxt>
          <Amt>230900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 CALIFORNIA STREET SUITE 315</AddressLine1Txt>
            <AddressLine2Txt>BOX 0962</AddressLine2Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RITUXIMAB FOLLOWED BY ABATACEPT FOR PREVENTION OR REVERSAL OF T1D</GrantOrContributionPurposeTxt>
          <Amt>230900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3333 CALIFORNIA STREET SUITE 315</AddressLine1Txt>
            <AddressLine2Txt>BOX 0962</AddressLine2Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94143</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RITUXIMAB FOLLOWED BY ABATACEPT FOR PREVENTION OR REVERSAL OF T1D</GrantOrContributionPurposeTxt>
          <Amt>230900</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>490 ILLINOIS STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94158</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ID ANALYSIS OF EXTREME FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY</GrantOrContributionPurposeTxt>
          <Amt>433333</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>490 ILLINOIS STREET</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94158</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ID ANALYSIS OF FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY</GrantOrContributionPurposeTxt>
          <Amt>433333</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>119036</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE: RISK ANALYSIS</GrantOrContributionPurposeTxt>
          <Amt>211200</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CULTURALLY SENSITIVE GROUP CLINIC MODEL FOR LATINO PATIENTS W/ DIABETES</GrantOrContributionPurposeTxt>
          <Amt>155711</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>313924</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE: RISK ANALYSIS</GrantOrContributionPurposeTxt>
          <Amt>317365</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ANSCHUTZ MEDICAL CAMPUS 13001 E</AddressLine1Txt>
            <AddressLine2Txt>17TH PLACE</AddressLine2Txt>
            <CityNm>AURORA</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80045</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FEASIBILITY EVAL OF AID IN PRIMARY CARE AND THROUGH TELEHEALTH</GrantOrContributionPurposeTxt>
          <Amt>705874</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF NEW MEXICO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>SPONSORED PROJECTS - PREAWARD 1</AddressLine1Txt>
            <AddressLine2Txt>UNIVERSITY OF NEW MEXICO</AddressLine2Txt>
            <CityNm>ALBUQUERQUE</CityNm>
            <StateAbbreviationCd>NM</StateAbbreviationCd>
            <ZIPCd>871310001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE ECHO INSTITUTE: REPLICATION OF THE ECHO MODEL</GrantOrContributionPurposeTxt>
          <Amt>1413438</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE REGENTS OF THE UNIVERSITY OF NEW MEXICO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>SPONSORED PROJECTS - PREAWARD 1</AddressLine1Txt>
            <AddressLine2Txt>UNIVERSITY OF NEW MEXICO</AddressLine2Txt>
            <CityNm>ALBUQUERQUE</CityNm>
            <StateAbbreviationCd>NM</StateAbbreviationCd>
            <ZIPCd>871310001</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE ECHO INSTITUTE: REPLICATION OF THE ECHO MODEL</GrantOrContributionPurposeTxt>
          <Amt>1188238</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SDEROT DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>6 BAR LEV STREET</AddressLine1Txt>
            <CityNm>SDEROT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SDEROT MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>1558573</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SDEROT DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>6 BAR LEV STREET</AddressLine1Txt>
            <CityNm>SDEROT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SDEROT COMPLEX, RESILIENCE CENTER AND PARENTHOOD HOUSE</GrantOrContributionPurposeTxt>
          <Amt>184286</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SDEROT DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>6 BAR LEV STREET</AddressLine1Txt>
            <CityNm>SDEROT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SDEROT MEDICAL CENTER</GrantOrContributionPurposeTxt>
          <Amt>614379</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA)</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>TEL-HASHOMER</AddressLine1Txt>
            <CityNm>RAMAT GAN</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMPREHENSIVE INDIVIDUALIZED PROACTIVE THERAPY OF CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>452624</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SONIA NABETA FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 2222</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100082222</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROJECT BODA-BODA</GrantOrContributionPurposeTxt>
          <Amt>314814</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE SONIA NABETA FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 2222</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100082222</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PROJECT BODA-BODA</GrantOrContributionPurposeTxt>
          <Amt>412944</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNITED NATIONS INSTITUTE FOR TRAINING AND RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNITED NATIONS INSTITUTE FOR</AddressLine1Txt>
            <AddressLine2Txt>TRAINING AND RESEARCH PALAIS DES NA</AddressLine2Txt>
            <CityNm>GENEVA</CityNm>
            <CountryCd>SZ</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ACCELERATING ACCESS: TREATMENT FOR NCDS LOW /MIDDLE-INCOME COUNTRIES</GrantOrContributionPurposeTxt>
          <Amt>2000000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNITED NATIONS INSTITUTE FOR TRAINING AND RESEARCH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNITED NATIONS INSTITUTE FOR</AddressLine1Txt>
            <AddressLine2Txt>TRAINING AND RESEARCH PALAIS DES NA</AddressLine2Txt>
            <CityNm>GENEVA</CityNm>
            <CountryCd>SZ</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ACCELERATING ACCESS: FOR NCDS IN LOW /MIDDLE-INCOME COUNTRIES.</GrantOrContributionPurposeTxt>
          <Amt>1000000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>487806</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>411939</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>487806</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IMMUNO-PHARMA TO PREDICT RESPONSE TO BIOLOGICS IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>305349</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A CELL ATLAS OF THE ILEAL COLONIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>487806</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF CHICAGO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5801 SOUTH ELLIS AVENUE</AddressLine1Txt>
            <CityNm>CHICAGO</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60637</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>305353</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MITOCHONDRIAL AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION</GrantOrContributionPurposeTxt>
          <Amt>469844</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DISCERN ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON IN T1D</GrantOrContributionPurposeTxt>
          <Amt>116077</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>400400</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>382456</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MITOCHONDRIAL AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION</GrantOrContributionPurposeTxt>
          <Amt>708833</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DISCERN ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION</GrantOrContributionPurposeTxt>
          <Amt>288719</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>444247</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE UNIVERSITY OF EDINBURGH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BHF CENTRE FOR CARDIOVASCULAR</AddressLine1Txt>
            <AddressLine2Txt>SCIENCES 47 LITTLE FRANCE CRESECENT</AddressLine2Txt>
            <CityNm>EDINBURGH</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>444246</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE QUANTUM MATERIALS DEVICES FABRICATION LAB</GrantOrContributionPurposeTxt>
          <Amt>165000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHN'S</GrantOrContributionPurposeTxt>
          <Amt>1421110</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE QUANTUM MATERIALS DEVICES FABRICATION LAB</GrantOrContributionPurposeTxt>
          <Amt>660000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>234 HERZEL ST</AddressLine1Txt>
            <CityNm>REHOVOT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE QUANTUM MATERIALS DEVICES FABRICATION LAB</GrantOrContributionPurposeTxt>
          <Amt>1750000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TOWNSEND HEALTH SYSTEMS INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>110 NORTH OAK</AddressLine1Txt>
            <CityNm>TOWNSEND</CityNm>
            <StateAbbreviationCd>MT</StateAbbreviationCd>
            <ZIPCd>59644</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT BROADWATER HEALTH CENTER</GrantOrContributionPurposeTxt>
          <Amt>12933</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF INDIANA UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>509 E 3RD ST</AddressLine1Txt>
            <CityNm>BLOOMINGTON</CityNm>
            <StateAbbreviationCd>MI</StateAbbreviationCd>
            <ZIPCd>474013654</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF REGULATORY ROADMAP FOR COLONOSCOPY PREP FOR CD</GrantOrContributionPurposeTxt>
          <Amt>290356</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ULTRA PROCESSED DIET, GUT MICROBIOME IN CD</GrantOrContributionPurposeTxt>
          <Amt>256967</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ULTRA PROCESSED DIET, GUT MICROBIOME IN CD</GrantOrContributionPurposeTxt>
          <Amt>256967</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ULTRA PROCESSED DIET, GUT MICROBIOME IN CD</GrantOrContributionPurposeTxt>
          <Amt>285463</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ULTRA PROCESSED DIET, GUT MICROBIOME IN CD</GrantOrContributionPurposeTxt>
          <Amt>285463</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ULTRA PROCESSED DIET, GUT MICROBIOME IN CD</GrantOrContributionPurposeTxt>
          <Amt>285079</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF RESEARCH SERVICES 3451</AddressLine1Txt>
            <AddressLine2Txt>WALNUT STREET</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>191046205</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ULTRA PROCESSED DIET, GUT MICROBIOME IN CD</GrantOrContributionPurposeTxt>
          <Amt>293370</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED HOSPITAL FUND OF NEW YORK</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1411 BROADWAY</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10018</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NEW YORK STATE MEDICAL RESPITE PILOT PROGRAM DESIGN</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED OSTOMY ASSOCIATIONS OF AMERICA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 525</AddressLine1Txt>
            <CityNm>KENNEBUNK</CityNm>
            <StateAbbreviationCd>ME</StateAbbreviationCd>
            <ZIPCd>040430525</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPMENT OF CROHN'S DISEASE CONTENT AND AWARENESS</GrantOrContributionPurposeTxt>
          <Amt>40350</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED STATES AFRICAN DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1400 I STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>LIVELIHOOD IMPROVEMENT PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>1779762</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNITED STATES AFRICAN DEVELOPMENT FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1400 I STREET NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>LIVELIHOOD IMPROVEMENT PROGRAM</GrantOrContributionPurposeTxt>
          <Amt>1283255</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITE CATHOLIQUE DE LOUVAIN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>PLACE DE LUNIVERSITE 1</AddressLine1Txt>
            <CityNm>LOUVAINLANEUVE</CityNm>
            <CountryCd>BE</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DIRECT AND INDIRECT CAUSES FOR THE GLUCAGON SECRETION IN T1D</GrantOrContributionPurposeTxt>
          <Amt>246186</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY COLLEGE LONDON</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>GOWER STREET</AddressLine1Txt>
            <CityNm>LONDON</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SPIT-C: USING SALIVA TO PREDICT CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>380649</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF BIRMINGHAM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>INSTITUTE OF IMMUNOLOGY AND</AddressLine1Txt>
            <AddressLine2Txt>IMMUNOTHERAPY</AddressLine2Txt>
            <CityNm>BIRMINGHAM</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANTIGEN SPECIFIC IMMUNOTHERAPY IN TYPE 1 DIABETES</GrantOrContributionPurposeTxt>
          <Amt>102647</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF CAMBRIDGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>THE OLD SCHOOLS TRINITY LANE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>247545</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF CAMBRIDGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>THE OLD SCHOOLS TRINITY LANE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>496568</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF CAMBRIDGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>THE OLD SCHOOLS TRINITY LANE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF CAMBRIDGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>THE OLD SCHOOLS TRINITY LANE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>353223</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF DUNDEE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>NETHERGATE</AddressLine1Txt>
            <CityNm>DUNDEE</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA</GrantOrContributionPurposeTxt>
          <Amt>279562</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF EXETER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>NORTHCOTE HOUSE THE QUEENS DRIVE</AddressLine1Txt>
            <CityNm>EXETER</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D</GrantOrContributionPurposeTxt>
          <Amt>323139</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF EXETER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>NORTHCOTE HOUSE THE QUEENS DRIVE</AddressLine1Txt>
            <CityNm>EXETER</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D</GrantOrContributionPurposeTxt>
          <Amt>268565</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN ATLAS NEONATAL DEVELOPMENTAL EARLY LIFE PANCREAS/IMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1034449</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>T1D RESEARCH: NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>1199692</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>T CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER &amp; TECHNOLOGY</GrantOrContributionPurposeTxt>
          <Amt>248597</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>HUMAN ATLAS NEONATAL DEVELOPMENTAL EARLY LIFE PANCREAS/IMMUNITY</GrantOrContributionPurposeTxt>
          <Amt>1043638</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>219 GRINTER HALL</AddressLine1Txt>
            <CityNm>GAINESVILLE</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>326115500</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D</GrantOrContributionPurposeTxt>
          <Amt>1199692</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF GLASGOW COURT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY AVENUE</AddressLine1Txt>
            <CityNm>GLASGOW</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE CLINICAL EFFECTIVENESS OF CD-TREAT IN CROHN'S PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>391290</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF IOWA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DIVISION OF SPONSORED PROGRAMS 2</AddressLine1Txt>
            <AddressLine2Txt>GILMORE HALL</AddressLine2Txt>
            <CityNm>IOWA CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52442</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>RUPRI HEALTH PANEL SUPPORT</GrantOrContributionPurposeTxt>
          <Amt>174321</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF IOWA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DIVISION OF SPONSORED PROGRAMS 2</AddressLine1Txt>
            <AddressLine2Txt>GILMORE HALL</AddressLine2Txt>
            <CityNm>IOWA CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52442</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SIMULATION IN MOTION IOWA (SIM-IA)</GrantOrContributionPurposeTxt>
          <Amt>2470869</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF IOWA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DIVISION OF SPONSORED PROGRAMS 2</AddressLine1Txt>
            <AddressLine2Txt>GILMORE HALL</AddressLine2Txt>
            <CityNm>IOWA CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52442</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SIMULATION IN MOTION IOWA (SIM-IA)</GrantOrContributionPurposeTxt>
          <Amt>999877</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF IOWA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>DIVISION OF SPONSORED PROGRAMS 2</AddressLine1Txt>
            <AddressLine2Txt>GILMORE HALL</AddressLine2Txt>
            <CityNm>IOWA CITY</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52442</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>SIMULATION IN MOTION IOWA (SIM-IA)</GrantOrContributionPurposeTxt>
          <Amt>748244</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MELBOURNE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ALAN GILBERT BUILDING 161 BARRY</AddressLine1Txt>
            <AddressLine2Txt>STREET LEVEL 4</AddressLine2Txt>
            <CityNm>CARLTON</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>552076</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MELBOURNE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>ALAN GILBERT BUILDING 161 BARRY</AddressLine1Txt>
            <AddressLine2Txt>STREET LEVEL 4</AddressLine2Txt>
            <CityNm>CARLTON</CityNm>
            <CountryCd>AS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR</GrantOrContributionPurposeTxt>
          <Amt>703827</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1320 SOUTH DIXIE HIGHWAY SUITE 650</AddressLine1Txt>
            <CityNm>CORAL GABLES</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33146</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE</GrantOrContributionPurposeTxt>
          <Amt>323935</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1320 SOUTH DIXIE HIGHWAY SUITE 650</AddressLine1Txt>
            <CityNm>CORAL GABLES</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33146</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOP A METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICE</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1320 SOUTH DIXIE HIGHWAY SUITE 650</AddressLine1Txt>
            <CityNm>CORAL GABLES</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33146</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A HOLISTIC DIET INTERVENTION FOR PEOPLE WITH CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>637761</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1320 SOUTH DIXIE HIGHWAY SUITE 650</AddressLine1Txt>
            <CityNm>CORAL GABLES</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33146</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE</GrantOrContributionPurposeTxt>
          <Amt>326055</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1320 SOUTH DIXIE HIGHWAY SUITE 650</AddressLine1Txt>
            <CityNm>CORAL GABLES</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33146</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE</GrantOrContributionPurposeTxt>
          <Amt>328238</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NEBRASKA FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1010 LINCOLN MALL</AddressLine1Txt>
            <CityNm>LINCOLN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOBILE RURAL HEALTHCARE PROVIDER TRAINING</GrantOrContributionPurposeTxt>
          <Amt>592963</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NEBRASKA FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1010 LINCOLN MALL</AddressLine1Txt>
            <CityNm>LINCOLN</CityNm>
            <StateAbbreviationCd>NE</StateAbbreviationCd>
            <ZIPCd>68501</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOBILE RURAL HEALTHCARE PROVIDER TRAINING</GrantOrContributionPurposeTxt>
          <Amt>582072</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANTI-TNF COMBINATION CLINICAL TRIAL IN PEDIATRIC CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>42022</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>153617</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MOLECULAR PROFILES PREDICTIVE OF POST-OPERATIVE CD OUTCOMES</GrantOrContributionPurposeTxt>
          <Amt>585750</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS</GrantOrContributionPurposeTxt>
          <Amt>681830</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFYING PROFILES PREDICTIVE OF POST-OPERATIVE CD OUTCOMES</GrantOrContributionPurposeTxt>
          <Amt>585750</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>104 AIRPORT DRIVE SUITE 2200 CB</AddressLine1Txt>
            <AddressLine2Txt>1350</AddressLine2Txt>
            <CityNm>CHAPEL HILL</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>275991350</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>IDENTIFYING MOLECULAR PROFILES OF POST-OPERATIVE CD OUTCOMES</GrantOrContributionPurposeTxt>
          <Amt>581625</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STUDY OF COVID-19 ANTIBODY RESPONSE UNDER IMMUNE SUPPRESSION</GrantOrContributionPurposeTxt>
          <Amt>627089</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PHARMACOLOGICAL MODULATION TO ADDRESS GLUCAGON SECRETION IN T1D</GrantOrContributionPurposeTxt>
          <Amt>287947</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>STUDY OF COVID-19 ANTIBODY RESPONSE UNDER IMMUNE SUPPRESSION</GrantOrContributionPurposeTxt>
          <Amt>152072</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF OXFORD</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>UNIVERSITY OFFICES WELLINGTON</AddressLine1Txt>
            <AddressLine2Txt>SQUARE</AddressLine2Txt>
            <CityNm>OXFORD</CityNm>
            <CountryCd>UK</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>PHARMACOLOGICAL MODULATION TO ADDRESS GLUCAGON SECRETION IN T1D</GrantOrContributionPurposeTxt>
          <Amt>389575</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF UTAH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>201 S PRESIDENTS CIRCLE</AddressLine1Txt>
            <CityNm>SALT LAKE CITY</CityNm>
            <StateAbbreviationCd>UT</StateAbbreviationCd>
            <ZIPCd>84112</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANTI-PHAGE ANTIBODIES: CROHN'S DIAGNOSIS AND TREATMENT RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>246267</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF UTAH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>201 S PRESIDENTS CIRCLE</AddressLine1Txt>
            <CityNm>SALT LAKE CITY</CityNm>
            <StateAbbreviationCd>UT</StateAbbreviationCd>
            <ZIPCd>84112</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANTI-PHAGE ANTIBODIES: CROHN'S DIAGNOSIS AND TREATMENT RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>246267</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF UTAH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>201 S PRESIDENTS CIRCLE</AddressLine1Txt>
            <CityNm>SALT LAKE CITY</CityNm>
            <StateAbbreviationCd>UT</StateAbbreviationCd>
            <ZIPCd>84112</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ANTI-PHAGE ANTIBODIES: CROHN'S DIAGNOSIS AND TREATMENT RESPONSE</GrantOrContributionPurposeTxt>
          <Amt>249717</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UPPSALA UNIVERSITET</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BOX 256</AddressLine1Txt>
            <CityNm>UPPSALA</CityNm>
            <CountryCd>SW</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION</GrantOrContributionPurposeTxt>
          <Amt>249929</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UPPSALA UNIVERSITET</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>BOX 256</AddressLine1Txt>
            <CityNm>UPPSALA</CityNm>
            <CountryCd>SW</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>ALPHA-CELL SIGNALING FOR GLUCAGON SECRETION</GrantOrContributionPurposeTxt>
          <Amt>177173</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VAN BUREN COUNTY HOSPITAL</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>304 FRANKLIN STREET</AddressLine1Txt>
            <CityNm>KEOSAUQUA</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>52565</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EEMERGENCY AT VAN BUREN COUNTY HOSPITAL</GrantOrContributionPurposeTxt>
          <Amt>17766</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3319 WEST END AVENUE SUITE 970</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S DISEASE GUT CELL ATLAS</GrantOrContributionPurposeTxt>
          <Amt>509159</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3319 WEST END AVENUE SUITE 970</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEVELOPING AN ISLET MODEL THAT MIMICS T1D</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3319 WEST END AVENUE SUITE 970</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S GUT CELL ATLAS</GrantOrContributionPurposeTxt>
          <Amt>509159</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3319 WEST END AVENUE SUITE 970</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>COMBINATORIAL SINGLE CELL STRATEGIES FOR CROHN'S DISEASE GUT CELL ATLAS</GrantOrContributionPurposeTxt>
          <Amt>509159</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VANDERBILT UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2201 WEST END AVE</AddressLine1Txt>
            <CityNm>NASHVILLE</CityNm>
            <StateAbbreviationCd>TN</StateAbbreviationCd>
            <ZIPCd>37235</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>UNDERSTANDING CALCIUM SIGNALING IN ALPHA CELLS IN T1D</GrantOrContributionPurposeTxt>
          <Amt>231831</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VILLAGES OF HOPE AFRICA SOCIETY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>2450 MILLTOWER COURT</AddressLine1Txt>
            <CityNm>MISSISSAUGA</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOOD PRODUCTION, WATER SUPPLY, EDUCATION FACILITIES</GrantOrContributionPurposeTxt>
          <Amt>622818</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>VILLAGES OF HOPE AFRICA SOCIETY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>2450 MILLTOWER COURT</AddressLine1Txt>
            <CityNm>MISSISSAUGA</CityNm>
            <CountryCd>CA</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>FOOD PRODUCTION, WATER SUPPLY, EDUCATION FACILITIES</GrantOrContributionPurposeTxt>
          <Amt>502010</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>660 S EUCLID AVE</AddressLine1Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>63110</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MANIPULATING ALPHA CELL SIGNALING TO RESTORE GLUCAGON SECRETORY</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>660 S EUCLID AVE</AddressLine1Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>63110</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VACCINE SAFETY AND EFFICACY</GrantOrContributionPurposeTxt>
          <Amt>473150</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>660 S EUCLID AVE</AddressLine1Txt>
            <CityNm>ST LOUIS</CityNm>
            <StateAbbreviationCd>MO</StateAbbreviationCd>
            <ZIPCd>63110</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>VACCINE SAFETY AND EFFICACY</GrantOrContributionPurposeTxt>
          <Amt>333006</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WATERAID AMERICA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>233 BROADWAY</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10279</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>2839148</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WATERAID AMERICA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>233 BROADWAY</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10279</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>CREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA</GrantOrContributionPurposeTxt>
          <Amt>2166773</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1300 YORK AVENUE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>100654805</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>TARGETING THE MYCOBIOME IN CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>283903</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING DEPARTMENT OF HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6101 YELLOWSTONE RD SUITE 400</AddressLine1Txt>
            <CityNm>CHEYENNE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82009</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WYOMING FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>269693</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING DEPARTMENT OF HEALTH</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6101 YELLOWSTONE RD SUITE 400</AddressLine1Txt>
            <CityNm>CHEYENNE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82009</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>WYOMING FIRST RESPONDER AED PROJECT</GrantOrContributionPurposeTxt>
          <Amt>183693</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING STATE PARKS AND CULTURAL RESOURCES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2301 CENTRAL AVENUE</AddressLine1Txt>
            <CityNm>CHEYENNE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82002</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE</GrantOrContributionPurposeTxt>
          <Amt>885000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WYOMING STATE PARKS AND CULTURAL RESOURCES</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2301 CENTRAL AVENUE</AddressLine1Txt>
            <CityNm>CHEYENNE</CityNm>
            <StateAbbreviationCd>WY</StateAbbreviationCd>
            <ZIPCd>82002</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>INTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE</GrantOrContributionPurposeTxt>
          <Amt>30000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROJECTS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>208327</AddressLine2Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>065208327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPOSOMICS FOR EARLY LIFE CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>405488</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROJECTS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>208327</AddressLine2Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>065208327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>THERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS</GrantOrContributionPurposeTxt>
          <Amt>336846</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROJECTS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>208327</AddressLine2Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>065208327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPOSOMICS FOR EARLY LIFE CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>443827</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>OFFICE OF SPONSORED PROJECTS PO BOX</AddressLine1Txt>
            <AddressLine2Txt>208327</AddressLine2Txt>
            <CityNm>NEW HAVEN</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>065208327</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EXPOSOMICS FOR EARLY LIFE CROHN'S DISEASE</GrantOrContributionPurposeTxt>
          <Amt>298606</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YOUTH DEVELOPMENT ORGANIZATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>15 UNION STREET 563</AddressLine1Txt>
            <CityNm>LAWRENCE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01840</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EDUCATION AND CHARACTER DEVELOPMENT FOR LOCAL YOUTH</GrantOrContributionPurposeTxt>
          <Amt>14516</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>ZIV MEDICAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientForeignAddress>
            <AddressLine1Txt>RAMBAM ST</AddressLine1Txt>
            <CityNm>ZEFAT</CityNm>
            <CountryCd>IS</CountryCd>
          </RecipientForeignAddress>
          <RecipientRelationshipTxt>NA</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>REINFORCE CRUCIAL SITES DURING EMERGENCIES</GrantOrContributionPurposeTxt>
          <Amt>1503124</Amt>
        </GrantOrContriApprvForFutGrp>
        <TotalGrantOrContriApprvFutAmt>385738876</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <ProgramServiceRevPartVIIGrp>
          <Desc>PRI LOAN INTEREST</Desc>
          <ExclusionCd>14</ExclusionCd>
          <RelatedOrExemptFunctionIncmAmt>8723</RelatedOrExemptFunctionIncmAmt>
        </ProgramServiceRevPartVIIGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>28719</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DivAndIntFromSecPartVIIGrp>
          <BusinessCd>525990</BusinessCd>
          <UnrelatedBusinessTaxblIncmAmt>1734019</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>35651936</ExclusionAmt>
        </DivAndIntFromSecPartVIIGrp>
        <OtherInvestmentIncmPartVIIGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>21829255</ExclusionAmt>
        </OtherInvestmentIncmPartVIIGrp>
        <GainSalesAstOthThanInvntryGrp>
          <BusinessCd>525990</BusinessCd>
          <UnrelatedBusinessTaxblIncmAmt>14265112</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>645372664</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <OtherRevenueDescribedGrp>
          <Desc>GRANT RECOVERIES</Desc>
          <ExclusionCd>01</ExclusionCd>
          <ExclusionAmt>1880763</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>OTHER TAXABLE INCOME</Desc>
          <ExclusionCd>01</ExclusionCd>
          <ExclusionAmt>1755953</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>RENTAL INCOME SUBTENANT</Desc>
          <ExclusionCd>16</ExclusionCd>
          <ExclusionAmt>305476</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>FEDERAL EXCISE TAX BENEFIT</Desc>
          <ExclusionCd>01</ExclusionCd>
          <ExclusionAmt>369064</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>PRI LOAN INTEREST WRITE OFF</Desc>
          <RelatedOrExemptFunctionIncmAmt>-20378</RelatedOrExemptFunctionIncmAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>UBI LOSS THROUGH K-1S - NOT ON BOOKS</Desc>
          <BusinessCd>525990</BusinessCd>
          <UnrelatedBusinessTaxblIncmAmt>-2105671</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>2105671</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <UnrelatedBusinessTaxblIncmAmt>13893460</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionAmt>709299501</ExclusionAmt>
          <RelatedOrExemptFunctionIncmAmt>-11655</RelatedOrExemptFunctionIncmAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>723181306</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <RlnOfActyToAccomOfExmptPrpsGrp>
        <RlnOfActyToAccomOfExmptPrpsGrp>
          <LineNumberTxt>1A</LineNumberTxt>
          <RelationshipStatementTxt>PRI LOAN INTEREST EARNED THROUGH STRATEGIC PHILANTHROPIC INVESTMENTS</RelationshipStatementTxt>
        </RlnOfActyToAccomOfExmptPrpsGrp>
        <RlnOfActyToAccomOfExmptPrpsGrp>
          <LineNumberTxt>11E</LineNumberTxt>
          <RelationshipStatementTxt>WRITE OFF OF ACCRUED INTEREST ON UNCOLLECTIBLE PRI</RelationshipStatementTxt>
        </RlnOfActyToAccomOfExmptPrpsGrp>
      </RlnOfActyToAccomOfExmptPrpsGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>1</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>0</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>0</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>0</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>0</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>0</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>0</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>0</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>0</SharingOfFacilitiesEtcInd>
        <TransferScheduleDetail>
          <LineNumberTxt>1a(1)</LineNumberTxt>
          <InvolvedAmt>600000</InvolvedAmt>
          <NoncharitableExemptOrgName>
            <BusinessNameLine1Txt>ASSOCIATION OF DIABETES CARE &amp; EDUCATION SPECIALISTS</BusinessNameLine1Txt>
          </NoncharitableExemptOrgName>
          <TransfersTransAndShrArrngmDesc>GRANT IN SUPPORT OF AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS</TransfersTransAndShrArrngmDesc>
        </TransferScheduleDetail>
        <TransferScheduleDetail>
          <LineNumberTxt>1a(1)</LineNumberTxt>
          <InvolvedAmt>1110000</InvolvedAmt>
          <NoncharitableExemptOrgName>
            <BusinessNameLine1Txt>SOUTH DAKOTA BROADCASTERS ASSOCIATION</BusinessNameLine1Txt>
          </NoncharitableExemptOrgName>
          <TransfersTransAndShrArrngmDesc>GRANT FOR COVID-19 PUBLIC AWARENESS AND BEHAVIOR</TransfersTransAndShrArrngmDesc>
        </TransferScheduleDetail>
        <RelationshipsNonchrtblEOInd>0</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <AccountingFeesSchedule documentId="RetDoc2002200001">
      <AccountingFeesDetail>
        <CategoryTxt>DEMASCO, SENA &amp; JAHELKA LLP</CategoryTxt>
        <Amt>31660</Amt>
        <NetInvestmentIncomeAmt>10608</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>25194</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
      <AccountingFeesDetail>
        <CategoryTxt>PKF O'CONNOR DAVIES, LLP</CategoryTxt>
        <Amt>480385</Amt>
        <NetInvestmentIncomeAmt>255460</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>142800</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
      <AccountingFeesDetail>
        <CategoryTxt>PRICEWATERHOUSECOOPERS ADVISORY LTD.</CategoryTxt>
        <Amt>107435</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>98185</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
      <AccountingFeesDetail>
        <CategoryTxt>UKG INC. (DBA ULTIMATE SOFTWARE GROUP)</CategoryTxt>
        <Amt>97</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>97</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <AllOthProgRltdInvestmentsSch documentId="RetDoc2063500001">
      <AllOtherProgramRelatedInvstGrp>
        <Desc>PERCUSENSE, INC. - DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER FOR TREATMENT IN T1D</Desc>
        <Amt>750000</Amt>
      </AllOtherProgramRelatedInvstGrp>
      <AllOtherProgramRelatedInvstGrp>
        <Desc>DIABETOMICS, INC. - POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION</Desc>
        <Amt>500000</Amt>
      </AllOtherProgramRelatedInvstGrp>
      <AllOtherProgramRelatedInvstGrp>
        <Desc>BIORASIS, INC. - EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD IN CARE FOR T1D</Desc>
        <Amt>410000</Amt>
      </AllOtherProgramRelatedInvstGrp>
      <AllOtherProgramRelatedInvstGrp>
        <Desc>ZUCARA THERAPEUTICS - PRECLINICAL DEVELOPMENT OF ZT-01 TO PREVENT HYPOGLYCEMIA IN T1D</Desc>
        <Amt>339000</Amt>
      </AllOtherProgramRelatedInvstGrp>
    </AllOthProgRltdInvestmentsSch>
    <ExpenditureResponsibilityStmt documentId="RetDoc2118100001">
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>A GLIMMER OF HOPE FOUNDATION</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>3600 N CAPITAL OF TEXAS HWY BLDG B</AddressLine1Txt>
          <AddressLine2Txt>SUITE 330</AddressLine2Txt>
          <CityNm>AUSTIN</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78746</ZIPCd>
        </USAddress>
        <GrantDt>2019-09-09</GrantDt>
        <GrantAmt>7923870</GrantAmt>
        <PurposeOfGrantTxt>INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>2561121</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>1/2020, 7/2020, 1/2021, 3/2021, 7/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>A GLIMMER OF HOPE FOUNDATION</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>3600 N CAPITAL OF TEXAS HWY BLDG B</AddressLine1Txt>
          <AddressLine2Txt>SUITE 330</AddressLine2Txt>
          <CityNm>AUSTIN</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78746</ZIPCd>
        </USAddress>
        <GrantDt>2018-02-20</GrantDt>
        <GrantAmt>5000000</GrantAmt>
        <PurposeOfGrantTxt>INTEGRATED COMMUNITY DEVELOPMENT IN AMHARA, ETHIOPIA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>4234223</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>1/2019, 1/2020, 2/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AKSTON BIOSCIENCES CORPORATION</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>100 CUMMINGS CENTER SUITE 454C</AddressLine1Txt>
          <CityNm>BEVERLY</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01915</ZIPCd>
        </USAddress>
        <GrantDt>2017-03-01</GrantDt>
        <GrantAmt>6194000</GrantAmt>
        <PurposeOfGrantTxt>PRECLINICAL TRIAL OF INSULIN-FUSION TO END AUTOIMMUNITY &amp; IMPROVE T1D CARE</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>5256000</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>10/2018, 1/2019, 4/2019, 8/2019, 10/2019, 3/2020, 10/2020, 2/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ALIMENTIV INC (FKA ROBARTS)</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>100 DUNDAS STREET</AddressLine1Txt>
          <CityNm>LONDON</CityNm>
          <ProvinceOrStateNm>ON</ProvinceOrStateNm>
          <CountryCd>CA</CountryCd>
          <ForeignPostalCd>N6A5B6</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2018-11-20</GrantDt>
        <GrantAmt>3390428</GrantAmt>
        <PurposeOfGrantTxt>STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM FOR TREATMENT OF CROHN'S</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>1310317</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>1/2019, 8/2019, 12/2019, 1/2020, 6/2020, 12/2020, 1/2021, 6/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ASSOCIATION OF DIABETES CARE &amp; EDUCATION SPECIALISTS</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>125 S WACKER DRIVE SUITE 600</AddressLine1Txt>
          <CityNm>CHICAGO</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60606</ZIPCd>
        </USAddress>
        <GrantDt>2018-07-11</GrantDt>
        <GrantAmt>2679637</GrantAmt>
        <PurposeOfGrantTxt>AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>2152012</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>2/2019, 8/2019, 1/2020, 8/2020, 1/2021, 6/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ASITY MADAGASCAR</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>LOT IAB 39 TER C ANALAMHINTSY</AddressLine1Txt>
          <CityNm>ANTANANARIVO</CityNm>
          <CountryCd>MA</CountryCd>
          <ForeignPostalCd>101</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2017-03-01</GrantDt>
        <GrantAmt>284790</GrantAmt>
        <PurposeOfGrantTxt>IMPLEMENT SUSTAINABLE MANAGEMENT STRATEGIES FOR WETLAND CONSERVATION</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>284790</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>2/2018, 2/2019, 5/2020, 9/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>LEVEL 2 55 VICTORIA PARADE</AddressLine1Txt>
          <CityNm>FITZROY</CityNm>
          <CountryCd>AS</CountryCd>
          <ForeignPostalCd>3065</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2020-07-23</GrantDt>
        <GrantAmt>2309216</GrantAmt>
        <PurposeOfGrantTxt>FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>2/2021, 8/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>LEVEL 2 55 VICTORIA PARADE</AddressLine1Txt>
          <CityNm>FITZROY</CityNm>
          <CountryCd>AS</CountryCd>
          <ForeignPostalCd>3065</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2017-02-15</GrantDt>
        <GrantAmt>3719569</GrantAmt>
        <PurposeOfGrantTxt>THE ENIGMA STUDIES - EASTERN INFLAMMATORY BOWEL DISEASE GUT MICROBIOTA</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>3469534</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>9/2018, 3/2019, 7/2019, 11/2019, 1/2020, 4/2020, 10/2020, 11/2020, 3/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>BIORASIS INC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>1392 STORRS RD U4213 ATL ROOM 106</AddressLine1Txt>
          <CityNm>STORRS</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06269</ZIPCd>
        </USAddress>
        <GrantDt>2018-02-06</GrantDt>
        <GrantAmt>3016000</GrantAmt>
        <PurposeOfGrantTxt>EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD IN CARE FOR T1D</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>1206466</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>1/2019, 7/2019, 9/2019, 2/2020, 5/2020, 8/2020, 11/2020, 2/2021, 7/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>CAPILLARY BIOMEDICAL INC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>2 WRIGLEY</AddressLine1Txt>
          <CityNm>IRVINE</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>92617</ZIPCd>
        </USAddress>
        <GrantDt>2020-09-02</GrantDt>
        <GrantAmt>1500000</GrantAmt>
        <PurposeOfGrantTxt>ADVANCED EXTENDED INFUSION SET TO IMPROVE CARE IN T1D</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>497275</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>10/2020, 3/2021, 4/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>DIABETOMICS INC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>2345 NE OVERLOOK DRIVE SUITE 140</AddressLine1Txt>
          <CityNm>HILLSBORO</CityNm>
          <StateAbbreviationCd>OR</StateAbbreviationCd>
          <ZIPCd>97006</ZIPCd>
        </USAddress>
        <GrantDt>2018-01-11</GrantDt>
        <GrantAmt>4031900</GrantAmt>
        <PurposeOfGrantTxt>POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>2936143</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>7/2018, 6/2019, 1/2020, 5/2020, 10/2020, 4/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>DREAMED DIABETES LTD</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>5 MOTA GUR ST</AddressLine1Txt>
          <CityNm>PETAH TIKVA</CityNm>
          <CountryCd>IS</CountryCd>
          <ForeignPostalCd>4952701</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2016-02-01</GrantDt>
        <GrantAmt>3585828</GrantAmt>
        <PurposeOfGrantTxt>MD-LOGIC PUMP GUIDE4U - ADVISORY SYSTEM TO IMPROVE CARE OF T1D</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>3546253</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>10/2016, 1/2017, 7/2017, 9/2017, 2/2018, 6/2018, 9/2018, 12/2019</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>FEROX THERAPEUTICS</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>111 TOWN SQUARE PLACE SUITE 1203</AddressLine1Txt>
          <AddressLine2Txt>PMB 1034</AddressLine2Txt>
          <CityNm>JERSEY CITY</CityNm>
          <StateAbbreviationCd>NJ</StateAbbreviationCd>
          <ZIPCd>07310</ZIPCd>
        </USAddress>
        <GrantDt>2018-11-20</GrantDt>
        <GrantAmt>872300</GrantAmt>
        <PurposeOfGrantTxt>INSULIN INDUCED HYPOGLYCEMIA PREVENTION PROGRAM</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>872300</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>7/2019, 10/2019, 1/2020, 4/2020, 7/2020, 12/2020, 1/2021, 4/2021, 7/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>GCF GROUP LLC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>4805 N ILLINOIS ST</AddressLine1Txt>
          <CityNm>INDIANAPOLIS</CityNm>
          <StateAbbreviationCd>IN</StateAbbreviationCd>
          <ZIPCd>46208</ZIPCd>
        </USAddress>
        <GrantDt>2014-12-08</GrantDt>
        <GrantAmt>389000</GrantAmt>
        <PurposeOfGrantTxt>IMPROVING EMERGENCY FOOD ASSISTANCE IN NYC</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>389000</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>1/2016, 9/2016, 7/2017, 10/2020</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>GRAND CANYON UNIVERSITY</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>3300 WEST CAMELBACK ROAD</AddressLine1Txt>
          <CityNm>PHOENIX</CityNm>
          <StateAbbreviationCd>AZ</StateAbbreviationCd>
          <ZIPCd>85017</ZIPCd>
        </USAddress>
        <GrantDt>2019-06-26</GrantDt>
        <GrantAmt>2274027</GrantAmt>
        <PurposeOfGrantTxt>DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>1410072</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>6/2020, 7/2020, 7/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>INTEGRATED BIOBANK OF LUXEMBOURG (IBBL)</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>1 RUE LOUIS RECH</AddressLine1Txt>
          <CityNm>DUDELANGE</CityNm>
          <CountryCd>LU</CountryCd>
          <ForeignPostalCd>L-3555</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2017-12-19</GrantDt>
        <GrantAmt>500817</GrantAmt>
        <PurposeOfGrantTxt>BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>115230</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>2/2019, 4/2020, 2/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>200 VESEY STREET 28TH FLOOR</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10281</ZIPCd>
        </USAddress>
        <GrantDt>2012-05-21</GrantDt>
        <GrantAmt>8200000</GrantAmt>
        <PurposeOfGrantTxt>ORTHOGONALLY REDUNDANT GLUCOSE SENSOR TO IMPROVE CARE OF T1D</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>8200000</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>7/2015, 5/2016, 7/2016, 6/2017, 6/2019, 11/2019, 5/2020, 8/2020</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MEDIZINISCHE HOCHSCHULE HANNOVER</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>CARL NEUBERG STREET 1</AddressLine1Txt>
          <CityNm>HANNOVER</CityNm>
          <CountryCd>GM</CountryCd>
          <ForeignPostalCd>30625</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2017-12-19</GrantDt>
        <GrantAmt>420804</GrantAmt>
        <PurposeOfGrantTxt>CREATING T1D-SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR REGULATORY T-CELLS</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>420804</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>3/2018, 8/2019, 2/2020, 12/2020</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>NURU INTERNATIONAL</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>2020 PENNSYLVANIA AVE NW</AddressLine1Txt>
          <CityNm>WASHINGTON</CityNm>
          <StateAbbreviationCd>DC</StateAbbreviationCd>
          <ZIPCd>20006</ZIPCd>
        </USAddress>
        <GrantDt>2013-11-25</GrantDt>
        <GrantAmt>4680506</GrantAmt>
        <PurposeOfGrantTxt>CREATING A SELF-SUSTAINING, SCALING, AGRICULTURE-BASED DEVELOPMENT MODEL</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>4680506</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>6/2014, 1/2015, 11/2015, 12/2015, 1/2017, 2/2018, 1/2019, 1/2020, 6/2020</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>PACIFIC DIABETES TECHNOLOGIES</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>12154 SW GARDEN PLACE</AddressLine1Txt>
          <CityNm>PORTLAND</CityNm>
          <StateAbbreviationCd>OR</StateAbbreviationCd>
          <ZIPCd>97223</ZIPCd>
        </USAddress>
        <GrantDt>2014-09-08</GrantDt>
        <GrantAmt>2867072</GrantAmt>
        <PurposeOfGrantTxt>DUAL USE CATHETER FOR INSULIN DELIVERY &amp; SENSING TO IMPROVE CARE OF T1D</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>2867072</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>1/2015, 5/2015, 12/2015, 2/2016, 7/2016, 2/2017, 12/2017, 6/2018</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>PERCUSENSE INC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>25134 RYE CANYON LOOP</AddressLine1Txt>
          <CityNm>VALENCIA</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91355</ZIPCd>
        </USAddress>
        <GrantDt>2020-09-02</GrantDt>
        <GrantAmt>2500000</GrantAmt>
        <PurposeOfGrantTxt>DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER FOR TREATMENT IN T1D</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>641203</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>7/2021, 8/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>SOUTH DAKOTA BROADCASTERS ASSOCIATION</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>106 WEST CAPITOL AVE</AddressLine1Txt>
          <CityNm>PIERRE</CityNm>
          <StateAbbreviationCd>SD</StateAbbreviationCd>
          <ZIPCd>57501</ZIPCd>
        </USAddress>
        <GrantDt>2020-12-03</GrantDt>
        <GrantAmt>1110000</GrantAmt>
        <PurposeOfGrantTxt>COVID-19 PUBLIC AWARENESS AND BEHAVIOR</PurposeOfGrantTxt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>5/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>THE LEGATUM INSTITUTE FOUNDATION</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>11 CHARLES STREET</AddressLine1Txt>
          <CityNm>LONDON</CityNm>
          <CountryCd>UK</CountryCd>
          <ForeignPostalCd>W1J 5DW</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2017-12-04</GrantDt>
        <GrantAmt>1013551</GrantAmt>
        <PurposeOfGrantTxt>UNITED STATES PROSPERITY INDEX</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>880575</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>8/2018, 1/2019, 6/2019, 7/2019, 8/2019, 1/2020, 7/2020, 12/2020, 1/2021</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>XERIS PHARMACEUTICALS INC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>180 NORTH LASALLE STREET SUITE 1600</AddressLine1Txt>
          <CityNm>CHICAGO</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60601</ZIPCd>
        </USAddress>
        <GrantDt>2014-02-19</GrantDt>
        <GrantAmt>421600</GrantAmt>
        <PurposeOfGrantTxt>RAPID ACTING INSULIN FORMULATIONS FOR TREATMENT OF DIABETES</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>421600</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>7/2014, 8/2014, 3/2015, 7/2015, 9/2015, 5/2016</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
      <ExpenditureResponsibilityGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ZUCARA THERAPEUTICS</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>1300-661 UNIVERSITY AVENUE</AddressLine1Txt>
          <CityNm>TORONTO</CityNm>
          <ProvinceOrStateNm>ON</ProvinceOrStateNm>
          <CountryCd>CA</CountryCd>
          <ForeignPostalCd>M5G 0B7</ForeignPostalCd>
        </ForeignAddress>
        <GrantDt>2018-02-06</GrantDt>
        <GrantAmt>3900000</GrantAmt>
        <PurposeOfGrantTxt>PRECLINICAL DEVELOPMENT OF ZT-01 TO PREVENT HYPOGLYCEMIA IN T1D</PurposeOfGrantTxt>
        <ExpendedByGranteeAmt>3900000</ExpendedByGranteeAmt>
        <AnyDiversionByGranteeTxt>NONE</AnyDiversionByGranteeTxt>
        <DatesOfReportsByGranteeTxt>9/2018,3/2019,4/2019,7/2019,10/2019,1/2020,4/2020,7/2020,2/2021,4/2021,7/202</DatesOfReportsByGranteeTxt>
      </ExpenditureResponsibilityGrp>
    </ExpenditureResponsibilityStmt>
    <GeneralExplanationAttachment documentId="RetDoc2258700001">
      <GeneralExplanationGrp>
        <IdentifierTxt>CONTROLLED ENTITIES</IdentifierTxt>
        <FormAndLineReferenceDesc>FORM 990-PF, PART VII-A, LINE 11</FormAndLineReferenceDesc>
        <MediumExplanationTxt>THE FOLLOWING CONTROLLED ENTITIES ARE NOT EXCESS BUSINESS HOLDINGS:ACADIAN FRONTIER MARKETS EQUITY FUND260 FRANKLIN STREETBOSTON, MA 02110EIN# 20-5852756CHATHAM CO-INVEST26 MAIN STREET, SUITE 204CHATHAM, NJ 07928EIN# 85-0651355ESTATE OF LEONA M. HELMSLEY230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 20-7535047HELMSLEY ENTERPRISES, INC.230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 13-2665914LACM GLOBAL EQUITY FUND, LP11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025EIN# 45-3646231 LACM WORLD SMALL CAP EQUITY FUND, L.P.11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025EIN# 83-2888004MARATHON-LONDON GLOBAL SELECTORION HOUSE, 5 UPPER ST. MARTIN'S LANELONDON, UKEIN# 61-1915057MHR LONGEVITY PARTNERS1345 AVENUE OF THE AMERICAS 42ND FLOORNEW YORK, NY 10105EIN# 98-1471155NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER, L.P.2929 ARCH STREET 17TH FLOORPHILADELPHIA, PA 19104EIN# 98-1142649PITANGO SPVBEIT ACKERSHTEIN - BLDG. B, 11 HAMENOFIM ST. 11TH FL.HERZLIYA, ISRAELEIN# 98-1492234</MediumExplanationTxt>
      </GeneralExplanationGrp>
      <GeneralExplanationGrp>
        <FormAndLineReferenceDesc>FORM 990-PF, PART VII-B, LINE 1B</FormAndLineReferenceDesc>
        <MediumExplanationTxt>ALL TRANSACTIONS THAT REQUIRE COURT APPROVAL, HAVE RECEIVED COURT APPROVAL UNDER REG. SECTION 53.4941(D)-1(B)(3).</MediumExplanationTxt>
      </GeneralExplanationGrp>
      <GeneralExplanationGrp>
        <FormAndLineReferenceDesc>FORM 990-PF, PART VIII, LINE 1 AND 2, COLUMN (C), COMPENSATION</FormAndLineReferenceDesc>
        <MediumExplanationTxt>ALL REPORTED COMPENSATION AMOUNTS INCLUDE "SALARY, FEES, BONUSES AND SEVERANCE PAYMENTS RECEIVED BY EACH PERSON LISTED," AS WELL AS CURRENT YEAR PAYMENTS OF AMOUNTS REPORTED OR REPORTABLE AS DEFERRED COMPENSATION IN CURRENT OR PRIOR YEARS.</MediumExplanationTxt>
      </GeneralExplanationGrp>
    </GeneralExplanationAttachment>
    <InvestmentsCorpStockSchedule documentId="RetDoc2018900001">
      <InvestmentsCorporateStockGrp>
        <StockNm>ALPHABET INC-CL C, 2,586 SHRS</StockNm>
        <EOYBookValueAmt>5349477</EOYBookValueAmt>
        <EOYFMVAmt>5349477</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AMAZON.COM INC, 1,745 SHRS</StockNm>
        <EOYBookValueAmt>5399170</EOYBookValueAmt>
        <EOYFMVAmt>5399170</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AMERICAN TOWER CORP, 28,873 SHRS</StockNm>
        <EOYBookValueAmt>6902379</EOYBookValueAmt>
        <EOYFMVAmt>6902379</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ANSYS INC, 16,775 SHRS</StockNm>
        <EOYBookValueAmt>5696119</EOYBookValueAmt>
        <EOYFMVAmt>5696119</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BIO-TECHNE CORP, 20,584 SHRS</StockNm>
        <EOYBookValueAmt>7861647</EOYBookValueAmt>
        <EOYFMVAmt>7861647</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BLACK KNIGHT INC, 68,488 SHRS</StockNm>
        <EOYBookValueAmt>5067427</EOYBookValueAmt>
        <EOYFMVAmt>5067427</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BLACKLINE INC, 43,535 SHRS</StockNm>
        <EOYBookValueAmt>4719194</EOYBookValueAmt>
        <EOYFMVAmt>4719194</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BROOKS AUTOMATION INC, 13,673 SHRS</StockNm>
        <EOYBookValueAmt>1116400</EOYBookValueAmt>
        <EOYFMVAmt>1116400</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CBRE GROUP INC, 71,273 SHRS</StockNm>
        <EOYBookValueAmt>5638407</EOYBookValueAmt>
        <EOYFMVAmt>5638407</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CABLE ONE INC, 3,602 SHRS</StockNm>
        <EOYBookValueAmt>6585753</EOYBookValueAmt>
        <EOYFMVAmt>6585753</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CARMAX INC, 40,848 SHRS</StockNm>
        <EOYBookValueAmt>5418896</EOYBookValueAmt>
        <EOYFMVAmt>5418896</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>COSTAR GROUP INC, 3,157 SHRS</StockNm>
        <EOYBookValueAmt>2594707</EOYBookValueAmt>
        <EOYFMVAmt>2594707</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CROWDSTRIKE HOLDINGS INC, 12,660 SHRS</StockNm>
        <EOYBookValueAmt>2310577</EOYBookValueAmt>
        <EOYFMVAmt>2310577</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DANAHER CORP, 32,743 SHRS</StockNm>
        <EOYBookValueAmt>7369794</EOYBookValueAmt>
        <EOYFMVAmt>7369794</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DOLLAR GENERAL CORP, 20,890 SHRS</StockNm>
        <EOYBookValueAmt>4232732</EOYBookValueAmt>
        <EOYFMVAmt>4232732</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ECOLAB INC, 26,484 SHRS</StockNm>
        <EOYBookValueAmt>5669430</EOYBookValueAmt>
        <EOYFMVAmt>5669430</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ENVESTNET INC, 24,621 SHRS</StockNm>
        <EOYBookValueAmt>1778375</EOYBookValueAmt>
        <EOYFMVAmt>1778375</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>FASTENAL CO, 76,547 SHRS</StockNm>
        <EOYBookValueAmt>3848783</EOYBookValueAmt>
        <EOYFMVAmt>3848783</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>GUIDEWIRE SOFTWARE INC, 18,869 SHRS</StockNm>
        <EOYBookValueAmt>1917656</EOYBookValueAmt>
        <EOYFMVAmt>1917656</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>HEICO CORP, 49,158 SHRS</StockNm>
        <EOYBookValueAmt>5584349</EOYBookValueAmt>
        <EOYFMVAmt>5584349</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>IDEXX LABORATORIES INC, 7,126 SHRS</StockNm>
        <EOYBookValueAmt>3486823</EOYBookValueAmt>
        <EOYFMVAmt>3486823</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ILLUMINA INC, 17,816 SHRS</StockNm>
        <EOYBookValueAmt>6842413</EOYBookValueAmt>
        <EOYFMVAmt>6842413</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>INTUITIVE SURGICAL INC, 10,556 SHRS</StockNm>
        <EOYBookValueAmt>7800251</EOYBookValueAmt>
        <EOYFMVAmt>7800251</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MARKEL CORP, 6,106 SHRS</StockNm>
        <EOYBookValueAmt>6958520</EOYBookValueAmt>
        <EOYFMVAmt>6958520</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MASIMO CORP, 4,479 SHRS</StockNm>
        <EOYBookValueAmt>1028647</EOYBookValueAmt>
        <EOYFMVAmt>1028647</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MASTERCARD INC, 24,587 SHRS</StockNm>
        <EOYBookValueAmt>8754201</EOYBookValueAmt>
        <EOYFMVAmt>8754201</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MOODY'S CORP, 12,174 SHRS</StockNm>
        <EOYBookValueAmt>3635278</EOYBookValueAmt>
        <EOYFMVAmt>3635278</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>OKTA INC, 9,884 SHRS</StockNm>
        <EOYBookValueAmt>2178730</EOYBookValueAmt>
        <EOYFMVAmt>2178730</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PROS HOLDINGS INC, 43,680 SHRS</StockNm>
        <EOYBookValueAmt>1856400</EOYBookValueAmt>
        <EOYFMVAmt>1856400</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>QUALCOMM INC, 33,476 SHRS</StockNm>
        <EOYBookValueAmt>4438583</EOYBookValueAmt>
        <EOYFMVAmt>4438583</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ROPER TECHNOLOGIES INC, 10,261 SHRS</StockNm>
        <EOYBookValueAmt>4138672</EOYBookValueAmt>
        <EOYFMVAmt>4138672</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>S&amp;P GLOBAL INC, 18,895 SHRS</StockNm>
        <EOYBookValueAmt>6667479</EOYBookValueAmt>
        <EOYFMVAmt>6667479</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SBA COMMUNICATIONS CORP, 11,882 SHRS</StockNm>
        <EOYBookValueAmt>3297849</EOYBookValueAmt>
        <EOYFMVAmt>3297849</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>TELEFLEX INC, 14,702 SHRS</StockNm>
        <EOYBookValueAmt>6108093</EOYBookValueAmt>
        <EOYFMVAmt>6108093</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>THERMO FISHER SCIENTIFIC INC, 16,717 SHRS</StockNm>
        <EOYBookValueAmt>7629304</EOYBookValueAmt>
        <EOYFMVAmt>7629304</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>TRANSDIGM GROUP INC, 9,526 SHRS</StockNm>
        <EOYBookValueAmt>5600526</EOYBookValueAmt>
        <EOYFMVAmt>5600526</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>TWILIO INC, 4,885 SHRS</StockNm>
        <EOYBookValueAmt>1664613</EOYBookValueAmt>
        <EOYFMVAmt>1664613</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>VEEVA SYSTEMS INC, 4,006 SHRS</StockNm>
        <EOYBookValueAmt>1046527</EOYBookValueAmt>
        <EOYFMVAmt>1046527</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>VERISK ANALYTICS INC, 19,295 SHRS</StockNm>
        <EOYBookValueAmt>3409234</EOYBookValueAmt>
        <EOYFMVAmt>3409234</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>VISA INC, 50,674 SHRS</StockNm>
        <EOYBookValueAmt>10729206</EOYBookValueAmt>
        <EOYFMVAmt>10729206</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>VULCAN MATERIALS CO, 45,312 SHRS</StockNm>
        <EOYBookValueAmt>7646400</EOYBookValueAmt>
        <EOYFMVAmt>7646400</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>WASTE CONNECTIONS INC, 50,079 SHRS</StockNm>
        <EOYBookValueAmt>5407530</EOYBookValueAmt>
        <EOYFMVAmt>5407530</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>WORKIVA INC, 9,854 SHRS</StockNm>
        <EOYBookValueAmt>869714</EOYBookValueAmt>
        <EOYFMVAmt>869714</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ATLASSIAN CORP PLC, 4,851 SHRS</StockNm>
        <EOYBookValueAmt>1022397</EOYBookValueAmt>
        <EOYFMVAmt>1022397</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BERKSHIRE HATHAWAY INC, 67,351 SHRS</StockNm>
        <EOYBookValueAmt>17206160</EOYBookValueAmt>
        <EOYFMVAmt>17206160</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BOOKING HOLDINGS INC, 3,986 SHRS</StockNm>
        <EOYBookValueAmt>9286742</EOYBookValueAmt>
        <EOYFMVAmt>9286742</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>COMCAST CORP, 225,997 SHRS</StockNm>
        <EOYBookValueAmt>12228698</EOYBookValueAmt>
        <EOYFMVAmt>12228698</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DOLLAR GENERAL CORP, 58,565 SHRS</StockNm>
        <EOYBookValueAmt>11866440</EOYBookValueAmt>
        <EOYFMVAmt>11866440</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DOLLAR TREE INC, 96,035 SHRS</StockNm>
        <EOYBookValueAmt>10992166</EOYBookValueAmt>
        <EOYFMVAmt>10992166</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DOVER CORP, 39,400 SHRS</StockNm>
        <EOYBookValueAmt>5402922</EOYBookValueAmt>
        <EOYFMVAmt>5402922</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EMERSON ELECTRIC CO, 41,015 SHRS</StockNm>
        <EOYBookValueAmt>3700373</EOYBookValueAmt>
        <EOYFMVAmt>3700373</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EXPEDITORS INTERNATIONAL OF WA, 51,721 SHRS</StockNm>
        <EOYBookValueAmt>5569834</EOYBookValueAmt>
        <EOYFMVAmt>5569834</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>FRESENIUS MEDICAL CARE AG &amp; CO, 166,612 SHRS</StockNm>
        <EOYBookValueAmt>6144651</EOYBookValueAmt>
        <EOYFMVAmt>6144651</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>JPMORGAN CHASE &amp; CO, 66,691 SHRS</StockNm>
        <EOYBookValueAmt>10152371</EOYBookValueAmt>
        <EOYFMVAmt>10152371</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>KONINKLIJKE PHILIPS NV, 164,894 SHRS</StockNm>
        <EOYBookValueAmt>9403905</EOYBookValueAmt>
        <EOYFMVAmt>9403905</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MASCO CORP, 234,500 SHRS</StockNm>
        <EOYBookValueAmt>14046550</EOYBookValueAmt>
        <EOYFMVAmt>14046550</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MICRON TECHNOLOGY INC, 83,959 SHRS</StockNm>
        <EOYBookValueAmt>7406023</EOYBookValueAmt>
        <EOYFMVAmt>7406023</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NESTLE SA, 41,913 SHRS</StockNm>
        <EOYBookValueAmt>4691196</EOYBookValueAmt>
        <EOYFMVAmt>4691196</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NORTHERN TRUST CORP, 71,004 SHRS</StockNm>
        <EOYBookValueAmt>7463230</EOYBookValueAmt>
        <EOYFMVAmt>7463230</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>OMNICOM GROUP INC, 96,510 SHRS</StockNm>
        <EOYBookValueAmt>7156217</EOYBookValueAmt>
        <EOYFMVAmt>7156217</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PPG INDUSTRIES INC, 48,857 SHRS</StockNm>
        <EOYBookValueAmt>7341253</EOYBookValueAmt>
        <EOYFMVAmt>7341253</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PACCAR INC, 60,667 SHRS</StockNm>
        <EOYBookValueAmt>5637178</EOYBookValueAmt>
        <EOYFMVAmt>5637178</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PEPSICO INC, 37,711 SHRS</StockNm>
        <EOYBookValueAmt>5334221</EOYBookValueAmt>
        <EOYFMVAmt>5334221</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PROGRESSIVE CORP/THE, 73,335 SHRS</StockNm>
        <EOYBookValueAmt>7011559</EOYBookValueAmt>
        <EOYFMVAmt>7011559</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>QUEST DIAGNOSTICS INC, 86,162 SHRS</StockNm>
        <EOYBookValueAmt>11058031</EOYBookValueAmt>
        <EOYFMVAmt>11058031</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCHLUMBERGER LTD, 153,380 SHRS</StockNm>
        <EOYBookValueAmt>4170402</EOYBookValueAmt>
        <EOYFMVAmt>4170402</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CHARLES SCHWAB CORP/THE, 163,540 SHRS</StockNm>
        <EOYBookValueAmt>10659537</EOYBookValueAmt>
        <EOYFMVAmt>10659537</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SMITH &amp; NEPHEW PLC, 173,236 SHRS</StockNm>
        <EOYBookValueAmt>6565644</EOYBookValueAmt>
        <EOYFMVAmt>6565644</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SONY GROUP CORP, 110,154 SHRS</StockNm>
        <EOYBookValueAmt>11677426</EOYBookValueAmt>
        <EOYFMVAmt>11677426</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>TJX COS INC/THE, 94,527 SHRS</StockNm>
        <EOYBookValueAmt>6252961</EOYBookValueAmt>
        <EOYFMVAmt>6252961</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>UNILEVER PLC, 168,500 SHRS</StockNm>
        <EOYBookValueAmt>9407355</EOYBookValueAmt>
        <EOYFMVAmt>9407355</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>UNITEDHEALTH GROUP INC, 25,635 SHRS</StockNm>
        <EOYBookValueAmt>9538014</EOYBookValueAmt>
        <EOYFMVAmt>9538014</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ARCH CAPITAL GROUP LTD, 81,778 SHRS</StockNm>
        <EOYBookValueAmt>3137822</EOYBookValueAmt>
        <EOYFMVAmt>3137822</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EATON CORP PLC, 61,498 SHRS</StockNm>
        <EOYBookValueAmt>8503943</EOYBookValueAmt>
        <EOYFMVAmt>8503943</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CHUBB LTD, 41,766 SHRS</StockNm>
        <EOYBookValueAmt>6597775</EOYBookValueAmt>
        <EOYFMVAmt>6597775</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>WOLTERS KLUWER NV, 27,579 SHRS</StockNm>
        <EOYBookValueAmt>2402496</EOYBookValueAmt>
        <EOYFMVAmt>2402496</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>KIRIN HOLDINGS CO LTD, 81,630 SHRS</StockNm>
        <EOYBookValueAmt>1566483</EOYBookValueAmt>
        <EOYFMVAmt>1566483</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NINTENDO CO LTD, 18,500 SHRS</StockNm>
        <EOYBookValueAmt>10348281</EOYBookValueAmt>
        <EOYFMVAmt>10348281</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>TGS NOPEC GEOPHYSICAL CO ASA, 169,383 SHRS</StockNm>
        <EOYBookValueAmt>2703548</EOYBookValueAmt>
        <EOYFMVAmt>2703548</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BRITISH AMERICAN TOBACCO PLC, 313,043 SHRS</StockNm>
        <EOYBookValueAmt>11981057</EOYBookValueAmt>
        <EOYFMVAmt>11981057</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>RECKITT BENCKISER GROUP PLC, 96,006 SHRS</StockNm>
        <EOYBookValueAmt>8607217</EOYBookValueAmt>
        <EOYFMVAmt>8607217</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>INFORMA PLC, 692,085 SHRS</StockNm>
        <EOYBookValueAmt>5345360</EOYBookValueAmt>
        <EOYFMVAmt>5345360</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NOVARTIS AG, 108,613 SHRS</StockNm>
        <EOYBookValueAmt>9321226</EOYBookValueAmt>
        <EOYFMVAmt>9321226</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NESTLE SA, 78,886 SHRS</StockNm>
        <EOYBookValueAmt>8829465</EOYBookValueAmt>
        <EOYFMVAmt>8829465</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CIE FINANCIERE RICHEMONT SA, 95,405 SHRS</StockNm>
        <EOYBookValueAmt>9198374</EOYBookValueAmt>
        <EOYFMVAmt>9198374</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALCON INC, 99,067 SHRS</StockNm>
        <EOYBookValueAmt>6966216</EOYBookValueAmt>
        <EOYFMVAmt>6966216</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>RICHEMONT(CIE FIN) WTS, 201,014 SHRS</StockNm>
        <EOYBookValueAmt>76890</EOYBookValueAmt>
        <EOYFMVAmt>76890</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALPHABET INC-CL A, 3,015 SHRS</StockNm>
        <EOYBookValueAmt>6218498</EOYBookValueAmt>
        <EOYFMVAmt>6218498</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALTRIA GROUP INC, 117,949 SHRS</StockNm>
        <EOYBookValueAmt>6034271</EOYBookValueAmt>
        <EOYFMVAmt>6034271</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>APPLE INC, 31,069 SHRS</StockNm>
        <EOYBookValueAmt>3795078</EOYBookValueAmt>
        <EOYFMVAmt>3795078</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AUTODESK INC, 3,463 SHRS</StockNm>
        <EOYBookValueAmt>959770</EOYBookValueAmt>
        <EOYFMVAmt>959770</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BOOKING HOLDINGS INC, 3,495 SHRS</StockNm>
        <EOYBookValueAmt>8142791</EOYBookValueAmt>
        <EOYFMVAmt>8142791</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BRISTOL-MYERS SQUIBB CO, 120,910 SHRS</StockNm>
        <EOYBookValueAmt>7633048</EOYBookValueAmt>
        <EOYFMVAmt>7633048</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CME GROUP INC, 24,028 SHRS</StockNm>
        <EOYBookValueAmt>4907238</EOYBookValueAmt>
        <EOYFMVAmt>4907238</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CORTEVA INC, 224,902 SHRS</StockNm>
        <EOYBookValueAmt>10484931</EOYBookValueAmt>
        <EOYFMVAmt>10484931</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EBAY INC, 96,906 SHRS</StockNm>
        <EOYBookValueAmt>5934523</EOYBookValueAmt>
        <EOYFMVAmt>5934523</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ELECTRONIC ARTS INC, 43,069 SHRS</StockNm>
        <EOYBookValueAmt>5830251</EOYBookValueAmt>
        <EOYFMVAmt>5830251</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>FOX CORP, 292,592 SHRS</StockNm>
        <EOYBookValueAmt>10565497</EOYBookValueAmt>
        <EOYFMVAmt>10565497</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>JOHNSON &amp; JOHNSON, 40,264 SHRS</StockNm>
        <EOYBookValueAmt>6617388</EOYBookValueAmt>
        <EOYFMVAmt>6617388</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MICROSOFT CORP, 29,790 SHRS</StockNm>
        <EOYBookValueAmt>7023588</EOYBookValueAmt>
        <EOYFMVAmt>7023588</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NEWS CORP, 340,037 SHRS</StockNm>
        <EOYBookValueAmt>8647141</EOYBookValueAmt>
        <EOYFMVAmt>8647141</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NEWS CORP, 116,381 SHRS</StockNm>
        <EOYBookValueAmt>2730298</EOYBookValueAmt>
        <EOYFMVAmt>2730298</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ORACLE CORP, 132,057 SHRS</StockNm>
        <EOYBookValueAmt>9266440</EOYBookValueAmt>
        <EOYFMVAmt>9266440</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PHILIP MORRIS INTERNATIONAL IN, 154,522 SHRS</StockNm>
        <EOYBookValueAmt>13712282</EOYBookValueAmt>
        <EOYFMVAmt>13712282</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>S&amp;P GLOBAL INC, 16,109 SHRS</StockNm>
        <EOYBookValueAmt>5684383</EOYBookValueAmt>
        <EOYFMVAmt>5684383</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>WESTERN UNION CO/THE, 236,469 SHRS</StockNm>
        <EOYBookValueAmt>5831326</EOYBookValueAmt>
        <EOYFMVAmt>5831326</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AON PLC, 38,824 SHRS</StockNm>
        <EOYBookValueAmt>8933791</EOYBookValueAmt>
        <EOYFMVAmt>8933791</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ACCENTURE PLC, 927 SHRS</StockNm>
        <EOYBookValueAmt>256084</EOYBookValueAmt>
        <EOYFMVAmt>256084</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ACCENTURE PLC, 17,748 SHRS</StockNm>
        <EOYBookValueAmt>4902885</EOYBookValueAmt>
        <EOYFMVAmt>4902885</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AFFIRM HOLDINGS INC, 13,462 SHRS</StockNm>
        <EOYBookValueAmt>952033</EOYBookValueAmt>
        <EOYFMVAmt>952033</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BERKELEY LIGHTS INC, 11,200 SHRS</StockNm>
        <EOYBookValueAmt>562576</EOYBookValueAmt>
        <EOYFMVAmt>562576</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CROWDSTRIKE HOLDINGS INC, 7,112 SHRS</StockNm>
        <EOYBookValueAmt>1298011</EOYBookValueAmt>
        <EOYFMVAmt>1298011</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DADA NEXUS LTD, 20,224 SHRS</StockNm>
        <EOYBookValueAmt>548879</EOYBookValueAmt>
        <EOYFMVAmt>548879</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EVENTBRITE INC, 1,045 SHRS</StockNm>
        <EOYBookValueAmt>23157</EOYBookValueAmt>
        <EOYFMVAmt>23157</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>FACEBOOK INC, 30,000 SHRS</StockNm>
        <EOYBookValueAmt>8835900</EOYBookValueAmt>
        <EOYFMVAmt>8835900</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>GUARDANT HEALTH INC, 16,000 SHRS</StockNm>
        <EOYBookValueAmt>2442400</EOYBookValueAmt>
        <EOYFMVAmt>2442400</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PAGERDUTY INC, 45,000 SHRS</StockNm>
        <EOYBookValueAmt>1810350</EOYBookValueAmt>
        <EOYFMVAmt>1810350</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PINDUODUO INC, 25,639 SHRS</StockNm>
        <EOYBookValueAmt>3432549</EOYBookValueAmt>
        <EOYFMVAmt>3432549</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>TWILIO INC, 12,855 SHRS</StockNm>
        <EOYBookValueAmt>4380470</EOYBookValueAmt>
        <EOYFMVAmt>4380470</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ZAI LAB LTD, 705 SHRS</StockNm>
        <EOYBookValueAmt>94068</EOYBookValueAmt>
        <EOYFMVAmt>94068</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ZOOM VIDEO COMMUNICATIONS INC, 17,000 SHRS</StockNm>
        <EOYBookValueAmt>5461930</EOYBookValueAmt>
        <EOYFMVAmt>5461930</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>HARBOUR ENERGY PLC, 66,456,562 SHRS</StockNm>
        <EOYBookValueAmt>22187595</EOYBookValueAmt>
        <EOYFMVAmt>22187595</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <InvestmentsOtherSchedule2 documentId="RetDoc2018100001">
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>JP MORGAN US LARGE CAP CORE PLUS</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>140851791</BookValueAmt>
        <EOYFMVAmt>140851791</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SPDR S&amp;P 500 ETF TRUST</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>138061159</BookValueAmt>
        <EOYFMVAmt>138061159</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ISHARES IWM 2000 ETF</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>30931600</BookValueAmt>
        <EOYFMVAmt>30931600</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>JPM CORE BOND OPEN</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>765890331</BookValueAmt>
        <EOYFMVAmt>765890331</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>JPM SHORT DURATION BOND</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>401851612</BookValueAmt>
        <EOYFMVAmt>401851612</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>CHATHAM</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>102834462</BookValueAmt>
        <EOYFMVAmt>102834462</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>CHATHAM CO INVEST</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>110001921</BookValueAmt>
        <EOYFMVAmt>110001921</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>CHATHAM OFFSHORE</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>102071514</BookValueAmt>
        <EOYFMVAmt>102071514</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GOLDENTREE OFFSHORE</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>7596072</BookValueAmt>
        <EOYFMVAmt>7596072</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>BRILLIANT PARTNERS</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>112924700</BookValueAmt>
        <EOYFMVAmt>112924700</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>CAMBER</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>134473402</BookValueAmt>
        <EOYFMVAmt>134473402</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>JERICHO</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>201183081</BookValueAmt>
        <EOYFMVAmt>201183081</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CAP GLOBAL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>245951296</BookValueAmt>
        <EOYFMVAmt>245951296</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACADIAN FRONTIER</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>132506219</BookValueAmt>
        <EOYFMVAmt>132506219</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIGHCLERE INTL SC</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>228237797</BookValueAmt>
        <EOYFMVAmt>228237797</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIGHCLERE INTL SMID</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>150869897</BookValueAmt>
        <EOYFMVAmt>150869897</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>LA CAPITAL GLOBAL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>146761836</BookValueAmt>
        <EOYFMVAmt>146761836</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>LACM WORLD SMALL CAP</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>154701686</BookValueAmt>
        <EOYFMVAmt>154701686</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>MARATHON GLOBAL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>193021973</BookValueAmt>
        <EOYFMVAmt>193021973</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SILCHESTER INTL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>171986305</BookValueAmt>
        <EOYFMVAmt>171986305</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>BLACKROCK US DEBT</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>254236635</BookValueAmt>
        <EOYFMVAmt>254236635</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>BAYVIEW</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>60085988</BookValueAmt>
        <EOYFMVAmt>60085988</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>EIG ENERGY FUND XVI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>44526252</BookValueAmt>
        <EOYFMVAmt>44526252</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>EIG ENERGY XV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>9552136</BookValueAmt>
        <EOYFMVAmt>9552136</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GSO CAP SOLUTION III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>3890163</BookValueAmt>
        <EOYFMVAmt>3890163</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GSO CAPITAL SOLS II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5163176</BookValueAmt>
        <EOYFMVAmt>5163176</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GSO CAPITAL SOLUTION</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>523997</BookValueAmt>
        <EOYFMVAmt>523997</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG BAYSIDE III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6992530</BookValueAmt>
        <EOYFMVAmt>6992530</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>NEWMARKET IIFC</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>39473731</BookValueAmt>
        <EOYFMVAmt>39473731</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>MHR INST PARTNERS IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>42110860</BookValueAmt>
        <EOYFMVAmt>42110860</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED ROYALTY II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6439129</BookValueAmt>
        <EOYFMVAmt>6439129</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>YORK DISTRESSED III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>50202399</BookValueAmt>
        <EOYFMVAmt>50202399</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>YORK DISTRESSED IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>21106650</BookValueAmt>
        <EOYFMVAmt>21106650</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>YORK EUROPEAN</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>7410263</BookValueAmt>
        <EOYFMVAmt>7410263</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>YORK EUROPEAN II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>36920861</BookValueAmt>
        <EOYFMVAmt>36920861</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL GROWTH IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>32148844</BookValueAmt>
        <EOYFMVAmt>32148844</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL GROWTH II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>18352221</BookValueAmt>
        <EOYFMVAmt>18352221</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL GROWTH III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>13355146</BookValueAmt>
        <EOYFMVAmt>13355146</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL GROWTH V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>19320982</BookValueAmt>
        <EOYFMVAmt>19320982</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL INDIA V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>7754976</BookValueAmt>
        <EOYFMVAmt>7754976</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL INDIA VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>1937082</BookValueAmt>
        <EOYFMVAmt>1937082</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL LEADERS</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>16685490</BookValueAmt>
        <EOYFMVAmt>16685490</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL LEADERS II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8640203</BookValueAmt>
        <EOYFMVAmt>8640203</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL LEADERS III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5250000</BookValueAmt>
        <EOYFMVAmt>5250000</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL XI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5858731</BookValueAmt>
        <EOYFMVAmt>5858731</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL XII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>14605764</BookValueAmt>
        <EOYFMVAmt>14605764</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL XIII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8445475</BookValueAmt>
        <EOYFMVAmt>8445475</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ACCEL XIV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5747632</BookValueAmt>
        <EOYFMVAmt>5747632</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH BIO FUND I</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6835880</BookValueAmt>
        <EOYFMVAmt>6835880</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH BIO FUND II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>14352251</BookValueAmt>
        <EOYFMVAmt>14352251</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH BIO III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>7156459</BookValueAmt>
        <EOYFMVAmt>7156459</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH FUND VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>1827451</BookValueAmt>
        <EOYFMVAmt>1827451</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>114014328</BookValueAmt>
        <EOYFMVAmt>114014328</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH III PARALLEL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>21961520</BookValueAmt>
        <EOYFMVAmt>21961520</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>47797715</BookValueAmt>
        <EOYFMVAmt>47797715</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH IV PARALLEL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>24904170</BookValueAmt>
        <EOYFMVAmt>24904170</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH LSV II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5931556</BookValueAmt>
        <EOYFMVAmt>5931556</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH LSV I</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>36856533</BookValueAmt>
        <EOYFMVAmt>36856533</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>36148070</BookValueAmt>
        <EOYFMVAmt>36148070</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH V PARALLEL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>24463033</BookValueAmt>
        <EOYFMVAmt>24463033</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>AH VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>9758026</BookValueAmt>
        <EOYFMVAmt>9758026</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ANGELENO INV III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>19147871</BookValueAmt>
        <EOYFMVAmt>19147871</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ARBORETUM III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>7133618</BookValueAmt>
        <EOYFMVAmt>7133618</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ARBORETUM IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>41444410</BookValueAmt>
        <EOYFMVAmt>41444410</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ARBORETUM V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8286433</BookValueAmt>
        <EOYFMVAmt>8286433</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>COLLER VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>11134043</BookValueAmt>
        <EOYFMVAmt>11134043</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>COLLER VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>49154616</BookValueAmt>
        <EOYFMVAmt>49154616</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>COLLER VIII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5575183</BookValueAmt>
        <EOYFMVAmt>5575183</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>CRESTVIEW ELO</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>4401708</BookValueAmt>
        <EOYFMVAmt>4401708</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>CRESTVIEW III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>36118568</BookValueAmt>
        <EOYFMVAmt>36118568</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>CRESTVIEW IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6008414</BookValueAmt>
        <EOYFMVAmt>6008414</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>EIG ENERGY XVII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6331529</BookValueAmt>
        <EOYFMVAmt>6331529</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>EMERGENCE III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>183724669</BookValueAmt>
        <EOYFMVAmt>183724669</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>EMERGENCE IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>43731074</BookValueAmt>
        <EOYFMVAmt>43731074</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>EMERGENCE V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>15463340</BookValueAmt>
        <EOYFMVAmt>15463340</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>EPIRIS II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>11431037</BookValueAmt>
        <EOYFMVAmt>11431037</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>FORTISSIMO IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>22278236</BookValueAmt>
        <EOYFMVAmt>22278236</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>FORTISSIMO V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6055392</BookValueAmt>
        <EOYFMVAmt>6055392</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>FRAZIER IX</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>15293850</BookValueAmt>
        <EOYFMVAmt>15293850</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>FRAZIER X</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6362671</BookValueAmt>
        <EOYFMVAmt>6362671</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GAVEA IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>1219040</BookValueAmt>
        <EOYFMVAmt>1219040</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GAVEA V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>9074015</BookValueAmt>
        <EOYFMVAmt>9074015</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GAVEA V PLUS</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>2684545</BookValueAmt>
        <EOYFMVAmt>2684545</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GENERL ATLANTIC 2013</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>153945241</BookValueAmt>
        <EOYFMVAmt>153945241</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GENERL ATLANTIC 2018</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>116110607</BookValueAmt>
        <EOYFMVAmt>116110607</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>GOLDEN GATE OPPS</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>160389191</BookValueAmt>
        <EOYFMVAmt>160389191</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HARBOUR ENERGY</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>239895046</BookValueAmt>
        <EOYFMVAmt>239895046</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG BIOVENTURE II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>24426677</BookValueAmt>
        <EOYFMVAmt>24426677</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG BRAZIL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>2465370</BookValueAmt>
        <EOYFMVAmt>2465370</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG BRAZIL LATAM B</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>14194425</BookValueAmt>
        <EOYFMVAmt>14194425</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG BRAZIL LATAM C</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>14194425</BookValueAmt>
        <EOYFMVAmt>14194425</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG CAPITAL V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>22891464</BookValueAmt>
        <EOYFMVAmt>22891464</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG GROWTH B&amp;E F II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>35123015</BookValueAmt>
        <EOYFMVAmt>35123015</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG GROWTH III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>309980</BookValueAmt>
        <EOYFMVAmt>309980</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG MID MARKET II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>25670652</BookValueAmt>
        <EOYFMVAmt>25670652</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>HIG MID MARKET III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>1075176</BookValueAmt>
        <EOYFMVAmt>1075176</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>IDG BREYER</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>3686325</BookValueAmt>
        <EOYFMVAmt>3686325</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>IDG CHINA CAP III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>27200980</BookValueAmt>
        <EOYFMVAmt>27200980</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>IDG CHINA VTR IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>52477861</BookValueAmt>
        <EOYFMVAmt>52477861</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>IDG CHINA VTR V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>33882535</BookValueAmt>
        <EOYFMVAmt>33882535</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>IDG-ACCEL CHINA CAP</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>25492117</BookValueAmt>
        <EOYFMVAmt>25492117</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>IDG-ACCEL CHINA GWTH</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>33296162</BookValueAmt>
        <EOYFMVAmt>33296162</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>IRON POINT IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8171260</BookValueAmt>
        <EOYFMVAmt>8171260</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>JPM PEG SECONDARY</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>3834371</BookValueAmt>
        <EOYFMVAmt>3834371</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>JPM PEG SECONDARY II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8510110</BookValueAmt>
        <EOYFMVAmt>8510110</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>JPM PEG SECONDRY III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5867437</BookValueAmt>
        <EOYFMVAmt>5867437</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>MHR LONGEVITY</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>106690796</BookValueAmt>
        <EOYFMVAmt>106690796</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED ASIA III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>40301917</BookValueAmt>
        <EOYFMVAmt>40301917</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED ASIA IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6209025</BookValueAmt>
        <EOYFMVAmt>6209025</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED ISRAEL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>16005532</BookValueAmt>
        <EOYFMVAmt>16005532</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED ISRAEL II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>15755161</BookValueAmt>
        <EOYFMVAmt>15755161</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED PI VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>29072926</BookValueAmt>
        <EOYFMVAmt>29072926</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED PI VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>25748598</BookValueAmt>
        <EOYFMVAmt>25748598</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>ORBIMED PI VIII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>4699554</BookValueAmt>
        <EOYFMVAmt>4699554</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PEP IV CORE</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>25663</BookValueAmt>
        <EOYFMVAmt>25663</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PEP IV SUPPL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>7600</BookValueAmt>
        <EOYFMVAmt>7600</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PEP VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>334007</BookValueAmt>
        <EOYFMVAmt>334007</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PITANGO GROWTH</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>51369380</BookValueAmt>
        <EOYFMVAmt>51369380</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PITANGO GROWTH II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8429629</BookValueAmt>
        <EOYFMVAmt>8429629</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PITANGO HEALTHTECH I</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5842372</BookValueAmt>
        <EOYFMVAmt>5842372</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PITANGO SPV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>17921947</BookValueAmt>
        <EOYFMVAmt>17921947</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PITANGO VI, LP</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>36981945</BookValueAmt>
        <EOYFMVAmt>36981945</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PITANGO VTR VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>29464153</BookValueAmt>
        <EOYFMVAmt>29464153</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>PITANGO VTR VIII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>2134513</BookValueAmt>
        <EOYFMVAmt>2134513</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>RIDGEWOOD III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>32328252</BookValueAmt>
        <EOYFMVAmt>32328252</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>RIDGEWOOD IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>2980307</BookValueAmt>
        <EOYFMVAmt>2980307</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>S CAPITAL</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>9720686</BookValueAmt>
        <EOYFMVAmt>9720686</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>S CAPITAL II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>1293043</BookValueAmt>
        <EOYFMVAmt>1293043</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CH GWTH VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>9545709</BookValueAmt>
        <EOYFMVAmt>9545709</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CH VTR VIII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>1653916</BookValueAmt>
        <EOYFMVAmt>1653916</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CHINA GR III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>75376727</BookValueAmt>
        <EOYFMVAmt>75376727</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CHINA GR IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>47763819</BookValueAmt>
        <EOYFMVAmt>47763819</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CHINA GRTH V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>25462970</BookValueAmt>
        <EOYFMVAmt>25462970</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CHINA VE VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8979219</BookValueAmt>
        <EOYFMVAmt>8979219</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CHINA VTR IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>14287495</BookValueAmt>
        <EOYFMVAmt>14287495</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CHINA VTR V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>12366393</BookValueAmt>
        <EOYFMVAmt>12366393</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA CHINA VTR VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>8068567</BookValueAmt>
        <EOYFMVAmt>8068567</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA GBL GRTH III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>98269819</BookValueAmt>
        <EOYFMVAmt>98269819</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA GG 3 CH ANX</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>3070900</BookValueAmt>
        <EOYFMVAmt>3070900</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA GLB GROWTH</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>70356877</BookValueAmt>
        <EOYFMVAmt>70356877</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA GLB GRWTH II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>74424934</BookValueAmt>
        <EOYFMVAmt>74424934</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA IND GWTH III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>3984579</BookValueAmt>
        <EOYFMVAmt>3984579</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA IND VTR VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>455458</BookValueAmt>
        <EOYFMVAmt>455458</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA INDIA V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>10520828</BookValueAmt>
        <EOYFMVAmt>10520828</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA INDIA VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>5817966</BookValueAmt>
        <EOYFMVAmt>5817966</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA ISRAEL V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>4106892</BookValueAmt>
        <EOYFMVAmt>4106892</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA SCOUT III</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>1125849</BookValueAmt>
        <EOYFMVAmt>1125849</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA SCOUT IV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>28742</BookValueAmt>
        <EOYFMVAmt>28742</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US GROWTH V</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>7753589</BookValueAmt>
        <EOYFMVAmt>7753589</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US GRTH VIII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>9694842</BookValueAmt>
        <EOYFMVAmt>9694842</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US GRWTH VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>16257289</BookValueAmt>
        <EOYFMVAmt>16257289</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US GWTH IX</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>2010514</BookValueAmt>
        <EOYFMVAmt>2010514</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US GWTH VI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>15055099</BookValueAmt>
        <EOYFMVAmt>15055099</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US VENT XVI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>3201607</BookValueAmt>
        <EOYFMVAmt>3201607</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US VTR XIV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>29553439</BookValueAmt>
        <EOYFMVAmt>29553439</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US VTR XV</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>6321413</BookValueAmt>
        <EOYFMVAmt>6321413</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SEQUOIA US VTR XVII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>552099</BookValueAmt>
        <EOYFMVAmt>552099</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>SQUOIA GG 3 US IN AX</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>2082336</BookValueAmt>
        <EOYFMVAmt>2082336</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>STARWOOD X</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>32785123</BookValueAmt>
        <EOYFMVAmt>32785123</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>STARWOOD XI</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>24577785</BookValueAmt>
        <EOYFMVAmt>24577785</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>TAURUS RESOURCES II</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>23239496</BookValueAmt>
        <EOYFMVAmt>23239496</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>WTI VLL IX</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>10393562</BookValueAmt>
        <EOYFMVAmt>10393562</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>WTI VLL VII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>13533200</BookValueAmt>
        <EOYFMVAmt>13533200</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>WTI VLL VIII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>22087730</BookValueAmt>
        <EOYFMVAmt>22087730</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>YORK CO INVEST 1</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>FMV</ListedAtCostOrFMVCd>
        <BookValueAmt>3625218</BookValueAmt>
        <EOYFMVAmt>3625218</EOYFMVAmt>
      </InvestmentsOtherGrp>
    </InvestmentsOtherSchedule2>
    <LandEtcSchedule2 documentId="RetDoc2059000001">
      <LandEtcGrp>
        <CategoryOrItemTxt>FURNITURE, FIXTURES AND EQUIPMENT</CategoryOrItemTxt>
        <CostOrOtherBasisAmt>1359502</CostOrOtherBasisAmt>
        <AccumulatedDepreciationAmt>1356254</AccumulatedDepreciationAmt>
        <BookValueAmt>3248</BookValueAmt>
        <EOYFMVAmt>3248</EOYFMVAmt>
      </LandEtcGrp>
      <LandEtcGrp>
        <CategoryOrItemTxt>LEASEHOLD IMPROVEMENTS</CategoryOrItemTxt>
        <CostOrOtherBasisAmt>1426808</CostOrOtherBasisAmt>
        <AccumulatedDepreciationAmt>569115</AccumulatedDepreciationAmt>
        <BookValueAmt>857693</BookValueAmt>
        <EOYFMVAmt>857693</EOYFMVAmt>
      </LandEtcGrp>
      <LandEtcGrp>
        <CategoryOrItemTxt>WORK IN PROGRESS</CategoryOrItemTxt>
        <CostOrOtherBasisAmt>1896001</CostOrOtherBasisAmt>
        <AccumulatedDepreciationAmt>0</AccumulatedDepreciationAmt>
        <BookValueAmt>1896001</BookValueAmt>
        <EOYFMVAmt>1896001</EOYFMVAmt>
      </LandEtcGrp>
    </LandEtcSchedule2>
    <LegalFeesSchedule documentId="RetDoc2002100001">
      <LegalFeesGrp>
        <CategoryTxt>CURLEY, HURTGEN &amp; JOHNSRUD LLP</CategoryTxt>
        <LegalFeesAmt>0</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>2000</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>DAVIS WRIGHT TREMAINE LLP</CategoryTxt>
        <LegalFeesAmt>2370</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>2370</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>ERDINAST, BEN NATHAN, TOLEDANO &amp; CO., ADVOCATES</CategoryTxt>
        <LegalFeesAmt>53939</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>50868</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>HAROLD A. MERIAM III</CategoryTxt>
        <LegalFeesAmt>34564</LegalFeesAmt>
        <NetInvestmentIncomeAmt>34564</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>LOEB &amp; LOEB LLP</CategoryTxt>
        <LegalFeesAmt>43802</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>48804</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>PATTERSON BELKNAP WEBB &amp; TYLER LLP</CategoryTxt>
        <LegalFeesAmt>22541</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>51235</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>ROPES &amp; GRAY LLP</CategoryTxt>
        <LegalFeesAmt>99017</LegalFeesAmt>
        <NetInvestmentIncomeAmt>99017</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>WOODS, FULLER, SHULTZ &amp; SMITH P.C.</CategoryTxt>
        <LegalFeesAmt>6617</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>6617</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherAssetsSchedule documentId="RetDoc2046600001">
      <OtherAssetsScheduleGrp>
        <Desc>ACCRUED INCOME RECEIVABLE</Desc>
        <BOYBookValueAmt>2164139</BOYBookValueAmt>
        <EOYBookValueAmt>1758404</EOYBookValueAmt>
        <EOYFMVAmt>1758404</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>DUE FROM BROKER</Desc>
        <BOYBookValueAmt>61104240</BOYBookValueAmt>
        <EOYBookValueAmt>10708909</EOYBookValueAmt>
        <EOYFMVAmt>10708909</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>RETIREMENT PLAN ASSET</Desc>
        <BOYBookValueAmt>1107431</BOYBookValueAmt>
        <EOYBookValueAmt>1725098</EOYBookValueAmt>
        <EOYFMVAmt>1725098</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>ADVANCES AND OTHER RECEIVABLES</Desc>
        <BOYBookValueAmt>28748</BOYBookValueAmt>
        <EOYBookValueAmt>13</EOYBookValueAmt>
        <EOYFMVAmt>13</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>PREPAID FEDERAL EXCISE TAX</Desc>
        <BOYBookValueAmt>2785391</BOYBookValueAmt>
        <EOYBookValueAmt>9454455</EOYBookValueAmt>
        <EOYFMVAmt>9454455</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>PROGRAM RELATED INVESTMENTS, NET OF ALLOWANCE</Desc>
        <BOYBookValueAmt>12430200</BOYBookValueAmt>
        <EOYBookValueAmt>16614400</EOYBookValueAmt>
        <EOYFMVAmt>16614400</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>DEFERRED RENTAL INCOME</Desc>
        <BOYBookValueAmt>8721</BOYBookValueAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>ACCOUNTS RECEIVABLE OTHER - GRANT RECOVERY</Desc>
        <BOYBookValueAmt>19835</BOYBookValueAmt>
      </OtherAssetsScheduleGrp>
      <OtherAssetsScheduleGrp>
        <Desc>ACCRUED INTEREST RECEIVABLE - PRI DEBT</Desc>
        <BOYBookValueAmt>11655</BOYBookValueAmt>
      </OtherAssetsScheduleGrp>
    </OtherAssetsSchedule>
    <OtherDecreasesSchedule documentId="RetDoc2049800001">
      <OtherDecreasesDetail>
        <Desc>DEFERRED FEDERAL EXCISE TAX</Desc>
        <Amt>20502577</Amt>
      </OtherDecreasesDetail>
    </OtherDecreasesSchedule>
    <OtherExpensesSchedule documentId="RetDoc2003200001">
      <OtherExpensesScheduleGrp>
        <Desc>AMERICAN DEPOSITARY RECEIPT FEE</Desc>
        <RevenueAndExpensesPerBooksAmt>11621</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>11621</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>CONSULTING REIMBURSEMENTS</Desc>
        <RevenueAndExpensesPerBooksAmt>32336</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>137239</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>CUSTODY, BANK, &amp; PERFORMANCE REPORTING FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>726295</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>726253</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>42</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>FILING FEES AND PENALTIES</Desc>
        <RevenueAndExpensesPerBooksAmt>3809</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>1510</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>INFORMATION TECHNOLOGY/COMPUTERS</Desc>
        <RevenueAndExpensesPerBooksAmt>1269355</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>222032</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>951812</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>INSURANCE</Desc>
        <RevenueAndExpensesPerBooksAmt>256787</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>28997</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>261302</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>OFFICE EXPENSES</Desc>
        <RevenueAndExpensesPerBooksAmt>593952</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>292105</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>293169</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PORTFOLIO DEDUCTIONS</Desc>
        <RevenueAndExpensesPerBooksAmt>13008397</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>44291646</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PROVISION FOR POSSIBLE LOSSES - PRI DEBT</Desc>
        <RevenueAndExpensesPerBooksAmt>872300</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>TEMPORARY OFFICE HELP</Desc>
        <RevenueAndExpensesPerBooksAmt>0</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>9100</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="RetDoc2001500001">
      <OtherIncomeDetail>
        <Desc>FX TRANSACTION NET GAIN</Desc>
        <RevenueAndExpensesPerBooksAmt>933177</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>950943</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>933177</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>CLASS ACTION PROCEEDS, NET</Desc>
        <RevenueAndExpensesPerBooksAmt>53661</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>53661</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>53661</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>OTHER PARTNERSHIP INCOME</Desc>
        <RevenueAndExpensesPerBooksAmt>20842417</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>35976287</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>20842417</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>SECTION 951(A) INCOME INCLUSION</Desc>
        <NetInvestmentIncomeAmt>10535604</NetInvestmentIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>PRI LOAN INTEREST</Desc>
        <RevenueAndExpensesPerBooksAmt>8723</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>8723</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>8723</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>GRANT RECOVERIES</Desc>
        <RevenueAndExpensesPerBooksAmt>1880763</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>1880763</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>OTHER TAXABLE INCOME</Desc>
        <RevenueAndExpensesPerBooksAmt>1755953</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>1755953</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>1755953</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>RENTAL INCOME SUBTENANT</Desc>
        <RevenueAndExpensesPerBooksAmt>305476</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>305476</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>305476</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>FEDERAL EXCISE TAX BENEFIT</Desc>
        <RevenueAndExpensesPerBooksAmt>369064</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>369064</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>PRI LOAN INTEREST WRITE OFF</Desc>
        <RevenueAndExpensesPerBooksAmt>-20378</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>-20378</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>-20378</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherIncreasesSchedule documentId="RetDoc2049700001">
      <OtherIncreasesDetail>
        <Desc>UNREALIZED GAIN ON INVESTMENTS</Desc>
        <Amt>1989603066</Amt>
      </OtherIncreasesDetail>
    </OtherIncreasesSchedule>
    <OtherLiabilitiesSchedule documentId="RetDoc2065700001">
      <OtherLiabilitiesDetail>
        <Desc>DEFERRED FEDERAL EXCISE TAX</Desc>
        <BOYBookValueAmt>23452152</BOYBookValueAmt>
        <EOYBookValueAmt>43954729</EOYBookValueAmt>
      </OtherLiabilitiesDetail>
      <OtherLiabilitiesDetail>
        <Desc>RETIREMENT PLAN LIABILITY</Desc>
        <BOYBookValueAmt>1754039</BOYBookValueAmt>
        <EOYBookValueAmt>2389093</EOYBookValueAmt>
      </OtherLiabilitiesDetail>
      <OtherLiabilitiesDetail>
        <Desc>ACCRUED VACATION</Desc>
        <BOYBookValueAmt>612911</BOYBookValueAmt>
        <EOYBookValueAmt>934558</EOYBookValueAmt>
      </OtherLiabilitiesDetail>
      <OtherLiabilitiesDetail>
        <Desc>DEFERRED RENT EXPENSE</Desc>
        <BOYBookValueAmt>946933</BOYBookValueAmt>
        <EOYBookValueAmt>586204</EOYBookValueAmt>
      </OtherLiabilitiesDetail>
      <OtherLiabilitiesDetail>
        <Desc>REFUNDABLE DEPOSITS</Desc>
        <BOYBookValueAmt>317</BOYBookValueAmt>
        <EOYBookValueAmt>317</EOYBookValueAmt>
      </OtherLiabilitiesDetail>
      <OtherLiabilitiesDetail>
        <Desc>GRANT REFUNDS PENDING MODIFICATION</Desc>
        <BOYBookValueAmt>0</BOYBookValueAmt>
        <EOYBookValueAmt>1103455</EOYBookValueAmt>
      </OtherLiabilitiesDetail>
    </OtherLiabilitiesSchedule>
    <OtherProfessionalFeesSchedule documentId="RetDoc2002300001">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>ALLISON + PARTNERS LLC (PROGRAM CONSULTING)</CategoryTxt>
        <Amt>179164</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>171264</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>CECELIA HEALTH, INC. (PROGRAM CONSULTING)</CategoryTxt>
        <Amt>476306</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>452485</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>COLLER VI (INVESTMENT MANAGEMENT)</CategoryTxt>
        <Amt>577360</Amt>
        <NetInvestmentIncomeAmt>577360</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>COLLER VII (INVESTMENT MANAGEMENT)</CategoryTxt>
        <Amt>548497</Amt>
        <NetInvestmentIncomeAmt>548497</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>DF DENT &amp; COMPANY, INC. (INVESTMENT MANAGEMENT)</CategoryTxt>
        <Amt>880736</Amt>
        <NetInvestmentIncomeAmt>880736</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>FIDUCIARY MANAGEMENT, INC. (INVESTMENT MANAGEMENT)</CategoryTxt>
        <Amt>1001622</Amt>
        <NetInvestmentIncomeAmt>1001622</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>GAVEA INVESTMENT FUND V B L.P.</CategoryTxt>
        <Amt>494927</Amt>
        <NetInvestmentIncomeAmt>494927</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>GLOBAL HEALTH STRATEGIES (PROGRAM CONSULTING)</CategoryTxt>
        <Amt>348158</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>211026</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>GLOBAL STRATEGY GROUP LLC (PUBLIC RELATIONS)</CategoryTxt>
        <Amt>247500</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>220000</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>HIG BAYSIDE III (INVESTMENT MANAGEMENT)</CategoryTxt>
        <Amt>47862</Amt>
        <NetInvestmentIncomeAmt>47862</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>IFP GLOBAL EQUITY LP (INVESTMENT MANAGEMENT)</CategoryTxt>
        <Amt>1637020</Amt>
        <NetInvestmentIncomeAmt>1637020</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER CONSULTING FEES - GENERAL MANAGEMENT</CategoryTxt>
        <Amt>19150</Amt>
        <NetInvestmentIncomeAmt>978</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>20672</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER CONSULTING FEES - GRANTS MANAGEMENT</CategoryTxt>
        <Amt>123761</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>127631</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER CONSULTING FEES - HUMAN RESOURCES</CategoryTxt>
        <Amt>14491</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>14491</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER CONSULTING FEES - INFORMATION TECHNOLOGY</CategoryTxt>
        <Amt>31485</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>31898</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER INVESTMENT RELATED CONSULTING FEES</CategoryTxt>
        <Amt>10950</Amt>
        <NetInvestmentIncomeAmt>10950</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER PROGRAM RELATED CONSULTING FEES</CategoryTxt>
        <Amt>205280</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>191037</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER PUBLIC RELATIONS CONSULTING FEES</CategoryTxt>
        <Amt>82216</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>109884</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>OTHER RECRUITMENT FEES</CategoryTxt>
        <Amt>169476</Amt>
        <NetInvestmentIncomeAmt>5135</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>145929</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>SCOTT KAHN (PROGRAM CONSULTING)</CategoryTxt>
        <Amt>127050</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>130350</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>SOLUTION SIMPLE (INFORMATION TECHNOLOGY)</CategoryTxt>
        <Amt>249830</Amt>
        <NetInvestmentIncomeAmt>30786</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>229766</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>T. ROWE PRICE ASSOCIATES INC. (INVESTMENT MANAGEMENT)</CategoryTxt>
        <Amt>2865935</Amt>
        <NetInvestmentIncomeAmt>2865935</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>THE ADVERTISING COUNCIL (PROGRAM CONSULTING)</CategoryTxt>
        <Amt>150000</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>185000</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>WILSHIRE ASSOCIATES INCORPORATED (INVESTMENT ADVISORY)</CategoryTxt>
        <Amt>420610</Amt>
        <NetInvestmentIncomeAmt>420610</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="RetDoc2002500001">
      <TaxesDetail>
        <CategoryTxt>STATE UNRELATED BUSINESS INCOME TAX</CategoryTxt>
        <Amt>346305</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>FOREIGN TAXES WITHHELD</CategoryTxt>
        <Amt>281611</Amt>
        <NetInvestmentIncomeAmt>1892038</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>FEDERAL UBIT</CategoryTxt>
        <Amt>127000</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
    </TaxesSchedule>
    <TransfersFrmControlledEntities documentId="RetDoc2204900001">
      <TransfersFromControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>2929 ARCH STREET 17TH FLOOR</AddressLine1Txt>
          <CityNm>PHILADELPHIA</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>19104</ZIPCd>
        </USAddress>
        <EIN>981142649</EIN>
        <Desc>INCOME DISTRIBUTION</Desc>
        <Amt>712161</Amt>
      </TransfersFromControlledEntGrp>
      <TransfersFromControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MHR LONGEVITY PARTNERS</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>1345 AVENUE OF THE AMERICAS 42ND</AddressLine1Txt>
          <AddressLine2Txt>FLOOR</AddressLine2Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10105</ZIPCd>
        </USAddress>
        <EIN>981471155</EIN>
        <Desc>$12,839,741 RETURN OF CAPITAL; $1,922,746 INCOME DISTRIBUTION</Desc>
        <Amt>39900000</Amt>
      </TransfersFromControlledEntGrp>
      <TransfersFromControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ACADIAN FRONTIER MARKETS EQUITY FUND</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>260 FRANKLIN STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02110</ZIPCd>
        </USAddress>
        <EIN>205852756</EIN>
        <Desc>RETURN OF CAPITAL</Desc>
        <Amt>1268075</Amt>
      </TransfersFromControlledEntGrp>
      <TotalAmt>20191427</TotalAmt>
    </TransfersFrmControlledEntities>
    <TransfersToControlledEntities documentId="RetDoc2205000001">
      <TransfersToControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>2929 ARCH STREET 17TH FLOOR</AddressLine1Txt>
          <CityNm>PHILADELPHIA</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>19104</ZIPCd>
        </USAddress>
        <EIN>981142649</EIN>
        <Desc>CONTRIBUTION OF CAPITAL</Desc>
        <Amt>712161</Amt>
      </TransfersToControlledEntGrp>
      <TransfersToControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>MHR LONGEVITY PARTNERS</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>1345 AVENUE OF THE AMERICAS 42ND</AddressLine1Txt>
          <AddressLine2Txt>FLOOR</AddressLine2Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10105</ZIPCd>
        </USAddress>
        <EIN>981471155</EIN>
        <Desc>CONTRIBUTION OF CAPITAL</Desc>
        <Amt>39900000</Amt>
      </TransfersToControlledEntGrp>
      <TransfersToControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>PITANGO SPV</BusinessNameLine1Txt>
        </BusinessName>
        <ForeignAddress>
          <AddressLine1Txt>BEIT ACKERSHTEIN - BLDG B 11</AddressLine1Txt>
          <AddressLine2Txt>HAMENOFIM ST 11TH FL</AddressLine2Txt>
          <CityNm>HERZLIYA</CityNm>
          <CountryCd>IS</CountryCd>
        </ForeignAddress>
        <EIN>981492234</EIN>
        <Desc>CONTRIBUTION OF CAPITAL</Desc>
        <Amt>10650000</Amt>
      </TransfersToControlledEntGrp>
      <TransfersToControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>CHATHAM CO-INVEST</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>26 MAIN STREET SUITE 204</AddressLine1Txt>
          <CityNm>CHATHAM</CityNm>
          <StateAbbreviationCd>NJ</StateAbbreviationCd>
          <ZIPCd>07928</ZIPCd>
        </USAddress>
        <EIN>850651355</EIN>
        <Desc>CONTRIBUTION OF CAPITAL</Desc>
        <Amt>75000000</Amt>
      </TransfersToControlledEntGrp>
      <TransfersToControlledEntGrp>
        <BusinessName>
          <BusinessNameLine1Txt>ACADIAN FRONTIER MARKETS EQUITY FUND</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>260 FRANKLIN STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02110</ZIPCd>
        </USAddress>
        <EIN>205852756</EIN>
        <Desc>MANAGEMENT FEES</Desc>
        <Amt>1268075</Amt>
      </TransfersToControlledEntGrp>
      <TotalAmt>127530236</TotalAmt>
    </TransfersToControlledEntities>
  </ReturnData>
</Return>
